Tag: chronic

41 PALLETS 3129 CARTONS PH ARMACEUTICALS AS UNDER CARV EDILOL TAB 12.5MG 100 NDC COD E:68462016401 FDA PRODUCT COD E NO :62 O C A 22 HTS NO.300 4.90.9221 ANDA NO.78-251 THE RAPEUTICE USE:-BETA- ADRENOA MNBU0552050 001 CEPTOR ANTAGONIST TELMISAR TAN-HCTZ TAB 80MG/25MG 30UD N DC CODE:68462084213 62 O D A 09 3004.90.92.20 202544 TEL MISARTAN AND HYDROCHLOROTHIAZ IDE TABLETS ARE INDICATED FOR THE TREATMENT OF HYPERTENS ION, TO LOWER BLOOD PRESSURE. MNBU0552050 001 TOPIRAMATE ER CAP (Q) 200M G 30 NDC CODE:68462037130 30 04.49.00.20 61 M C B 40 2102 78 COLESEVELAM HCL TAB 625M G 180 NDC CODE:68462043318 F DA PRODUCT CODE NO.: 62 B D A 13 H. T. S NO.: 3004.49.00. 10 ANDA NO.: 203480 THERAPEU MNBU0552050 001 TICE USE: - ANTIHYPERLIPO PR OTEINEMIC. TELMISARTAN-HCTZ TAB 80MG/12.5MG 30UD NDC COD E:68462084113 62 O D A 09 30 04.90.92.20 202544 TELMISART AN AND HYDROCHLOROTHIAZIDE T ABLETS ARE INDICATED FOR THE TREATMENT OF HYPERTENSION, T MNBU0552050 001 O LOWER BLOOD PRESSURE. CA RVEDILOL TAB 12.5MG 500 NDC C ODE:68462016405 FDA PRODUCT C ODE NO :62 O C A 22 HTS NO.3 004.90.9221 ANDA NO.78-251 T HERAPEUTICE USE:-BETA- ADREN OACEPTOR ANTAGONIST SEVELA MER HCL TAB 800MG 180 NDC COD MNBU0552050 001 E:68462044718 FDA PRODUCT COD E NO.: 63 L D A 04 H. T. S N O.: 3004.90.92.60 ANDA NO.:2 04724 THERAPEUTICE USE:SEVEL AMER HYDROCHLORIDE TABLETS A RE A PHOSPHATE BINDER INDICAT ED FOR THE CONTROL OF SERUM P HOSPHORUS IN PATIENTS WITH CH MNBU0552050 001 RONIC KIDNEY DISEASE ON DIAL YSIS DILTIAZEM HCL ER CAP 1 2HR 90MG 100 NDC CODE:6846208 5101 62 O C B 24 3004.49.00. 10 212317 FOR THE TREATMENT OF HYPERTENSION. TACROLIMU S OINT 0.1% 60GM NDC CODE:684 62053465 FDA PRODUCT CODE NO. MNBU0552050 001 : 64 T C J 08 H. T. S NO.: 3004.49.00.50 ANDA NO.: 21039 3 THERAPEUTICE USE: - TACROL IMUS IS A TOPICAL IMMUNOSUPPR ESSIVE OINTMENT USED FOR THE TREATMENT OF MODERATE-TO-SEV ERE ATOPIC DERMATITIS (ECZEM A). PIMECROLIMUS CREAM 1% 6 MNBU0552050 001 0GM NDC CODE:68462060965 FDA PRODUCT CODE NO.: 61 S C J 0 4 H. T. S NO.: 3004.90.92.45 ANDA NO.: 211769 THERAPEUTI CE USE: - AS SECOUND-LINE THE RAPY FOR THE SHORT-TERM AND NON-CONTINUOS CHRONIC TRERTME NT OF MILD TO MODERATE ATOPIC MNBU0552050 001 DERMATITIS IN NONIMMUNOCOMP ROMISED ADULT AND CHILDREN 2 YEARS OF AGE SIROLIMUS TAB 1MG 100 NDC CODE:68462068301 FDA PRODUCT CODE NO.: 64 T C A 12 H. T. S NO.: 3004.90. 92.15 ANDA NO.: 208691 THERA PEUTICE USE: TO PREVENT REJEC MNBU0552050 001 TION OF KIDNEY TRANSPLANTS. PIMECROLIMUS CREAM 1% 30GM NDC CODE:68462060935 FDA PROD UCT CODE NO.: 61 S C J 04 H. T. S NO.: 3004.90.92.45 AND A NO.: 211769 THERAPEUTICE US E: - AS SECOUND-LINE THERAPY FOR THE SHORT-TERM AND NON-C MNBU0552050 001 ONTINUOS CHRONIC TRERTMENT OF MILD TO MODERATE ATOPIC DER MATITIS IN NONIMMUNOCOMPROMIS ED ADULT AND CHILDREN 2 YEAR S OF AGE COMMERCIAL & CUSTO M INVOICE NO. F22587000467 DT . 19.06.2024 F22587000468 DT. 19.06.2024 F22587000469 DT. MNBU0552050 001 19.06.2024 F22587000470 DT. 1 9.06.2024 F22587000471 DT. 19 .06.2024 S/BILL NO: 4010175 D T:20/06/2024 S/BILL NO: 40101 73 DT:20/06/2024 S/BILL NO: 4 010169 DT:20/06/2024 S/BILL N O: 4010170 DT:20/06/2024 S/BI LL NO: 4010172 DT:20/06/2024 MNBU0552050 001 NET WT. 6362.223 KGS 02 DATA LOGGERS HUMIDITY:65% SET TE MPERATURE : +18 DEGREES TEMPE RATURE RANGE : +15 DEGREES TO +25 DEGREES NOTIFY PARTY:2 G LENMARK PHARMACEUTICALS INC 7 50, CORPORATE DRIVE, NEW JERS EY MAHWAH - 07430 USA

46 PALLETS 3201 CARTONS PH ARMACEUTICALS AS UNDER ROPI NIROLE TAB 0.5MG 100 NDC CODE :68462025401 FDA PRODUCT CODE NO.:-62 J C A 17 H. T. S NO .: 3004.90.92.40 ANDA NO.:- 90-135 THERAPEUTICE USE:-TRE MCAU6028329 001 ATMENT OF PARKINSONISM TOP IRAMATE TAB 25MG 60 NDC CODE: 68462010860 FDA PRODUCT CODE NO.:-61 M C A 40 H. T. S NO. : 3004.49.00.20 ANDA NO.:- 7 7-627 THERAPEUTICE USE:-ANTI CONVULSANT ROPINIROLE TAB 1 MG 100 NDC CODE:68462025501 MCAU6028329 001 FDA PRODUCT CODE NO.:-62 J C A 17 H. T. S NO.: 3004.90.92 .40 ANDA NO.:- 90-135 THERAP EUTICE USE:-TREATMENT OF PAR KINSONISM LEVOCETIRIZINE DI HY TAB 5MG 90 NDC CODE:684620 34690 FDA PRODUCT CODE NO.: 61 X C A 51 H. T. S NO.: 300 MCAU6028329 001 4.90.91.80 ANDA NO.:90385 TH ERAPEUTICE USE: TREATMENT OF CHRONIC IDIOPATHIC URTICARIA OMEPRAZOLE DR CAP 20MG 1000 NDC CODE:68462039610 FDA PR ODUCT CODE NO.:62KCF10 HTS N O.3004.90.9255 ANDA NO.:91672 THERAPEUTICE USE: -TREATMEN MCAU6028329 001 T OF TREAT GASTROESOPHAGEAL R EFLUX DISEASE LITHIUM CARB CAP 600MG 100 NDC CODE:68462 022201 FDA PRODUCT CODE NO.: -61 N C E 37 H. T. S NO.: 30 04.49.00.20 ANDA NO.:- 79 -13 9 THERAPEUTICE USE:-ANTIMANI C AGENT VERAPAMIL HCL ER TA MCAU6028329 001 B 180MG 100 NDC CODE:68462029 301 NDC NO.: 68462029301 FDA PRODUCT CODE NO.: 62 O C B 1 3 HTS NO.3004.90.9221 ANDA N O.: 090700 THERAPEUTICE USE: --ANGINA VERAPAMIL HCL ER TAB 180MG 500 NDC CODE:684620 29305 NDC NO.: 68462029305 F MCAU6028329 001 DA PRODUCT CODE NO.: 62 O C B 13 HTS NO.3004.90.9221 ANDA NO.: 090700 THERAPEUTICE USE : --ANGINA MUPIROCIN OINT 2% 22GM NDC CODE:68462018022 FDA PRODUCT CODE NO.: 61 G J J 81 H. T. S NO.: 3004.90.9 2.45 ANDA NO.: 90-480 THERAP MCAU6028329 001 EUTICE USE: - ANTI-BACTERIAL COMMERCIAL & CUSTOM INVOICE NO. F22552001086 DT. 05.06.2 024 F22552001085 DT. 05.06.20 24 F22552001087 DT. 05.06.202 4 F22552001082 DT. 05.06.2024 S/BILL NO: 1480014 DT 06-JUN -2024 S/BILL NO: 1479656 DT 0 MCAU6028329 001 6-JUN-2024 S/BILL NO: 1479659 DT 06-JUN-2024 S/BILL NO: 14 79664 DT 06-JUN-2024 NET WT. 8552.560 KGS 02 DATA LOGGERS HUMIDITY:65% SET TEMPERATURE : +18 DEGREES TEMPERATURE RA NGE : +15 DEGREES TO +25 DEGRE ES NOTIFY PARTY:2 GLENMARK P MCAU6028329 001 HARMACEUTICALS INC 750, CORPO RATE DRIVE, NEW JERSEY MAHWA H - 07430 USA

PHARMACEUTICALS AS UNDER GABAPENTIN TAB 80 0MG 500 NDC CODE:68462012705 FDA PRODUCT C ODE:NO : 61 N C A 69 HTS NO.3004.90.9236 AN DA NO.:-77-662 THERAPEUTICE USE:-ANTICONVUL SANT OXCARBAZEPINE TAB 150MG 100 NDC CODE :68462013701 FDA PRODUCT CODE NO.:-61 M C A 45 HTS NO.3004.90.9236 ANDA NO.:-77-802 T HLBU9905170 001 HERAPEUTICE USE:-ANTI CONVULSANT AGENT LE VOCETIRIZINE DIHY TAB 5MG 90 NDC CODE:684620 34690 FDA PRODUCT CODE NO.: 61 X C A 51 H. T. S NO.: 3004.90.91.80 ANDA NO.:90385 TH ERAPEUTICE USE: TREATMENT OF CHRONIC IDIOPA THIC URTICARIA NAPROXEN TAB 500MG 500 NDC CODE:68462019005 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.90.92.40 ANDA N HLBU9905170 001 O.:-78-250 THERAPEUTICE USE:-ANTI-INFLAMMAT ORY, ANALGESIC CLOTRIMAZOLE CREAM 1% 15GM NDC CODE:68462018117 FDA PRODUCT CODE NO :61 W C J 04 HTS NO.3004.90.9240 ANDA NO.90 -219 THERAPEUTICE USE:-TREATMENT OF CANDID IASIS NORGEST/EE TAB 0.25/0.035MG 84 NDC CODE:68462030929 FDA PRODUCT CODE NO.: 65 J D A 27 H. T. S NO.: 3006.60.00.00 ANDA NO HLBU9905170 001 .: 200538 THERAPEUTICE USE: - ORAL CONTRACE PTIVES NORETHINDRONE ACE TAB 5MG 50 NDC C ODE:68462030450 FDA PRODUCT CODE NO.65 J C A 25 H. T. S NO.: 3004.39.00.50 ANDA NO.:- 91-090 THERAPEUTICE USE:- SECONDARY AMENOR RHEA,ENDOMETRIOS IS AND ABNORMAL UTERINE BL EEDING 03 DATA LOGGERS HUMIDITY:65 % SET TEMPERATURE : +20 DEGREES TEMPERATURE HLBU9905170 001 RANGE : +15 DEGREES TO +25 DEGREES CONTAINE R NO. HLBU9905170 COMMERCIAL & CUSTOM INVOICE NO. F22552000141 DT. 12.04.2024 F2 2552000143 DT. 12.04.2024 F22552000144 DT. 1 2.04.2024 F22552000142 DT. 12.04.2024 F2255 2000140 DT. 12.04.2024 F22552000145 DT. 12.0 4.2024

42 PALLETS 2227 CARTONS PH ARMACEUTICALS AS UNDER RANO LAZINE ER TAB 500MG 60 NDC CO DE:68462031960 FDA PRODUCT CO DE NO.: 61 D C B 02 H. T. S NO.: 3004.49.00.10 ANDA NO.: 211082 THERAPEUTIC USE: - IT MNBU3754230 001 IS AN ANTI-ANGINAL MEDICATIO N. IT WORKS BY IMPROVING BLOO D FLOW TO HELP THE HEART WORK MORE EFFICIENTLY. IT IS USED TO TREAT CHRONIC ANGINA (CH EST PAIN). IT IS NOT FOR USE DURING AN ACUTE (EMERGENCY) A TTACK OF ANGINA EZETIMIBE- MNBU3754230 001 SIMVA TAB 10/80MG 30 NDC CODE :68462032430 FDA PRODUCT CODE NO.: 61 J D C 15 H. T. S NO .: 3004.49.00.10 ANDA NO.: 2 08699 THERAPEUTICE USE: - THI S COMBINATION MEDICATION IS USED TO HELP LOWER BAD CHOLES TEROL AND FATS (SUCH AS LDL, MNBU3754230 001 TRIGLYCERIDES) AND RAISE GOO D CHOLESTEROL (HDL) IN THE BL OOD. EZETIMIBE WORKS BY REDUC ING THE AMOUNT OF CHOLESTEROL YOUR BODY ABSORBS FROM YOUR DIET. SIMVASTATIN BELONGS TO A GROUP OF DRUGS KNOWN AS "S TATINS." IT WORKS BY REDUCING MNBU3754230 001 THE AMOUNT OF CHOLESTEROL M ADE BY THE LIVER. CARVEDILO L TAB 25MG 500 NDC CODE:68462 016505 FDA PRODUCT CODE NO : 62 O C A 22 HTS NO.3004.90.92 21 ANDA NO.78-251 THERAPEUTI CE USE:-BETA- ADRENOACEPTOR ANTAGONIST RANOLAZINE ER T MNBU3754230 001 AB 500MG 60 NDC CODE:68462031 960 FDA PRODUCT CODE NO.: 61 D C B 02 H. T. S NO.: 3004. 49.00.10 ANDA NO.:211082 THE RAPEUTIC USE: - IT IS AN ANTI -ANGINAL MEDICATION. IT WORKS BY IMPROVING BLOOD FLOW TO HELP THE HEART WORK MORE EFFI MNBU3754230 001 CIENTLY. IT IS USED TO TREAT CHRONIC ANGINA (CHEST PAIN). IT IS NOT FOR USE DURING AN A CUTE (EMERGENCY) ATTACK OF A NGINA CARVEDILOL TAB 25MG 5 00 NDC CODE:68462016505 FDA PRODUCT CODE NO :62 O C A 22 HTS NO.3004.90.9221 ANDA NO. MNBU3754230 001 78-251 THERAPEUTICE USE:-BET A- ADRENOACEPTOR ANTAGONIST CARVEDILOL TAB 25MG 100 ND C CODE:68462016501 FDA PRODUC T CODE NO :62 O C A 22 HTS N O.3004.90.9221 ANDA NO.78-251 THERAPEUTICE USE:-BETA- AD RENOACEPTOR ANTAGONIST TER MNBU3754230 001 IFLUNOMIDE TAB 7MG 30 NDC COD E:68462042330 FDA PRODUCT COD E NO.: 60 L C A 99 H. T. S NO.:3004.90.9215 ANDA NO.: 20 9663 THERAPEUTICE USE: :#MUL TIPLE SCLEROSIS AGENT TACR OLIMUS OINT 0.1% 100GM NDC CO DE:68462053494 FDA PRODUCT CO MNBU3754230 001 DE NO.: 64 T C J 08 H. T. S NO.: 3004.49.00.50 ANDA NO.: 210393 THERAPEUTICE USE: - TACROLIMUS IS A TOPICAL IMMUN OSUPPRESSIVE OINTMENT USED FO R THE TREATMENT OF MODERATE- TO-SEVERE ATOPIC DERMATITIS (ECZEMA). SIROLIMUS TAB 1MG MNBU3754230 001 100 NDC CODE:68462068301 FD A PRODUCT CODE NO.: 64 T C A 12 H. T. S NO.: 3004.90.92.1 5 ANDA NO.: 208691 THERAPEUT ICE USE: TO PREVENT REJECTION OF KIDNEY TRANSPLANTS. AP REPITANT CAP 40MG 1UD NDC COD E:68462058340 FDA PRODUCT COD MNBU3754230 001 E NO.: 61 T C E 32 H. T. S N O.: 3004.90.92.40 ANDA NO.: 207777 THERAPEUTICE USE: -AP REPITANT IS USED WITH OTHER M EDICATIONS TO HELP PREVENT NA USEA AND VOMITING CAUSED BY CANCER DRUG TREATMENT (CHEMOT HERAPY). THIS MEDICATION IS A MNBU3754230 001 LSO USED TO PREVENT NAUSEA AN D VOMITING AFTER SURGERY. A- EMETIC/NAUSEANT / HUMAN - RX/ SINGLE INGREDIENT / DELAYED RELEASE TABLETS / APREPITANT COMMERCIAL & CUSTOM INVOICE NO. F22487002342 DT. 20.03.2 024 F22487002345 DT. 21.03.20 MNBU3754230 001 24 F22487002346 DT. 21.03.202 4 F22487002347 DT. 21.03.2024 F22487002348 DT. 21.03.2024 S/BILL NO: 4004831 DT: 21/03/ 2024 S/BILL NO: 4004832 DT: 2 1/03/2024 S/BILL NO: 4004833 DT: 21/03/2024 S/BILL NO: 400 4834 DT: 21/03/2024 S/BILL NO MNBU3754230 001 : 4004835 DT: 21/03/2024 GROS S WT. 10,515.652 NET WT.7695 .876 13 DATA LOGGERS SE T TEMPERATURE : +20 DEGREES NOTIFY PARTY:2 GLENMARK PHAR MACEUTICALS INC 750, CORPORAT E DRIVE, NEW JERSEY MAHWAH - 07430 USA NOTIFY PARTY:3 G MNBU3754230 001 LENMARK SPECIALTY S.A. SWITZE RLAND (GSSA) PLACE DU PORT 2 NEUCHATEL - 2000 SWITZERLAND

PHARMACEUTICALS AS UNDER LEVOCETIRIZINE DI HY TAB 5MG 90 NDC CODE:68462034690 FDA PROD UCT CODE NO.: 61 X C A 51 H. T. S NO.: 300 4.90.91.80 ANDA NO.:90385 THERAPEUTICE USE: TREATMENT OF CHRONIC IDIOPATHIC URTICARIA ZONISAMIDE CAP 50MG 100 NDC CODE:68462012 901 FDA PRODUCT CODE NO.:-61 M C E 44 H. T HLBU9549362 001 . S NO.: 3004.49.00.20 ANDA NO.:-77-651 TH ERAPEUTICE USE:-ANTISEIZURE DRUG GABAPENT IN TAB 600MG 500 NDC CODE:68462012605 FDA P RODUCT CODE:NO : 61 N C A 69 HTS NO.3004.90 .9236 ANDA NO.:-77-662 THERAPEUTICE USE:-A NTICONVULSANT OXCARBAZEPINE TAB 300MG 100 NDC CODE:68462013801 FDA PRODUCT CODE NO.: -61 M C A 45 HTS NO.3004.90.9236 ANDA NO.:- HLBU9549362 001 77-802 THERAPEUTICE USE:-ANTI CONVULSANT AG ENT 02 DATA LOGGERS HUMIDITY:65% SET TEMPERATURE : +20 DEGREES TEMPERATURE RA NGE : +15 DEGREES TO +25 DEGREES CONTAINER N O. HLBU9549362 COMMERCIAL & CUSTOM INVO ICE NO. F22452006228 DT. 19.03.2024 F224520 06230 DT. 19.03.2024 F22452006245 DT. 20.03. 2024

TACROLIMUS OINT 0.1% 488 CARTONS PHARMACEUTICALS AS UNDER TACROLIMUS OINT 0.1% 100GM NDC CODE 68462053494 HLBU9783370 001 FDA PRODUCT CODE NO. 62KCF10 HTS NO.3004.90.9255 ANDA NO. 91672 THERAPEUTICE USE -TREATMENT OF TREAT GASTROESOPHAGEAL REFLUX DISEASE HLBU9783370 001 VERAPAMIL HCL ER TAB 120MG 100 NDC CODE 68462029201 NDC NO. 68462029201 FDA PRODUCT CODE NO. 62 O C B 13 HTS NO.3004.90.9221 ANDA NO. 090700 HLBU9783370 001 THERAPEUTICE USE --ANGINA TOPIRAMATE TAB 25MG 500 NDC CODE 68462010805 FDA PRODUCT CODE NO. 61 M C A 40 H. T. S NO. 3004.49.00.20 HLBU9783370 001 ANDA NO. 077627 THERAPEUTICE USE ANTICONVULSANT TOPIRAMATE TAB 25MG 60 NDC CODE 68462010860 FDA PRODUCT CODE NO. -61 M C A 40 H. T. S NO. HLBU9783370 001 3004.49.00.20 ANDA NO. - 77-627 THERAPEUTICE USE -ANTICONVULSANT LITHIUM CARB ER TAB 450MG 100 NDC CODE 68462022401 FDA PRODUCT CODE NO. 61 N C B 37 HLBU9783370 001 H. T. S NO. 3004.49.00.20 ANDA NO. 91-616 THERAPEUTICE USE - INDICATED IN THE TREATMENT OF MANIC EPISODES OF BIPOLAR DISORDER. HLBU9783370 001 BIPOLAR DISORDER, MANIC (DSM-IV) IS EQUIVALENT TO MANIC DEPRESSIVE ILLNESS, MANIC, IN THE OLDER DSM-II TERMINOLOGY. ALSO INDICATED AS A MAINTENANCE TREATMENT FOR INDIVIDUALS HLBU9783370 001 WITH A DIAGNOSIS OF BIPOLAR DISORDER. MAINTENANCE THERAPY REDUCES THE FREQUENCY OF MANIC EPISODES AND DIMINISHES THE INTENSITY OF THOSE EPISODES WHICH HLBU9783370 001 MAY OCCUR. COMMERCIAL & CUSTOM INVOICE NO. F22452005990 DT. 06.03.2024 F22452005993 DT. 06.03.2024 F22452005991 DT. 06.03.2024 S/BILL NO 8133429 DT 07-MAR-2024 HLBU9783370 001 S/BILL NO 8133390 DT 07-MAR-2024 S/BILL NO 8133392 DT 07-MAR-2024 SCAC CODE YASV HBL NO BOM0062162 GROSS WT. 5,154.364 KGS NET WT.4092.619 KGS HLBU9783370 001 11 DATA LOGGERS HUMIDITY 65% HLBU9783370 002 FDA PRODUCT CODE NO. 64 T C J 08 H. T. S NO. 3004.49.00.50 ANDA NO. 210393 THERAPEUTICE USE - TACROLIMUS IS A TOPICAL IMMUNOSUPPRESSIVE HLBU9783370 002 OINTMENT USED FOR THE TREATMENT OF MODERATE-TO-SEVERE ATOPIC DERMATITIS (ECZEMA). TACROLIMUS OINT 0.1% 60GM NDC CODE 68462053465 HLBU9783370 002 FDA PRODUCT CODE NO. 64 T C J 08 H. T. S NO. 3004.49.00.50 ANDA NO. 210393 THERAPEUTICE USE - TACROLIMUS IS A TOPICAL IMMUNOSUPPRESSIVE HLBU9783370 002 OINTMENT USED FOR THE TREATMENT OF MODERATE-TO-SEVERE ATOPIC DERMATITIS (ECZEMA). PIMECROLIMUS CREAM 1% 30GM NDC CODE 68462060935 HLBU9783370 002 FDA PRODUCT CODE NO. 61 S C J 04 H. T. S NO. 3004.90.92.45 ANDA NO. 211769 THERAPEUTICE USE - AS SECOUND-LINE THERAPY FOR THE SHORT-TERM AND HLBU9783370 002 NON-CONTINUOS CHRONIC TRERTMENT OF MILD TO MODERATE ATOPIC DERMATITIS IN NON- IMMUNOCOMPROMISED ADULT AND CHILDREN 2 YEARS OF AGE HLBU9783370 002 PIMECROLIMUS CREAM 1% 60GM NDC CODE 68462060965 FDA PRODUCT CODE NO. 61 S C J 04 H. T. S NO. 3004.90.92.45 ANDA NO. 211769 HLBU9783370 002 THERAPEUTICE USE - AS SECOUND-LINE THERAPY FOR THE SHORT-TERM AND NON-CONTINUOS CHRONIC TRERTMENT OF MILD TO MODERATE ATOPIC DERMATITIS IN NON- HLBU9783370 002 IMMUNOCOMPROMISED ADULT AND CHILDREN 2 YEARS OF AGE TACROLIMUS OINTMENT 0.03% 30GM NDC CODE 68462088135 FDA PRODUCT CODE NO. 64 T C J 08 HLBU9783370 002 H. T. S NO. 3004.49.0050 ANDA NO. 210393 THERAPEUTICE USE TOPICAL IMMUNOSUPPRESSIVE AGENT COMMERCIAL & HLBU9783370 002 CUSTOM INVOICE NO. F22487002228 DT. 29.02.2024 SCAC CODE YASV HBL NO BOM0062163 XX CARGO DESCRIPTION XX

ASPIRIN-ER DIPYRIDAMOLECAP 25/200MG 6 PACKAGES 423 CARTONS PHARMACEUTICALS AS UNDER ASPIRIN-ER DIPYRIDAMOLE CAP 25/200MG 60 NDC CODE 68462040560 HLBU9711175 001 CODE NO 61 N C A 69 HTS NO.3004.90.9236 ANDA NO. -77-662 THERAPEUTICE USE -ANTICONVULSANT EZETIMIBE-SIMVA TAB 10/10MG 90 NDC CODE 68462032190 HLBU9711175 001 FDA PRODUCT CODE NO. 61 J D C 15 H. T. S NO. 3004.49.00.10 ANDA NO. 208699 THERAPEUTICE USE - THIS COMBINATION MEDICATION IS USED TO HELP LOWER HLBU9711175 001 BAD CHOLESTEROL AND FATS (SUCH AS LDL, TRIGLYCERIDES) AND RAISE GOOD CHOLESTEROL (HDL) IN THE BLOOD. EZETIMIBE WORKS BY REDUCING THE AMOUNT OF CHOLESTEROL YOUR BODY ABSORBS FROM HLBU9711175 001 YOUR DIET. SIMVASTATIN BELONGS TO A GROUP OF DRUGS KNOWN AS "STATINS." IT WORKS BY REDUCING THE AMOUNT OF CHOLESTEROL MADE BY THE LIVER BISOPROLOL-HCTZ TAB 5/6.25MG 30 HLBU9711175 001 NDC CODE 68462087930 FDA PRODUCT CODE NO 62 O D A 18 HTS NO.3004.49.0010 ANDA NO.215995 THERAPEUTICE USE -BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE HLBU9711175 001 TABLETS ARE INDICATED IN THE MANAGEMENT OF HYPERTENSION. GABAPENTIN TAB 600MG 500 NDC CODE 68462012605 FDA PRODUCT CODE NO 61 N C A 69 HLBU9711175 001 HTS NO.3004.90.9236 ANDA NO. -77-662 THERAPEUTICE USE -ANTICONVULSANT POTASSIUM CL ER CAP 10MEQ 100 NDC CODE 68462035701 FDA PRODUCT CODE NO. 65 R C F 14 HLBU9711175 001 H. T. S NO. 3004.90.92.90 ANDA NO. 202868 THERAPEUTICE USE - TREATMENT OR PREVENTION OF HYPOKALEMIA GABAPENTIN TAB 600MG 500 HLBU9711175 001 NDC CODE 68462012605 FDA PRODUCT CODE NO 61 N C A 69 HTS NO.3004.90.9236 ANDA NO. -77-662 THERAPEUTICE USE -ANTICONVULSANT METFORMIN HCL ER TAB HLBU9711175 001 (Z) 1000MG 90 NDC CODE 68462052190 FDA PRODUCT CODE NO. 61 P C A 55 H. T. S NO. 3004.90.92.40 ANDA NO. 212969 THERAPEUTICE USE THE HLBU9711175 001 MANAGEMENT OF TYPE 2 DIABETES XX CARGO DESCRIPTION XX HLBU9711175 002 H. T. S NO. 3004.90.92.40 ANDA NO. 212969 THERAPEUTICE USE THE MANAGEMENT OF TYPE 2 DIABETES GABAPENTIN TAB 600MG 500 NDC CODE 68462012605 HLBU9711175 002 FDA PRODUCT CODE NO 61 N C A 69 HTS NO.3004.90.9236 ANDA NO. -77-662 THERAPEUTICE USE -ANTICONVULSANT SAXAGLIPTIN TAB 5MG 90 NDC CODE 68462072790 HLBU9711175 002 FDA PRODUCT CODE NO. 61 P C A 99 H. T. S NO. 3004.90.9220 ANDA NO. 205994 THERAPEUTICE USE ANTI-DIABETIC AGENT EZETIMIBE TAB 10MG 500 HLBU9711175 002 NDC CODE 68462022605 FDA PRODUCT CODE NO. 61 J C A 15 H. T. S NO. 3004.49.00.10 ANDA NO. 078560 THERAPEUTICE USE LIPID LOWERING AGENT HLBU9711175 002 TACROLIMUS CAP 1MG 100 NDC CODE 68462068601 HTS NO 3004.90.92.15 FDA CODE 64 T C E 08 ANDA NO.206662 THERAPEUTIC USE TO PREVENT REJECTION OF A KIDNEY,HEART, OR LIVER HLBU9711175 002 TRANSPLANT SAXAGLIPTIN TAB 5MG 30 NDC CODE 68462072730 FDA PRODUCT CODE NO. 61 P C A 99 H. T. S NO. 3004.90.9220 ANDA NO. 205994 HLBU9711175 002 THERAPEUTICE USE ANTI-DIABETIC AGENT PIMECROLIMUS CREAM 1% 30GM NDC CODE 68462060935 FDA PRODUCT CODE NO. 61 S C J 04 H. T. S NO. HLBU9711175 002 3004.90.92.45 ANDA NO. 211769 THERAPEUTICE USE - AS SECOUND-LINE THERAPY FOR THE SHORT-TERM AND NON-CONTINUOS CHRONIC TRERTMENT OF MILD TO MODERATE ATOPIC HLBU9711175 002 DERMATITIS IN NONIMMUNOCOMPROMISED ADULT AND CHILDREN 2 YEARS OF AGE COMMERCIAL & CUSTOM INVOICE NO. F22487002201 DT. 29.02.2024 F22487002204 DT. 29.02.2024 HLBU9711175 002 F22487002212 DT. 29.02.2024 F22487002213 DT. 29.02.2024 F22487002216 DT. 29.02.2024 F22487002218 DT. 29.02.2024 F22487002220 DT. 29.02.2024 F22487002222 DT. 29.02.2024 F22487002224 DT. 29.02.2024 F22487002226 DT. 29.02.2024 HLBU9711175 002 F22487002231 DT. 29.02.2024 F22487002234 DT. 29.02.2024 F22487002235 DT. 29.02.2024 SCAC CODE YASV HBL NO BOM0062160 HLBU9711175 003 FDA PRODUCT CODE NO. 60 L D F 05 H. T. S NO. 3004.90.9220 ANDA NO. 210318 COMMERCIAL & CUSTOM INVOICE NO. F22487002202 DT. 29.02.2024 HLBU9711175 003 S/BILL NO 4003879 DT 06/03/3034 GROSS WT. 1,376.304 KGS NET WT.423.65 KGS SCAC CODE YASV HBL NO BOM0062161 06 DATA LOGGERS HUMIDITY 65%

40 PALLETS 2197 CARTONS PH ARMACEUTICALS AS UNDER CARV EDILOL TAB 25MG 500 NDC CODE: 68462016505 FDA PRODUCT CODE NO :62 O C A 22 HTS NO.3004. 90.9221 ANDA NO.78-251 THERA PEUTICE USE:-BETA- ADRENOACE MNBU0602763 001 PTOR ANTAGONIST NICARDIPIN E HCL CAP 30MG 90 NDC CODE:68 462012190 FDA PRODUCT CODE NO .: 62 O C E 48 H. T. S NO.: 3004.90.9220 ANDA NO.: 21635 7 THERAPEUTICE USE: :#CARDIO VASCULAR AGENT (CALCIUM CHANN EL BLOCKER) EZETIMIBE-SIMV MNBU0602763 001 A TAB 10/20MG 30 NDC CODE:684 62032230 FDA PRODUCT CODE NO. : 61 J D C 15 H. T. S NO.: 3004.49.00.10 ANDA NO.: 20869 9 THERAPEUTICE USE: :#LIPID LOWERING AGENT GABAPENTIN T AB 600MG 500 NDC CODE:6846201 2605 FDA PRODUCT CODE:NO : 6 MNBU0602763 001 1 N C A 69 HTS NO.3004.90.923 6 ANDA NO.:-77-662 THERAPEUT ICE USE:-ANTICONVULSANT PR OPAFENONE HCL ER CAP 225MG 60 NDC CODE:68462040860 FDA PRO DUCT CODE NO.: 63 E C F 28 H . T. S NO.: 3004.49.00.10 AN DA NO.:205268 THERAPEUTICE US MNBU0602763 001 E:AN ANTIARRHYTHMIC AGENT. I T IS USED TO TREAT IRREGULAR HEART RHYTHM AND CAN SLOW RA PID HEARTBEATS EZETIMIBE-S IMVA TAB 10/20MG 90 NDC CODE: 68462032290 FDA PRODUCT CODE NO.: 61 J D C 15 H. T. S NO. : 3004.49.00.10 ANDA NO.: 20 MNBU0602763 001 8699 THERAPEUTICE USE: :#LIP ID LOWERING AGENT RUFINAMID E TAB 400MG 120 NDC CODE:6846 2071408 61 M C A 99 3004.90. 92.30 205075 TO USED WITH OT HER MEDICATIONS TO PREVENT OR CONTROL SEIZURES (EPILEPSY) ASSOCIATED WITH LENNOX-GAST MNBU0602763 001 AUT SYNDROME (LGS BISOPROL OL-HCTZ TAB 10/6.25MG 30 NDC CODE:68462088030 FDA PRODUCT CODE NO :62 O D A 18 HTS NO. 3004.49.0010 ANDA NO.215995 THERAPEUTICE USE:-BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZ IDE TABLETS ARE INDICATED IN MNBU0602763 001 THE MANAGEMENT OF HYPERTENS ION. FENOFIBRATE CAP 67MG 1 00 NDC CODE:68462058001 FDA PRODUCT CODE NO.: 61 JCE 09 H. T. S NO.: 3004.90.92.20 A NDA NO.: 205566 THERAPEUTICE USE: - INDICATED AS ADJUNCTIV E THERAPY TO DIET FOR THE RE MNBU0602763 001 DUCTION OF LDL-C, TOTAL-C, TR IGLYCERIDES AND APO B IN DULT PATIENTS WITH PRMARY HYPER CHOLESTEROLEMIA OR MIXED DYSL IPIDEMIA CARVEDILOL TAB 25M G 500 NDC CODE:68462016505 F DA PRODUCT CODE NO :62 O C A 22 HTS NO.3004.90.9221 ANDA MNBU0602763 001 NO.78-251 THERAPEUTICE USE:- BETA- ADRENOACEPTOR ANTAGONI ST TACROLIMUS OINT 0.1% 100 GM NDC CODE:68462053494 FDA PRODUCT CODE NO.: 64 T C J 08 H. T. S NO.: 3004.49.00.50 ANDA NO.: 210393 THERAPEUTIC E USE: - TACROLIMUS IS A TOPI MNBU0602763 001 CAL IMMUNOSUPPRESSIVE OINTME NT USED FOR THE TREATMENT OF MODERATE-TO-SEVERE ATOPIC DE RMATITIS (ECZEMA). TACROLI MUS OINT 0.1% 30GM NDC CODE:6 8462053435 FDA PRODUCT CODE N O.: 64 T C J 08 H. T. S NO.: 3004.49.00.50 ANDA NO.: 210 MNBU0602763 001 393 THERAPEUTICE USE: - TACR OLIMUS IS A TOPICAL IMMUNOSUP PRESSIVE OINTMENT USED FOR TH E TREATMENT OF MODERATE-TO-S EVERE ATOPIC DERMATITIS (ECZ EMA). PIMECROLIMUS CREAM 1% 30GM NDC CODE:68462060935 F DA PRODUCT CODE NO.: 61 S C J MNBU0602763 001 04 H. T. S NO.: 3004.90.92. 45 ANDA NO.: 211769 THERAPEU TICE USE: - AS SECOUND-LINE T HERAPY FOR THE SHORT-TERM AND NON-CONTINUOS CHRONIC TRERT MENT OF MILD TO MODERATE ATOP IC DERMATITIS IN NONIMMUNOCO MPROMISED ADULT AND CHILDREN MNBU0602763 001 2 YEARS OF AGE TACROLIMUS OINTMENT 0.03% 100GM NDC CODE :68462088194 FDA PRODUCT CODE NO.:64 T C J 08 H. T. S NO. : 3004.49.0050 ANDA NO.:2103 93 THERAPEUTICE USE: TOPICAL IMMUNOSUPPRESSIVE AGENT COMMERCIAL & CUSTOM INVOICE NO MNBU0602763 001 . F22487001926 DT. 22.01.2024 F22487001922 DT. 20.01.2024 F22487001921 DT. 20.01.2024 F22487001920 DT. 20.01.2024 F 22487001919 DT. 20.01.2024 F2 2487001917 DT. 20.01.2024 S/B ILL NO: 4001056 DT: 22/01/2024 S/BILL NO: 4001055 DT: 22/01 MNBU0602763 001 /2024 S/BILL NO: 4001053 DT: 22/01/2024 S/BILL NO: 4001054 DT: 22/01/2024 S/BILL NO: 40 01052 DT: 22/01/2024 S/BILL N O: 4001051 DT: 22/01/2024 NET WT. 5823.454 KGS 02 DATA LO GGERS HUMIDITY:65% SET TEMPE RATURE : +20 DEGREES TEMPERAT MNBU0602763 001 URE RANGE : +15 DEGREES TO +25 DEGREES NOTIFY PARTY:2 GLEN MARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH-07430 USA

PRINTED EDUCATIONAL BOOKS 2X20FCL CONTAINERS TOTAL 1411 BOXES 1411 BOXES PACKED IN 39 PALLETS PRINTED EDUCATIONAL BOOKS HS CODE 4901 1010 2480 NOS OF LAVINS RADIOGRAPHY FOR GESU1140017 001 VETERINARY TECHNICIANS 7E ISBN 9780323763707 -003 1827 NOS OF ACUTE & CHRONIC WOUNDS, 6E ISBN 9780323711906 -002 3941 NOS OF SECTIONAL ANATOMY FOR IMAGING PROFESSIONALS ISBN 9780323414876 -006 GESU1140017 001 5125 NOS OF RADIOGRAPHIC IMAGE ANALYSIS ISBN 9780323930697 -001 600 NOS OF THE 12-LEAD ECG IN ACUTE CORONARY SYNDROMES ISBN 9780323497893 -006 INVOICE NO MTL/EXP/145/23-24 DT 30.11.2023 GESU1140017 001 SB NO. DT SERVICE EXPORT INVOICE NO. KAM3130720 DT 30.11.2023 NET WEIGHT 23270.000 KGS GROSS WEIGHT 25231.000 KGS FREIGHT COLLECT HBL AMS NO CCLAIC230296 GESU1140017 001 HBL SCAC CODE AEIG UACU3984283 001 VETERINARY TECHNICIANS 7E ISBN 9780323763707 -003 1827 NOS OF ACUTE & CHRONIC WOUNDS, 6E ISBN 9780323711906 -002 3941 NOS OF SECTIONAL ANATOMY FOR IMAGING PROFESSIONALS ISBN 9780323414876 -006 UACU3984283 001 5125 NOS OF RADIOGRAPHIC IMAGE ANALYSIS ISBN 9780323930697 -001 600 NOS OF THE 12-LEAD ECG IN ACUTE CORONARY SYNDROMES ISBN 9780323497893 -006 INVOICE NO MTL/EXP/145/23-24 DT 30.11.2023 UACU3984283 001 SB NO. DT SERVICE EXPORT INVOICE NO. KAM3130720 DT 30.11.2023 NET WEIGHT 23270.000 KGS GROSS WEIGHT 25231.000 KGS FREIGHT COLLECT HBL AMS NO CCLAIC230296 UACU3984283 001 HBL SCAC CODE AEIG

26 PALLETS 1305 CARTONS PH ARMACEUTICALS AS UNDER TACR OLIMUS OINT 0.1% 100GM NDC CO DE:68462053494 FDA PRODUCT CO DE NO.: 64 T C J 08 H. T. S NO.: 3004.49.00.50 ANDA NO.: 210393 THERAPEUTICE USE: - MNBU0632876 001 TACROLIMUS IS A TOPICAL IMMUN OSUPPRESSIVE OINTMENT USED FO R THE TREATMENT OF MODERATE- TO-SEVERE ATOPIC DERMATITIS (ECZEMA). TACROLIMUS OINT 0 .1% 30GM NDC CODE:68462053435 FDA PRODUCT CODE NO.: 64 T C J 08 H. T. S NO.: 3004.49. MNBU0632876 001 00.50 ANDA NO.: 210393 THERA PEUTICE USE: - TACROLIMUS IS A TOPICAL IMMUNOSUPPRESSIVE OINTMENT USED FOR THE TREATME NT OF MODERATE-TO-SEVERE ATO PIC DERMATITIS (ECZEMA). T ACROLIMUS OINT 0.1% 60GM NDC CODE:68462053465 FDA PRODUCT MNBU0632876 001 CODE NO.: 64 T C J 08 H. T. S NO.: 3004.49.00.50 ANDA NO .: 210393 THERAPEUTICE USE: - TACROLIMUS IS A TOPICAL IMM UNOSUPPRESSIVE OINTMENT USED FOR THE TREATMENT OF MODERAT E-TO-SEVERE ATOPIC DERMATITIS (ECZEMA). PIMECROLIMUS CR MNBU0632876 001 EAM 1% 30GM NDC CODE:68462060 935 FDA PRODUCT CODE NO.: 61 S C J 04 H. T. S NO.: 3004. 90.92.45 ANDA NO.: 211769 TH ERAPEUTICE USE: - AS SECOUND- LINE THERAPY FOR THE SHORT-TE RM AND NON-CONTINUOS CHRONIC TRERTMENT OF MILD TO MODERAT MNBU0632876 001 E ATOPIC DERMATITIS IN NONIM MUNOCOMPROMISED ADULT AND CHI LDREN 2 YEARS OF AGE POTAS SIUM CL ER CAP 10MEQ 100 NDC CODE:68462035701 FDA PRODUCT CODE NO.:65 R C F 14 H. T. S NO.: 3004.90.92.90 ANDA NO. :202868 THERAPEUTICE USE: - MNBU0632876 001 TREATMENT OR PREVENTION OF H YPOKALEMIA GABAPENTIN TAB 6 00MG 500 NDC CODE:68462012605 FDA PRODUCT CODE NO: 61 N C A 69 H. T. S NO.: 3004.90.9 2.30 ANDA NO.:-77-662 THERAP EUTICE USE:-ANTICONVULSANT A GENT COMMERCIAL & CUSTOM IN MNBU0632876 001 VOICE NO. F22487001678 DT. 20 .12.2023 F22487001679 DT. 20. 12.2023 F22487001682 DT. 20.1 2.2023 S/BILL NO: 4019640 DT: 21/12/2023 S/BILL NO: 4019641 DT:21/12/2023 S/BILL NO: 401 9645 DT:21/12/2023 NET WT. 42 93.181 KGS 02 DATA LOGGERS MNBU0632876 001 SET TEMPERATURE : +20 DEGRE ES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, COR PORATE DRIVE, NEW JERSEY MAH WAH - 07430 USA

46 PALLETS 2751 CARTONS PH ARMACEUTICALS AS UNDER PRAM IPEXOLE TAB 0.5MG 90 NDC CODE :68462033290 FDA PRODUCT CODE NO.: 62 J C A 15 H. T. S NO .: 3004.90.92.40 ANDA NO.: 9 0-781 THERAPEUTICE USE: USED MNBU0310400 001 IN PARKINSON'S DISEASE OLM ESARTAN MEDOX TAB 40MG 30 NDC CODE:68462043830 FDA PRODUCT CODE NO.: 62CCA68 H. T. S N O.: 3004.90.9220 ANDA NO.: 2 03281 THERAPEUTICE USE: - -T REATMENT OF HYPERTENSION, ALO NE OR WITH OTHER ANTIHYPERTE MNBU0310400 001 NSIVE AGENTS, TO LOWER BLOOD PRESSURE OLMESARTAN MEDOX T AB 40MG 90 NDC CODE:684620438 90 FDA PRODUCT CODE NO.: 62 CCA 68 H. T. S NO.: 3004.90. 9220 ANDA NO.: 203281 TREATM ENT OF HYPERTENSION, ALONE OR WITH OTHER ANTIHYPERTENSIVE MNBU0310400 001 AGENTS, TO LOWER BLOOD PRESS URE THEOPHYLLINE ER TAB 300 MG 100 NDC CODE:68462072101 63 B C B 30 3004.90.92.85 21 2184 TO RELEASE TABLETS ARE INDICATED FOR THE TREATMENT O F THE SYMPTOMS AND REVERSIBL E AIRFLOW OBSTRUCTION ASSOCIA MNBU0310400 001 TED WITH CHRONIC ASTHMA AND OTHER CHRONIC LUNG DISEASES, E.G., EMPHYSEMA AND CHRONIC BRONCHITIS PRAMIPEXOLE TAB 0.5MG 90 NDC CODE:68462033290 FDA PRODUCT CODE NO.: 62 J C A 15 H. T. S NO.: 3004.90. 92.40 ANDA NO.: 90-781 THERA MNBU0310400 001 PEUTICE USE: USED IN PARKINSO N'S DISEASE PRAMIPEXOLE TAB 1MG 90 NDC CODE:68462033390 FDA PRODUCT CODE NO.: 62 J C A 15 H. T. S NO.: 3004.90.9 2.40 ANDA NO.: 90-781 THERAP EUTICE USE: USED IN PARKINSON 'S DISEASE OLMESARTAN MEDOX MNBU0310400 001 TAB 40MG 30 NDC CODE:6846204 3830 FDA PRODUCT CODE NO.: 6 2CCA68 H. T. S NO.: 3004.90. 9220 ANDA NO.: 203281 THERAP EUTICE USE: - -TREATMENT OF HYPERTENSION, ALONE OR WITH O THER ANTIHYPERTENSIVE AGENTS, TO LOWER BLOOD PRESSURE M MNBU0310400 001 UPIROCIN OINT 2% 22GM NDC COD E:68462018022 FDA PRODUCT COD E NO.: 61 G J J 81 H. T. S N O.: 3004.90.92.45 ANDA NO.: 90-480 THERAPEUTICE USE: - A NTI-BACTERIAL MUPIROCIN OIN T 2% 22GM NDC CODE:6846201802 2 FDA PRODUCT CODE NO.: 61 G MNBU0310400 001 J J 81 H. T. S NO.: 3004.90 .92.45 ANDA NO.: 90-480 THER APEUTICE USE: - ANTI-BACTERIA L COMMERCIAL & CUSTOM INVOI CE NO. F22452003976 DT. 15.11 .2023 F22452003988 DT. 15.11. 2023 F22452003989 DT. 15.11.2 023 F22452003987 DT. 15.11.20 MNBU0310400 001 23 F22452003996 DT. 16.11.202 3 S/BILL NO: 5384179 DT 17-NO V-2023 S/BILL NO: 5384173 DT 17-NOV-2023 S/BILL NO: 538417 4 DT 17-NOV-2023 S/BILL NO: 5 386273 DT 17-NOV-2023 S/BILL NO:5386283 DT 17-NOV-2023 NET WT. 8656.120 KGS 02 DATA LO MNBU0310400 001 GGERS HUMIDITY:65% SET TEMPE RATURE : +18 DEGREES TEMPERAT URE RANGE : +15 DEGREES TO +25 DEGREES NOTIFY PARTY:2 GLEN MARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA

50 PALLETS 2898 CARTONS PHAR MACEUTICALS AS UNDER GABAPENT IN TAB 600MG 500 NDC CODE:684 62012605 FDA PRODUCT CODE NO: 61 N C A 69 H. T. S NO.: 3 004.90.92.30 ANDA NO.:-77-662 THERAPEUTICE USE:-ANTICONVU MNBU0443907 001 LSANT AGENT INDOMETHACIN CAP 50MG 100 NDC CODE:6846203020 1 FDA PRODUCT CODE NO.: 62 G C E 42 H. T. S NO.: 3004.90 .92.40 ANDA NO.:91-276 THERA PEUTICE USE: -ANTI-INFLAMATOR Y TOPIRAMATE TAB 25MG 500 ND C CODE:68462010805 FDA PRODUC MNBU0443907 001 T CODE NO.: 61 M C A 40 H. T . S NO.: 3004.49.00.20 ANDA NO.:077627 THERAPEUTICE USE: ANTICONVULSANT THEOPHYLLINE ER TAB 300MG 100 NDC CODE:684 62072101 63 B C B 30 3004.90 .92.85 212184 TO RELEASE TAB LETS ARE INDICATED FOR THE T MNBU0443907 001 REATMENT OF THE SYMPTOMS AND REVERSIBLE AIRFLOW OBSTRUCTI ON ASSOCIATED WITH CHRONIC AS THMA AND OTHER CHRONIC LUNG DISEASES, E.G., EMPHYSEMA AND CHRONIC BRONCHITIS INDOMETH ACIN CAP 50MG 500 NDC CODE:68 462030205 FDA PRODUCT CODE NO MNBU0443907 001 .: 62 G C E 42 H. T. S NO.: 3004.90.92.40 ANDA NO.:91-27 6 THERAPEUTICE USE: -ANTI-IN FLAMATORY ZOLMITRIPTAN TAB 5 MG 3UD NDC CODE:68462049833 FDA PRODUCT CODE NO.: 63OCA08 H. T. S NO.: 3004.90.92.28 ANDA NO.: 201779 THERAPEUTIC MNBU0443907 001 E USE: :#ANALGESIC/ HUMAN RX /SINGLE INGREDIENT PROMPT REL EASE TABLETS ZOLMITRIPTAN (A NALGESIC) DICLOFENAC SOD GEL 3% 100GM NDC CODE:68462035594 FDA PRODUCT CODE NO.:62 G C J 18 H. T. S NO.: 3004.90.9 2.40 ANDA NO.:208301 THERAPE MNBU0443907 001 UTICE USE: - USED FOR THE REL IEF OF JOINT PAIN OF OSTEOART HRITIS COMMERCIAL & CUSTOM IN VOICE NO. F22452003518 DT. 22 .10.2023 F22452003519 DT. 22. 10.2023 F22452003520 DT. 22.1 0.2023 F22452003539 DT. 24.10 .2023 F22452003540 DT. 24.10. MNBU0443907 001 2023 S/BILL NO: 4875188 DT 25 -OCT-2023 S/BILL NO: 4868560 DT 25-OCT-2023 S/BILL NO: 487 1617 DT 25-OCT-2023 S/BILL NO : 4867544 DT 25-OCT-2023 S/BI LL NO: 4864889 DT 25-OCT-2023 S/BILL NO: 4867540 DT 25-OCT- 2023 NET WT. 10,636.449 KGS MNBU0443907 001 02 DATA LOGGERS NOTIFY PA RTY:2 GLENMARK PHARMACEUTICAL S INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH 07430 USA

38 PALLETS 2370 CARTONS PH ARMACEUTICALS AS UNDER POTA SSIUM CL ER CAP 10MEQ 100 NDC CODE:68462035701 FDA PRODUCT CODE NO.:65 R C F 14 H. T. S NO.: 3004.90.92.90 ANDA NO .:202868 THERAPEUTICE USE: - MNBU0523406 001 TREATMENT OR PREVENTION OF HYPOKALEMIA INDOMETHACIN ER CAP 75MG 100 NDC CODE:684620 32501 FDA PRODUCT CODE NO.: 62GCE42 H. T. S NO.: 3004.90 .92.40 ANDA NO.: 203501 THER APEUTICE USE: :#INDOMETHACIN IS USED TO RELIEVE PAIN, SWE MNBU0523406 001 LLING,AND JOINT STIFFNESS CAU SED BY ARTHRITIS, GOUT, BURS ITIS,AND TENDONITIS.AND TEND ONITIS.IT IS ALSO USED TO REL IEVE PAIN FROM VARIOUS AS DEC REASE SWELLING ANDTHIS EFFECT HELPS TOANTI-INFLAMMATORY D RUGA NONSTEROIDALTHIS MEDICAT MNBU0523406 001 ION IS KNOWNCONDITIONS. IN DOMETHACIN ER CAP 75MG 60 NDC CODE:68462032560 FDA PRODUCT CODE: 62 GCE42 H. T. S NO. :3004.90.92.40 ANDA NO.203501 THERAPEUTIC USE: INDOMETHAC IN IS USED TO RELIEVE PAIN, S WELLING, AND JOINT STIFFNESS MNBU0523406 001 CAUSED BY ARTHRITIS, GOUT, BU RSITIS, AND TENDONITIS. IT I S ALSO USED TO RELIEVE PAIN F ROM VARIOUS OTHER CONDITIONS. THIS MEDICATION IS KNOWN AS A NONSTEROIDAL ANTI-INFLAMMA TORY DRUG (NSAID). ... THIS EFFECT HELPS TO DECREASE SWEL MNBU0523406 001 LING AND PAIN. CARVEDILOL TAB 25MG 500 NDC CODE:6846201 6505 FDA PRODUCT CODE NO : 6 2 O C A 22 H. T. S NO.: 3004 .90.92.20 ANDA NO.:- 78-251 THERAPEUTICE USE:-BETA- ADRE NOACEPTOR ANTAGONIST INDOM ETHACIN ER CAP 75MG 60 NDC CO MNBU0523406 001 DE:68462032560 FDA PRODUCT CO DE: 62 GCE42 H. T. S NO.:30 04.90.92.40 ANDA NO.203501 T HERAPEUTIC USE: INDOMETHACIN IS USED TO RELIEVE PAIN, SWEL LING, AND JOINT STIFFNESS CAU SED BY ARTHRITIS, GOUT, BURSI TIS, AND TENDONITIS. IT IS A MNBU0523406 001 LSO USED TO RELIEVE PAIN FROM VARIOUS OTHER CONDITIONS. T HIS MEDICATION IS KNOWN AS A NONSTEROIDAL ANTI-INFLAMMATOR Y DRUG (NSAID). ... THIS EFF ECT HELPS TO DECREASE SWELLIN G AND PAIN. ASPIRIN-ER DIP YRIDAMOLE CAP 25/200MG 60 NDC MNBU0523406 001 CODE:68462040560 FDA PRODUCT CODE NO.: 60 L D F 05 H. T. S NO.: 3004.90.9220 ANDA NO .:210318 TACROLIMUS CAP 1MG 100 NDC CODE:68462068601 HT S NO: 3004.90.92.15 FDA CODE : 64 T C E 08 ANDA NO.206662 THERAPEUTIC USE : TO PREVENT MNBU0523406 001 REJECTION OF A KIDNEY,HEART, OR LIVER TRANSPLANT TACRO LIMUS OINT 0.1% 100GM NDC COD E:68462053494 FDA PRODUCT COD E NO.: 64 T C J 08 H. T. S N O.: 3004.49.00.50 ANDA NO.: 210393 THERAPEUTICE USE: - T ACROLIMUS IS A TOPICAL IMMUNO MNBU0523406 001 SUPPRESSIVE OINTMENT USED FOR THE TREATMENT OF MODERATE-T O-SEVERE ATOPIC DERMATITIS ( ECZEMA). SEVELAMER HCL TAB 800MG 180 NDC CODE:6846204471 8 FDA PRODUCT CODE NO.: 63 L D A 04 H. T. S NO.: 3004.90 .92.60 ANDA NO.:204724 THERA MNBU0523406 001 PEUTICE USE:SEVELAMER HYDROC HLORIDE TABLETS ARE A PHOSPHA TE BINDER INDICATED FOR THE C ONTROL OF SERUM PHOSPHORUS IN PATIENTS WITH CHRONIC KIDNE Y DISEASE ON DIALYSIS PROP AFENONE HCL ER CAP 225MG 60 N DC CODE:68462040860 FDA PRODU MNBU0523406 001 CT CODE NO.: 63 E C F 28 H. T. S NO.: 3004.49.00.10 ANDA NO.:205268 THERAPEUTICE USE: AN ANTIARRHYTHMIC AGENT. IT IS USED TO TREAT IRREGULAR HE ART RHYTHM AND CAN SLOW RAPI D HEARTBEATS COMMERCIAL & CUSTOM INVOICE NO. F224870011 MNBU0523406 001 00 DT. 22.09.2023 F2248700110 1 DT. 22.09.2023 F22487001102 DT. 22.09.2023 F22487001103 DT. 22.09.2023 F22487001104 D T. 22.09.2023 F22487001105 DT . 22.09.2023 S/BILL NO: 40145 60 DT: 23/09/2023 S/BILL NO: 4014554 DT: 23/09/2023 S/BILL MNBU0523406 001 NO: 4014553 DT: 23/09/2023 S /BILL NO: 4014549 DT: 23/09/20 23 S/BILL NO: 4014551 DT: 23/ 09/2023 S/BILL NO: 4014550 DT : 23/09/2023 NET WT. 4287.102 KGS 03 DATA LOGGERS SET TEMPERATURE : +18 DEGREES NO TIFY PARTY:2 GLENMARK PHARMAC MNBU0523406 001 EUTICALS INC 750, CORPORATE D RIVE, NEW JERSEY MAHWAH - 07 430 USA NOTIFY PARTY:3 GLEN MARK SPECIALTY S.A. SWITZERLA ND (GSSA) PLACE DU PORT 2 NE UCHATEL - 2000 SWITZERLAND

36 PALLETS 2787 CARTONS PH ARMACEUTICALS AS UNDER EZET IMIBE-SIMVA TAB 10/20MG 30 ND C CODE:68462032230 FDA PRODUC T CODE NO.: 61 J D C 15 H. T . S NO.: 3004.49.00.10 ANDA NO.: 208699 THERAPEUTICE USE: MNBU0484399 001 :#LIPID LOWERING AGENT EZ ETIMIBE-SIMVA TAB 10/20MG 90 NDC CODE:68462032290 FDA PROD UCT CODE NO.: 61 J D C 15 H. T. S NO.: 3004.49.00.10 AND A NO.: 208699 THERAPEUTICE US E: :#LIPID LOWERING AGENT RANOLAZINE ER TAB 500MG 60 ND MNBU0484399 001 C CODE:68462031960 FDA PRODUC T CODE NO.: 61 D C B 02 H. T . S NO.: 3004.49.00.10 ANDA NO.:211082 THERAPEUTIC USE: - IT IS AN ANTI-ANGINAL MEDIC ATION. IT WORKS BY IMPROVING BLOOD FLOW TO HELP THE HEART WORK MORE EFFICIENTLY. IT IS MNBU0484399 001 USED TO TREAT CHRONIC ANGINA (CHEST PAIN). IT IS NOT FOR USE DURING AN ACUTE (EMERGENC Y) ATTACK OF ANGINA PRAVAS TATIN SOD TAB 10MG 500 NDC CO DE:68462019505 FDA PRODUCT CO DE NO.:-61 J C A 13 H. T. S NO.: 3004.90.92.20 ANDA NO.: MNBU0484399 001 -77-987 THERAPEUTICE USE:-HY POLIPDAEMIC TACROLIMUS CAP 1MG 100 NDC CODE:68462068601 HTS NO: 3004.90.92.15 FDA CO DE : 64 T C E 08 ANDA NO.2066 62 THERAPEUTIC USE : TO PREV ENT REJECTION OF A KIDNEY,HEA RT, OR LIVER TRANSPLANT TA MNBU0484399 001 CROLIMUS OINT 0.1% 100GM NDC CODE:68462053494 FDA PRODUCT CODE NO.: 64 T C J 08 H. T. S NO.: 3004.49.00.50 ANDA NO .: 210393 THERAPEUTICE USE: - TACROLIMUS IS A TOPICAL IMM UNOSUPPRESSIVE OINTMENT USED FOR THE TREATMENT OF MODERAT MNBU0484399 001 E-TO-SEVERE ATOPIC DERMATITIS (ECZEMA). CARVEDILOL TAB 25MG 500 NDC CODE:68462016505 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.90. 92.20 ANDA NO.:- 78-251 THER APEUTICE USE:-BETA- ADRENOAC EPTOR ANTAGONIST CARVEDILO MNBU0484399 001 L TAB 25MG 500 NDC CODE:68462 016505 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 30 04.90.92.20 ANDA NO.:- 78-251 THERAPEUTICE USE:-BETA- AD RENOACEPTOR ANTAGONIST COM MERCIAL & CUSTOM INVOICE NO. F22487001057 DT. 18.09.2023 F MNBU0484399 001 22487001058 DT. 18.09.2023 F2 2487001059 DT. 18.09.2023 F22 487001060 DT. 18.09.2023 F224 87001064 DT. 18.09.2023 F2248 7001065 DT. 18.09.2023 F22487 001068 DT. 18.09.2023 S/BILL NO:4014260 DT: 18/09/2023 S/B ILL NO: 4014262 DT: 18/09/2023 MNBU0484399 001 S/BILL NO: 4014264 DT: 18/09 /2023 S/BILL NO: 4014266 DT: 18/09/2023 S/BILL NO: 4014261 DT: 18/09/2023 S/BILL NO: 40 14265 DT: 18/09/2023 S/BILL N O: 4014263 DT: 18/09/2023 NET WT. 6171.094 KGS 00 DATA LO GGERS SET TEMPERATURE : +18 MNBU0484399 001 DEGREES NOTIFY PARTY:2 GL ENMARK PHARMACEUTICALS INC 75 0, CORPORATE DRIVE, NEW JERSE Y MAHWAH - 07430 USA

10 PALLETS 787 CARTONS PHA RMACEUTICALS AS UNDER PIMEC ROLIMUS CREAM 1% 30GM NDC COD E:68462060935 FDA PRODUCT COD E NO.: 61 S C J 04 H. T. S N O.: 3004.90.92.45 ANDA NO.: 211769 THERAPEUTICE USE: - AS MNBU0471766 001 SECOUND-LINE THERAPY FOR TH E SHORT-TERM AND NON-CONTINUO S CHRONIC TRERTMENT OF MILD T O MODERATE ATOPIC DERMATITIS IN NON- IMMUNOCOMPROMISED ADULT AND CHILDREN 2 YEARS OF AGE CARVEDILOL TAB 25MG 50 0 NDC CODE:68462016505 FDA P MNBU0471766 001 RODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.90.92.20 ANDA NO.:- 78-251 THERAPEUTIC E USE:-BETA- ADRENOACEPTOR ANTAGONIST CARVEDILOL TAB 2 5MG 500 NDC CODE:68462016505 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.90.9 MNBU0471766 001 2.20 ANDA NO.:- 78-251 THERA PEUTICE USE:-BETA- ADRENOACE PTOR ANTAGONIST COMMERCIAL & CUSTOM INVOICE NO. F224870 00989 DT. 31.08.2023 F2248700 0998 DT. 31.08.2023 F22487001 003 DT. 31.08.2023 S/BILL NO: 4013546 DT: 05/09/2023 S/BIL MNBU0471766 001 L NO:4013548 DT: 05/09/2023 S /BILL NO: 4013547 DT: 05/09/20 23 NET WT. 2560.957 KGS 04 D ATA LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW J ERSEY MAHWAH - 07430 USA

46 PALLETS 3658 CARTONS PH ARMACEUTICALS AS UNDER NORE THINDRONE ACE TAB 5MG 50 NDC CODE:68462030450 FDA PRODUCT CODE NO.65 J C A 25 H. T. S NO.: 3004.39.00.50 ANDA NO.: -91-090 THERAPEUTICE USE:- S MNBU0422632 001 ECONDARY AMENORRHEA,ENDOMETRI OS IS AND ABNORMAL UTERINE B LEEDING LEVONORGESTREL/EE T AB 0.09/0.02MG 84 NDC CODE:68 462063729 FDA PRODUCT CODE NO .: 64 G D A 29 H. T. S NO.: 3006.60.0000 ANDA NO.: 20279 1 THERAPEUTICE USE: - : USED MNBU0422632 001 FOR PREVENTING PREGNANCY CARVEDILOL TAB 3.125MG 100 ND C CODE:68462016201 FDA PRODUC T CODE NO - 62 O C A 22 H. T . S NO.: 3004.90.92.20 ANDA NO.:- 78-251 THERAPEUTICE US E:-BETA- ADRENOACEPTOR ANTAG ONIST CARVEDILOL TAB 3.125M MNBU0422632 001 G 500 NDC CODE:68462016205 F DA PRODUCT CODE NO ; 62 O C A 22 H. T. S NO.: 3004.90.92. 20 ANDA NO.:- 78-251 THERAPE UTICE USE:-BETA- ADRENOACEPT OR ANTAGONIST ONDANSETRON TAB 4MG 30 NDC CODE:684620105 30 FDA PRODUCT CODE NO.:-61 MNBU0422632 001 T C A 28 H. T. S NO.: 3004.9 0.92.40 ANDA NO.:- 77-535 TH ERAPEUTICE USE:-ANTI -EMETIC ZONISAMIDE CAP 100MG 100 N DC CODE:68462013001 FDA PRODU CT CODE NO.:-61 M C E 44 H. T. S NO.: 3004.49.00.20 ANDA NO.:-77-651 THERAPEUTICE US MNBU0422632 001 E:-ANTISEIZURE DRUG OXCARBA ZEPINE TAB 150MG 100 NDC CODE :68462013701 FDA PRODUCT CODE NO.:-61 M C A 45 H. T. S NO .: 3004.90.92.30 ANDA NO.:-7 7-802 THERAPEUTICE USE:-ANTI CONVULSANT AGENT OXCARBAZE PINE TAB 600MG 100 NDC CODE:6 MNBU0422632 001 8462013901 FDA PRODUCT CODE NO.:-61 M C A 45 H. T. S NO.: 3004.90.92.30 ANDA NO.:-77- 802 THERAPEUTICE USE:-ANTI C ONVULSANT AGENT OXCARBAZEPI NE TAB 150MG 100 NDC CODE:684 62013701 FDA PRODUCT CODE NO .:-61 M C A 45 H. T. S NO.: MNBU0422632 001 3004.90.92.30 ANDA NO.:-77-80 2 THERAPEUTICE USE:-ANTI CON VULSANT AGENT THEOPHYLLINE ER TAB 300MG 100 NDC CODE:684 62072101 63 B C B 30 3004.90 .92.85 212184 TO RELEASE TAB LETS ARE INDICATED FOR THE T REATMENT OF THE SYMPTOMS AND MNBU0422632 001 REVERSIBLE AIRFLOW OBSTRUCTI ON ASSOCIATED WITH CHRONIC AS THMA AND OTHER CHRONIC LUNG DISEASES, E.G., EMPHYSEMA AND CHRONIC BRONCHITIS CARVED ILOL TAB 3.125MG 500 NDC CODE :68462016205 FDA PRODUCT CODE NO ; 62 O C A 22 H. T. S NO MNBU0422632 001 .: 3004.90.92.20 ANDA NO.:- 78-251 THERAPEUTICE USE:-BET A- ADRENOACEPTOR ANTAGONIST COMMERCIAL & CUSTOM INVOICE NO. F22452002702 DT. 05.09.2 023 F22452002696 DT. 05.09.20 23 F22452002697 DT. 05.09.202 3 F22452002705 DT. 05.09.2023 MNBU0422632 001 F22452002706 DT. 05.09.2023 F22452002707 DT. 05.09.2023 F22452002708 DT. 05.09.2023 S /BILL NO: 3747588 DT 06-SEP-20 23 S/BILL NO: 3747589 DT 06-S EP-2023 S/BILL NO: 3747294 DT 06-SEP-2023 S/BILL NO: 37436 51 DT 06-SEP-2023 S/BILL NO: MNBU0422632 001 3747292 DT 06-SEP-2023 S/BILL NO: 3747298 DT 06-SEP-2023 S /BILL NO: 3747297 DT 06-SEP-20 23 NET WT. 7,162.785 KGS 02 DATA LOGGERS HUMIDITY:65% S ET TEMPERATURE : +18 DEGREES TEMPERATURE RANGE : +15 DEGREE S TO +25 DEGREES NOTIFY PARTY MNBU0422632 001 :2 GLENMARK PHARMACEUTICALS I NC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA

31 PALLETS 2634 CARTONS PHARMACEUTICALS AS UNDER PR OPAFENONE HCL ER CAP 225MG 60 NDC CODE:68462040860 FDA PRO DUCT CODE NO.: 63 E C F 28 H . T. S NO.: 3004.49.00.10 AN DA NO.:205268 THERAPEUTICE US MNBU0520665 001 E:AN ANTIARRHYTHMIC AGENT. I T IS USED TO TREAT IRREGULAR HEART RHYTHM AND CAN SLOW RA PID HEARTBEATS FENOFIBRATE CAP 200MG 100 NDC CODE:68462 058201 FDA PRODUCT CODE NO.: 61 JCE 09 H. T. S NO.: 3004 .90.92.20 ANDA NO.: 205566 T MNBU0520665 001 HERAPEUTICE USE: - INDICATED AS ADJUNCTIVE THERAPY TO DIET FOR THE REDUCTION OF LDL-C, TOTAL-C, TRIGLYCERIDES AND A PO B IN DULT PATIENTS WITH P RMARY HYPERCHOLESTEROLEMIA OR MIXED DYSLIPIDEMIA CARVED ILOL TAB 12.5MG 500 NDC CODE: MNBU0520665 001 68462016405 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO. : 3004.90.92.20 ANDA NO.:- 7 8-251 THERAPEUTICE USE:-BETA - ADRENOACEPTOR ANTAGONIST VORICONAZOLE TAB 200MG 30 N DC CODE:68462057330 FDA PRODU CT CODE NO.:61 W C A 59 H. T MNBU0520665 001 . S NO.: 3004.90.92.10 ANDA NO.:203503 THERAPEUTICE USE: -USED TO TREAT FUNGAL INFECT IONS PIMECROLIMUS CREAM 1% 30GM NDC CODE:68462060935 FD A PRODUCT CODE NO.: 61 S C J 04 H. T. S NO.: 3004.90.92.4 5 ANDA NO.: 211769 THERAPEUT MNBU0520665 001 ICE USE: - AS SECOUND-LINE TH ERAPY FOR THE SHORT-TERM AND NON-CONTINUOS CHRONIC TRERTM ENT OF MILD TO MODERATE ATOPI C DERMATITIS IN NON- IMMUNO COMPROMISED ADULT AND CHILDRE N 2 YEARS OF AGE EZETIMIBE TAB 10MG 500 NDC CODE:684620 MNBU0520665 001 22605 FDA PRODUCT CODE NO.: 61 J C A 15 H. T. S NO.: 300 4.49.00.10 ANDA NO.: #078560 THERAPEUTICE USE: LIPID LOWE RING AGENT 02 DATA LOGGERS SET TEMPERATURE : +18 DEGRE ES NET WT:5648.991KGS COM MERCIAL & CUSTOM INVOICE NO. MNBU0520665 001 F22487000953 DT. 29.08.2023 F 22487000955 DT. 30.08.2023 F2 2487000956 DT. 30.08.2023 F22 487000958 DT. 30.08.2023 S/BI LL NO:4013197 DT:30.08.2023 S /BILL NO:4013196 DT:30.08.2023 S/BILL NO:4013193 DT:30.08.2 023 S/BILL NO:4013199 DT:30.0 MNBU0520665 001 8.2023 NOTIFY PARTY:2 GLENMA RK PHARMACEUTICALS INC 750, C ORPORATE DRIVE, NEW JERSEY M AHWAH - 07430 USA

BEER MADE FROM MALT HS CODE: 220300 24 X DESCHUTES BLACK BUTTE PORTER CASES (355 ML BOTTLES) 24 X DESCHUTES MIRROR POND PALE ALE CASES (355 ML BOTTLES) 96 X DESCHUTES FRESH SQUEEZED IPA CASES (355 ML BOTTLES) 20 X DESCHUTES BLACK BUTTE PORTER CASES (355 ML CANS) 20 X DESCHUTES CATHARINA SOUR CASES (355 ML CANS) 30 X DESCHUTES FRESH HAZE IPA CASES (355 ML CANS) 40 X DESCHUTES FRESH SQUEEZED IPA CASES (355 ML CANS) 10 X DESCHUTES SQUEEZY RIDER CASES (355 ML CANS) 20 X DESCHUTES TROPICAL FRESH IPA CASES (355 ML CANS) 20 X DESCHUTES TWILIGHT SUMMER ALE CASES (355 ML CANS) 60 X DESCHUTES FRESH HAZE IPA CASES (568 ML CANS) 60 X DESCHUTES FRESH SQUEEZED IPA CASES (568 ML CANS) 20 X DESCHUTES HAZE TRON IMPERIAL HAZY IPA CASES (568 ML CANS) 20 X DESCHUTES ROYAL FRESH IMPERIAL IPA CASES (568 ML CANS) 60 X DESCHUTES SYMPHONIC CHRONIC IIPA CASES (568 ML CANS) 20 X DESCHUTES BLACK BUTTE PORTER 20 L KEGS 40 X DESCHUTES FRESH HAZE IPA 20 L KEGS 110 X DESCHUTES FRESH SQUEEZED IPA 20 L KEGS 10 X DESCHUTES KING CRISPY 20 L KEGS 10 X DESCHUTES MIRROR POND PALE ALE 20 L KEGS 40 X DESCHUTES TROPICAL FRESH IPA 20 L KEGS 10 X DESCHUTES SQUEEZY RIDER 20 L KEGS BEER MADE FROM MALT HS CODE: 220300 20 X ROGUE COLOSSAL CLAUDE CASES (355 ML CANS) 10 X ROGUE DEAD GUY ALE CASES (355 ML CANS) 20 X ROGUE DEAD GUY IPA CASES (355 ML CANS) 20 X ROGUE DEAD GUY PILSNER CASES (355 ML CANS) 10 X ROGUE DREAMLAND LAGER CASES (355 ML CANS) 20 X ROGUE HAZELNUT BROWN NECTAR CASES (355 ML CANS) 20 X ROGUE HONEY KOLSCH CASES (355 ML CANS) 20 X ROGUE CHOCOLATE STOUT NITRO 20 L KEGS 10 X ROGUE DEAD GUY ALE 20 L KEGS 10 X ROGUE DREAMLAND LAGER 20 L KEGS 10 X ROGUE HONEY KOLSCH 20 L KEGS 10 X ROGUE SHAKESPEARE OATMEAT STOUT NITRO 20 L KEGS ASSORTED ALCOHOLIC BEVERAGES HS CODE: 220830 10 X ROGUE SPIRITS CUCUMBER GIN FIZZ CASES (355 ML CANS) 10 X ROGUE SPIRITS CRANBERRY VODKA SODA CASES (355 ML CANS) 10 X ROGUE SPIRITS GRAPEFRUIT VODKA SODA CASES (355 ML CANS) 10 X ROGUE SPIRITS MOSCOW MULE CASES (355 ML CANS) 10 X ROGUE SPIRITS WHISKEY GINGER CASES (355 ML CANS) 10 X ROGUE SPIRITS LEMONADE ICE TEA VODKA SODA CASES (355 ML CANS) 10 X ROGUE SPIRITS PEACH BERRY VODKA SODA CASES (355 ML CANS)

33 PALLETS 2431 CARTONS PH ARMACEUTICALS AS UNDER RANO LAZINE ER TAB 1000MG 60 NDC C ODE:68462032060 FDA PRODUCT C ODE NO.: 61 D C B 02 H. T. S NO.: 3004.49.00.10 ANDA NO. :211082 THERAPEUTIC USE: - IT MNBU0603097 001 IS AN ANTI-ANGINAL MEDICATI ON. IT WORKS BY IMPROVING BLO OD FLOW TO HELP THE HEART WOR K MORE EFFICIENTLY. IT IS USE D TO TREAT CHRONIC ANGINA (C HEST PAIN). IT IS NOT FOR USE DURING AN ACUTE (EMERGENCY) ATTACK OF ANGINA NAPROXEN MNBU0603097 001 SOD TAB 550MG 100 NDC CODE:68 462017901 FDA PRODUCT CODE N O.:-62 G C A 50 H. T. S NO.: 3004.90.92.40 ANDA NO.:-78-3 14 THERAPEUTICE USE:-ANTI -I NFLAMMATORY, ANALGESIC FENO FIBRATE CAP 134MG 100 NDC COD E:68462058101 FDA PRODUCT COD MNBU0603097 001 E NO.: 61 JCE 09 H. T. S NO. : 3004.90.92.20 ANDA NO.: 20 5566 THERAPEUTICE USE: - IND ICATED AS ADJUNCTIVE THERAPY TO DIET FOR THE REDUCTION OF LDL-C, TOTAL-C, TRIGLYCERIDES AND APO B IN DULT PATIENTS WITH PRMARY HYPERCHOLESTEROL MNBU0603097 001 EMIA OR MIXED DYSLIPIDEMIA CARVEDILOL TAB 25MG 500 NDC CODE:68462016505 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.90.92.20 ANDA NO .:- 78-251 THERAPEUTICE USE: -BETA- ADRENOACEPTOR ANTAGON IST TACROLIMUS CAP 5MG 100 MNBU0603097 001 NDC CODE:68462068701 HTS NO: 3004.90.92.15 FDA CODE : 64 T C E 08 ANDA NO.206662 THER APEUTICE USE: TO PREVENT REJE CTION OF A KIDNEY, HEART, OR LIVER TRANSPLANT PIMECROLI MUS CREAM 1% 100GM NDC CODE:6 8462060994 FDA PRODUCT CODE N MNBU0603097 001 O.: 61 S C J 04 H. T. S NO.: 3004.90.92.45 ANDA NO.: 211 769 THERAPEUTICE USE: - AS S ECOUND-LINE THERAPY FOR THE S HORT-TERM AND NON-CONTINUOS C HRONIC TRERTMENT OF MILD TO MODERATE ATOPIC DERMATITIS IN NONIMMUNOCOMPROMISED ADULT MNBU0603097 001 AND CHILDREN 2 YEARS OF AGE PIMECROLIMUS CREAM 1% 30GM NDC CODE:68462060935 FDA PROD UCT CODE NO.: 61 S C J 04 H. T. S NO.: 3004.90.92.45 AND A NO.: 211769 THERAPEUTICE US E: - AS SECOUND-LINE THERAPY FOR THE SHORT-TERM AND NON-C MNBU0603097 001 ONTINUOS CHRONIC TRERTMENT OF MILD TO MODERATE ATOPIC DER MATITIS IN NON- IMMUNOCOMPR OMISED ADULT AND CHILDREN 2 YEARS OF AGE POTASSIUM CL E R CAP 10MEQ 500 NDC CODE:6846 2035705 FDA PRODUCT CODE NO.: 65 R C F 14 H. T. S NO.: 3 MNBU0603097 001 004.90.92.90 ANDA NO.: 202868 THERAPEUTICE USE: - TREATME NT OR PREVENTION OF HYPOKALEM IA CARVEDILOL TAB 25MG 500 NDC CODE:68462016505 FDA PRO DUCT CODE NO : 62 O C A 22 H . T. S NO.: 3004.90.92.20 AN DA NO.:- 78-251 THERAPEUTICE MNBU0603097 001 USE:-BETA- ADRENOACEPTOR AN TAGONIST COMMERCIAL & CUSTO M INVOICE NO. F22487000922 DT . 22.08.2023 F22487000924 DT. 22.08.2023 F22487000925 DT. 23.08.2023 F22487000928 DT. 2 3.08.2023 F22487000929 DT. 23 .08.2023 S/BILL NO: 4012795 D MNBU0603097 001 T: 23.08.2023 S/BILL NO: 4012 793 DT: 23.08.2023 S/BILL NO: 4012792 DT: 23.08.2023 S/BIL L NO: 4012797 DT: 23.08.2023 S/BILL NO: 4012798 DT: 23.08.2 023 NET WT. 6847.701 KGS 0 2 DATA LOGGERS HUMIDITY:65% SET TEMPERATURE : +18 DEGREES MNBU0603097 001 TEMPERATURE RANGE : +15 DEGRE ES TO +25 DEGREES NOTIFY PART Y:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NE W JERSEY MAHWAH - 07430 USA

32 PALLETS 2157 CARTONS PHA RMACEUTICALS AS UNDER GABAP ENTIN TAB 600MG 500 NDC CODE: 68462012605 FDA PRODUCT CODE NO: 61 N C A 69 H. T. S NO.: 3004.90.92.30 ANDA NO.:-77- 662 THERAPEUTICE USE:-ANTICO MNBU0250826 001 NVULSANT AGENT PRAVASTATIN SOD TAB 80MG 90 NDC CODE:684 62019890 FDA PRODUCT CODE NO .:-61 J C A 13 H. T. S NO.: 3004.90.92.20 ANDA NO.:-77-98 7 THERAPEUTICE USE:-HYPOLIPD AEMIC POTASSIUM CL ER CAP 1 0MEQ 500 NDC CODE:68462035705 MNBU0250826 001 FDA PRODUCT CODE NO.: 65 R C F 14 H. T. S NO.: 3004.90. 92.90 ANDA NO.: 202868 THERA PEUTICE USE: - TREATMENT OR P REVENTION OF HYPOKALEMIA P OTASSIUM CL ER CAP 10MEQ 100 NDC CODE:68462035701 FDA PROD UCT CODE NO.:65 R C F 14 H. MNBU0250826 001 T. S NO.: 3004.90.92.90 ANDA NO.:202868 THERAPEUTICE USE: - TREATMENT OR PREVENTION O F HYPOKALEMIA PIMECROLIMUS CREAM 1% 30GM NDC CODE:68462 060935 FDA PRODUCT CODE NO.: 61 S C J 04 H. T. S NO.: 30 04.90.92.45 ANDA NO.: 211769 MNBU0250826 001 THERAPEUTICE USE: - AS SECOU ND-LINE THERAPY FOR THE SHORT -TERM AND NON-CONTINUOS CHRON IC TRERTMENT OF MILD TO MODE RATE ATOPIC DERMATITIS IN NO N- IMMUNOCOMPROMISED ADULT A ND CHILDREN 2 YEARS OF AGE PIMECROLIMUS CREAM 1% 60GM N MNBU0250826 001 DC CODE:68462060965 FDA PRODU CT CODE NO.: 61 S C J 04 H. T. S NO.: 3004.90.92.45 ANDA NO.: 211769 THERAPEUTICE USE : - AS SECOUND-LINE THERAPY F OR THE SHORT-TERM AND NON-CO NTINUOS CHRONIC TRERTMENT OF MILD TO MODERATE ATOPIC DERM MNBU0250826 001 ATITIS IN NON- IMMUNOCOMPROM ISED ADULT AND CHILDREN 2 YE ARS OF AGE EZETIMIBE TAB 10 MG 90 NDC CODE:68462022690 F DA PRODUCT CODE NO.: 61 J C A 15 H. T. S NO.: 3004.49.00. 10 ANDA NO.: #078560 THERAPE UTICE USE: LIPID LOWERING AGE MNBU0250826 001 NT 02 DATA LOGGERS SET T EMPERATURE : +18 DEGREES NET WT:4386.002KGS COMMERCIAL & C USTOM INVOICE NO. F2248700088 7 DT. 17.08.2023 F22487000888 DT. 17.08.2023 F22487000891 DT. 17.08.2023 F22487000893 D T. 17.08.2023 F22487000894 DT MNBU0250826 001 . 17.08.2023 S/BILL NO:401247 7 DT:17.08.2023 S/BILL NO:401 2467 DT:17.08.2023 S/BILL NO: 4012469 DT:17.08.2023 S/BILL NO:4012472 DT:17.08.2023 S/BI LL NO:4012468 DT:17.08.2023 N OTIFY PARTY:2 GLENMARK PHARMA CEUTICALS INC 750, CORPORATE MNBU0250826 001 DRIVE, NEW JERSEY MAHWAH - 0 7430 USA

11 PALLETS 634 CARTONS PHA RMACEUTICALS AS UNDER RANOL AZINE ER TAB 500MG 60 NDC COD E:68462031960 FDA PRODUCT COD E NO.: 61 D C B 02 H. T. S N O.: 3004.49.00.10 ANDA NO.:2 11082 THERAPEUTIC USE: - IT I MNBU0548889 001 S AN ANTI-ANGINAL MEDICATION . IT WORKS BY IMPROVING BLOOD FLOW TO HELP THE HEART WORK MORE EFFICIENTLY. IT IS USED TO TREAT CHRONIC ANGINA (CHE ST PAIN). IT IS NOT FOR USE D URING AN ACUTE (EMERGENCY) AT TACK OF ANGINA GABAPENTIN MNBU0548889 001 TAB 600MG 500 NDC CODE:684620 12605 FDA PRODUCT CODE NO: 6 1 N C A 69 H. T. S NO.: 3004 .90.92.30 ANDA NO.:-77-662 T HERAPEUTICE USE:-ANTICONVULSA NT AGENT COMMERCIAL & CUST OM INVOICE NO. F22487000775 D T. 24.07.2023 F22487000776 DT MNBU0548889 001 . 24.07.2023 NET WT. 2257.922 KGS S/BILL NO: 4011064 DT: 25.07.2023 S/BILL NO: 4011067 DT:25.07.2023 02 DATA LO GGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GL ENMARK PHARMACEUTICALS INC 75 0, CORPORATE DRIVE, NEW JERSE MNBU0548889 001 Y MAHWAH - 07430 USA

27 PALLETS 2115 CARTONS PH ARMACEUTICALS AS UNDER THEO PHYLLINE ER TAB 300MG 100 NDC CODE:68462072101 63 B C B 30 3004.90.92.85 212184 TO RE LEASE TABLETS ARE INDICATED F OR THE TREATMENT OF THE SYMP MNBU0415675 001 TOMS AND REVERSIBLE AIRFLOW OBSTRUCTION ASSOCIATED WITH C HRONIC ASTHMA AND OTHER CHRO NIC LUNG DISEASES, E.G., EMPH YSEMA AND CHRONIC BRONCHITIS OMEPRAZOLE DR CAP 40MG 90 NDC CODE:68462039790 FDA PROD UCT CODE NO.: 62KCF10 H. T. MNBU0415675 001 S NO.: 3004.90.9160 ANDA NO. : 91672 THERAPEUTICE USE: - -TREATMENT OF TREAT GASTROESO PHAGEAL REFLUX DISEASE OXC ARBAZEPINE TAB 600MG 100 NDC CODE:68462013901 FDA PRODUCT CODE NO.:-61 M C A 45 H. T. S NO.: 3004.90.92.30 ANDA NO MNBU0415675 001 .:-77-802 THERAPEUTICE USE:-A NTI CONVULSANT AGENT ROPIN IROLE TAB 0.25MG 100 NDC CODE :68462025301 FDA PRODUCT CODE NO.:-62 J C A 17 H. T. S NO .: 3004.90.92.40 ANDA NO.:- 90-135 THERAPEUTICE USE:-TRE ATMENT OF PARKINSONISM ATO MNBU0415675 001 VAQUONE-PROG TAB 250/100MG 100 NDC CODE:68462040401 FDA PR ODUCT CODE NO.: 62 L D A 44 H. T. S NO.: 3004.90.92.90 A NDA NO.: 91-211 THERAPEUTICE USE: - ANTI MALARIAL S/B ILL NO: 2538688 DT 18-JUL-2023 S/BILL NO: 2538687 DT 18-JUL MNBU0415675 001 -2023 COMMERCIAL & CUSTOM INVOICE NO. F22452001855 DT. 17.07.2023 F22452001856 DT. 17.07.2023 NET WT. 5667.44 KG S 01 DATA LOGGERS HUMIDITY:6 5% SET TEMPERATURE : +18 DEGR EES TEMPERATURE RANGE : +15 D EGREES TO +25 DEGREES NOTIFY MNBU0415675 001 PARTY:2 SHOROUQ COMMODITIES T RADING DMCC UNIT NO. 98, DMCC BUSINESS CENTRE, LEVEL NO. 8 , JEWELLERY & GEMPLEX 2, DUBA I DUBAI UTD.ARAB EMIR.

PRINTED EDUCATIONAL BOOKS 2X20FCL CONTAINERS TOTAL 2008 BOXES PRINTED EDUCATIONAL BOOKS HS CODE 4901 1010 1200 NOS GREENS OPERATIVE HAND SURGERY - TWO VOLUME SET VOLUME 1 UACU3914711 001 ISBN 9780323833974 -002 1200 NOS GREENS OPERATIVE HAND SURGERY - TWO VOLUME SET VOLUME 2 ISBN 9780323833981-002 1260 NOS PHYSICIAN ASSISTANT BOARD REVIEW ISBN 9780323934206 -001 4000 NOS FORDNEYS MEDICAL UACU3914711 001 INSURANCE AND BILLING 6E ISBN 9780323795357 -002 1200 NOS GREENS OPERATIVE HAND SURGERY - TWO VOLUME SET VOLUME 1 ISBN 9780323833974 -002 1200 NOS GREENS OPERATIVE HAND SURGERY - TWO VOLUME SET VOLUME 2 UACU3914711 001 ISBN 9780323833981-002 1260 NOS PHYSICIAN ASSISTANT BOARD REVIEW ISBN 9780323934206 -001 4000 NOS FORDNEYS MEDICAL INSURANCE AND BILLING 6E ISBN 9780323795357 -002 560 NOS CONCEPTS FOR NURSING UACU3914711 001 PRACTICE (WITH EBOOK ACCESS ON VITALSOURCE) ISBN 9780323581936 - 005 5 NOS COMMUNICATION IN MIDWIFERY ISBN 9780323883993 -001 50 NOS ONCOLOGY AN INTRODUCTION FOR NURSES AND HEALTHCARE PROFESSIONALS UACU3914711 001 ISBN 9780323880817- 001 608 NOS MANUAL OF SPLINTING AND CASTING, 2E ISBN 9780323878296 - 001 840 NOS PEDIATRIC HEMATOLOGY & ONCOLOGY SECRETS ISBN 9780323810470 -002 800 NOS STUDY GUIDE FOR LILLEYS UACU3914711 001 PHARMACOLOGY FOR CANADIAN HEALTH CARE PRACTICE 4E ISBN 9780323694582 -003 3500 NOS RAPID REVIEW PATHOLOGY ISBN 9780323870573- 001 1700 NOS ACUTE & CHRONIC WOUNDS,6E ISBN 9780323711906 -001 INVOICE NO MTL/EXP/020/2023-24 DT UACU3914711 001 30.05.2023 SB NO. 1426584 DT 31.05.2023 SERVICE EXPORT INVOICE NO. KAM3108065 DT 30.05.2023 NET WT 20107.00 KGS HBL AMS NO CCLAIC230161 SCAC CODE AEIG FREIGHT COLLECT UACU3914711 001 INVOICE NO MTL/EXP/023/2023-24 DT 31.05.2023 SB NO. 1466610 DT 06.01.2023 SERVICE EXPORT INVOICE NO. KAM3108257 DT 35.05.2023 NET WT CAIU2792716 001 ISBN 9780323833974 -002 1200 NOS GREENS OPERATIVE HAND SURGERY - TWO VOLUME SET VOLUME 2 ISBN 9780323833981-002 1260 NOS PHYSICIAN ASSISTANT BOARD REVIEW ISBN 9780323934206 -001 4000 NOS FORDNEYS MEDICAL CAIU2792716 001 INSURANCE AND BILLING 6E ISBN 9780323795357 -002 1200 NOS GREENS OPERATIVE HAND SURGERY - TWO VOLUME SET VOLUME 1 ISBN 9780323833974 -002 1200 NOS GREENS OPERATIVE HAND SURGERY - TWO VOLUME SET VOLUME 2 CAIU2792716 001 ISBN 9780323833981-002 1260 NOS PHYSICIAN ASSISTANT BOARD REVIEW ISBN 9780323934206 -001 4000 NOS FORDNEYS MEDICAL INSURANCE AND BILLING 6E ISBN 9780323795357 -002 560 NOS CONCEPTS FOR NURSING CAIU2792716 001 PRACTICE (WITH EBOOK ACCESS ON VITALSOURCE) ISBN 9780323581936 - 005 5 NOS COMMUNICATION IN MIDWIFERY ISBN 9780323883993 -001 50 NOS ONCOLOGY AN INTRODUCTION FOR NURSES AND HEALTHCARE PROFESSIONALS CAIU2792716 001 ISBN 9780323880817- 001 608 NOS MANUAL OF SPLINTING AND CASTING, 2E ISBN 9780323878296 - 001 840 NOS PEDIATRIC HEMATOLOGY & ONCOLOGY SECRETS ISBN 9780323810470 -002 800 NOS STUDY GUIDE FOR LILLEYS CAIU2792716 001 PHARMACOLOGY FOR CANADIAN HEALTH CARE PRACTICE 4E ISBN 9780323694582 -003 3500 NOS RAPID REVIEW PATHOLOGY ISBN 9780323870573- 001 1700 NOS ACUTE & CHRONIC WOUNDS,6E ISBN 9780323711906 -001 INVOICE NO MTL/EXP/020/2023-24 DT CAIU2792716 001 30.05.2023 SB NO. 1426584 DT 31.05.2023 SERVICE EXPORT INVOICE NO. KAM3108065 DT 30.05.2023 NET WT 20107.00 KGS HBL AMS NO CCLAIC230161 SCAC CODE AEIG FREIGHT COLLECT CAIU2792716 001 INVOICE NO MTL/EXP/023/2023-24 DT 31.05.2023 SB NO. 1466610 DT 06.01.2023 SERVICE EXPORT INVOICE NO. KAM3108257 DT 35.05.2023 NET WT

27 PALLETS 1796 CARTONS P HARMACEUTICALS AS UNDER RAN OLAZINE ER TAB 500MG 60 NDC C ODE:68462031960 FDA PRODUCT C ODE NO.: 61 D C B 02 H. T. S NO.: 3004.49.00.10 ANDA NO. :211082 THERAPEUTIC USE: - IT MNBU0516618 001 IS AN ANTI-ANGINAL MEDICATI ON. IT WORKS BY IMPROVING BLO OD FLOW TO HELP THE HEART WOR K MORE EFFICIENTLY. IT IS USE D TO TREAT CHRONIC ANGINA (C HEST PAIN). IT IS NOT FOR USE DURING AN ACUTE (EMERGENCY) ATTACK OF ANGINA RANOLAZIN MNBU0516618 001 E ER TAB 1000MG 60 NDC CODE:6 8462032060 FDA PRODUCT CODE N O.: 61 D C B 02 H. T. S NO.: 3004.49.00.10 ANDA NO.:2110 82 THERAPEUTIC USE: - IT IS AN ANTI-ANGINAL MEDICATION. I T WORKS BY IMPROVING BLOOD FL OW TO HELP THE HEART WORK MOR MNBU0516618 001 E EFFICIENTLY. IT IS USED TO TREAT CHRONIC ANGINA (CHEST PAIN). IT IS NOT FOR USE DURI NG AN ACUTE (EMERGENCY) ATTAC K OF ANGINA EZETIMIBE-SIMV A TAB 10/40MG 30 NDC CODE:684 62032330 FDA PRODUCT CODE NO. : 61 J D C 15 H. T. S NO.: MNBU0516618 001 3004.49.00.10 ANDA NO.: 20869 9 THERAPEUTICE USE: - THIS C OMBINATION MEDICATION IS USED TO HELP LOWER BAD CHOLESTERO L AND FATS (SUCH AS LDL, TRI GLYCERIDES) AND RAISE GOOD CH OLESTEROL (HDL) IN THE BLOOD. EZETIMIBE WORKS BY REDUCING MNBU0516618 001 THE AMOUNT OF CHOLESTEROL YO UR BODY ABSORBS FROM YOUR DIE T. SIMVASTATIN BELONGS TO A G ROUP OF DRUGS KNOWN AS "STATI NS." IT WORKS BY REDUCING THE AMOUNT OF CHOLESTEROL MADE BY THE LIVER. TOPIRAMATE ER CAP (Q) 25MG 30 NDC CODE:684 MNBU0516618 001 62037230 3004.49.00.20 61 M C B 40 210278 RUFINAMIDE T AB 400MG 120 NDC CODE:6846207 1408 61 M C A 99 3004.90.92. 30 205075 TO USED WITH OTHER MEDICATIONS TO PREVENT OR C ONTROL SEIZURES (EPILEPSY) A SSOCIATED WITH LENNOX-GASTAUT MNBU0516618 001 SYNDROME (LGS FENOFIBRATE CAP 200MG 100 NDC CODE:68462 058201 FDA PRODUCT CODE NO.: 61 JCE 09 H. T. S NO.: 3004 .90.92.20 ANDA NO.: 205566 T HERAPEUTICE USE: - INDICATED AS ADJUNCTIVE THERAPY TO DIET FOR THE REDUCTION OF LDL-C, MNBU0516618 001 TOTAL-C, TRIGLYCERIDES AND A PO B IN DULT PATIENTS WITH P RMARY HYPERCHOLESTEROLEMIA OR MIXED DYSLIPIDEMIA CARVED ILOL TAB 12.5MG 500 NDC CODE: 68462016405 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO. : 3004.90.92.20 ANDA NO.:- 7 MNBU0516618 001 8-251 THERAPEUTICE USE:-BETA - ADRENOACEPTOR ANTAGONIST EZETIMIBE-SIMVA TAB 10/40MG 90 NDC CODE:68462032390 FDA PRODUCT CODE NO.: 61 J D C 15 H. T. S NO.: 3004.49.00.10 ANDA NO.: 208699 THERAPEUTIC E USE: :#LIPID LOWERING AGENT MNBU0516618 001 TACROLIMUS OINT 0.1% 100GM NDC CODE:68462053494 FDA PR ODUCT CODE NO.: 64 T C J 08 H. T. S NO.: 3004.49.00.50 A NDA NO.: 210393 THERAPEUTICE USE: - TACROLIMUS IS A TOPICA L IMMUNOSUPPRESSIVE OINTMENT USED FOR THE TREATMENT OF M MNBU0516618 001 ODERATE-TO-SEVERE ATOPIC DERM ATITIS (ECZEMA). 02 DATA LOGGERS HUMIDITY:65% SET TEMPERATURE : +18 DEGREE S TEMPERATURE RANGE : +15 DEGREES TO +25 DEGREES COM MERCIAL & CUSTOM INVOICE NO. F22487000139 DT. 26.04.2023 F MNBU0516618 001 22487000141 DT. 26.04.2023 F2 2487000142 DT. 26.04.2023 S /BILL NO:4005995 DT:27.04.2023 S/BILL NO:4005998 DT:27.04.2 023 S/BILL NO:4006001 DT:27.0 4.2023 NET WT.:2452.388 NO TIFY PARTY:2 GLEN MARK PHARMACEUTICALS INC MNBU0516618 001 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA

PHARMACEUTICALS AS UNDER CLINDAMYCIN HCL C AP 150MG 100 NDC CODE:68462014301 CLINDAM YCIN HCL CAP 150MG 500 NDC CODE:68462014305 POTASSIUM CL ER CAP 10MEQ 100 NDC CODE:68 462035701 FDA PRODUCT CODE NO.:65 R C F 14 H. T. S NO.: 3004.90.92.90 ANDA NO.:202868 THERAPEUTICE USE: - TREATMENT OR PREVENTIO SZLU9440976 001 N OF HYPOKALEMIA CLINDAMYCIN HCL CAP 300 MG 100 NDC CODE:68462014401 TACROLIMUS OI NT 0.1% 30GM NDC CODE:68462053435 FDA PRODU CT CODE NO.: 64 T C J 08 H. T. S NO.: 3004 .49.00.50 ANDA NO.: 210393 THERAPEUTICE USE : - TACROLIMUS IS A TOPICAL IMMUNOSUPPRESSI VE OINTMENT USED FOR THE TREATMENT OF MODE RATE-TO-SEVERE ATOPIC DERMATITIS (ECZEMA). SZLU9440976 001 CARVEDILOL TAB 12.5MG 500 NDC CODE:684620 16405 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.90.92.20 ANDA NO.:- 78-251 THERAPEUTICE USE:-BETA- ADRENOACEPTOR ANT AGONIST RANOLAZINE ER TAB 500MG 60 NDC CO DE:68462031960 FDA PRODUCT CODE NO.: 61 D C B 02 H. T. S NO.: 3004.49.00.10 ANDA NO.: 211082 THERAPEUTIC USE: - IT IS AN ANTI-ANG SZLU9440976 001 INAL MEDICATION. IT WORKS BY IMPROVING BLOO D FLOW TO HELP THE HEART WORK MORE EFFICIEN TLY. IT IS USED TO TREAT CHRONIC ANGINA (CH EST PAIN). IT IS NOT FOR USE DURING AN ACUTE (EMERGENCY) ATTACK OF ANGINA TACROLIMUS OINT 0.1% 60GM NDC CODE:68462053465 FDA PR ODUCT CODE NO.: 64 T C J 08 H. T. S NO.: 3 004.49.00.50 ANDA NO.: 210393 THERAPEUTICE SZLU9440976 001 USE: - TACROLIMUS IS A TOPICAL IMMUNOSUPPRE SSIVE OINTMENT USED FOR THE TREATMENT OF M ODERATE-TO-SEVERE ATOPIC DERMATITIS (ECZEMA ). 02 DATA LOGGERS HUMIDITY:65% SE T TEMPERATURE : +20 DEGREES TEMPERATURE RANG E : +15 DEGREES TO +25 DEGREES CONTAINER NO. SZLU9440976 COMMERCIAL & CUSTOM INVOICE NO. F22387002459 DT. 31.03.2023 F2238700246 SZLU9440976 001 9 DT. 31.03.2023 F22387002472 DT. 31.03.2023 F22387002476 DT. 31.03.2023 F22387002490 D T. 31.03.2023 F22387002493 DT. 31.03.2023 F 22387002501 DT. 31.03.2023

40 PALLETS 2247 CARTONS PHA RMACEUTICALS AS UNDER PRAV ASTATIN SOD TAB 20MG 90 NDC C ODE:68462019690 FDA PRODUCT C ODE NO.:-61 J C A 13 H. T. S NO.: 3004.90.92.20 ANDA NO. :-77-987 THERAPEUTICE USE:-H MNBU0315505 001 YPOLIPDAEMIC RANOLAZINE ER TAB 1000MG 60 NDC CODE:68462 032060 FDA PRODUCT CODE NO.: 61 D C B 02 H. T. S NO.: 30 04.49.00.10 ANDA NO.:211082 THERAPEUTIC USE: - IT IS AN A NTI-ANGINAL MEDICATION. IT WO RKS BY IMPROVING BLOOD FLOW T MNBU0315505 001 O HELP THE HEART WORK MORE E FFICIENTLY. IT IS USED TO TRE AT CHRONIC ANGINA (CHEST PAIN ). IT IS NOT FOR USE DURING A N ACUTE (EMERGENCY) ATTACK OF ANGINA EZETIMIBE-SIMVA T AB 10/10MG 90 NDC CODE:684620 32190 FDA PRODUCT CODE NO.: MNBU0315505 001 61 J D C 15 H. T. S NO.: 300 4.49.00.10 ANDA NO.: 208699 THERAPEUTICE USE: - THIS COMB INATION MEDICATION IS USED TO HELP LOWER BAD CHOLESTEROL A ND FATS (SUCH AS LDL, TRIGLY CERIDES) AND RAISE GOOD CHOLE STEROL (HDL) IN THE BLOOD. EZ MNBU0315505 001 ETIMIBE WORKS BY REDUCING THE AMOUNT OF CHOLESTEROL YOUR BODY ABSORBS FROM YOUR DIET. SIMVASTATIN BELONGS TO A GROU P OF DRUGS KNOWN AS "STATINS. " IT WORKS BY REDUCING THE A MOUNT OF CHOLESTEROL MADE BY THE LIVER. EZETIMIBE-SIMVA MNBU0315505 001 TAB 10/40MG 30 NDC CODE:6846 2032330 FDA PRODUCT CODE NO.: 61 J D C 15 H. T. S NO.: 3 004.49.00.10 ANDA NO.: 208699 THERAPEUTICE USE: - THIS CO MBINATION MEDICATION IS USED TO HELP LOWER BAD CHOLESTEROL AND FATS (SUCH AS LDL, TRIG MNBU0315505 001 LYCERIDES) AND RAISE GOOD CHO LESTEROL (HDL) IN THE BLOOD. EZETIMIBE WORKS BY REDUCING T HE AMOUNT OF CHOLESTEROL YOU R BODY ABSORBS FROM YOUR DIET . SIMVASTATIN BELONGS TO A GR OUP OF DRUGS KNOWN AS "STATIN S." IT WORKS BY REDUCING THE MNBU0315505 001 AMOUNT OF CHOLESTEROL MADE B Y THE LIVER. EZETIMIBE-SIM VA TAB 10/40MG 90 NDC CODE:68 462032390 FDA PRODUCT CODE NO .: 61 J D C 15 H. T. S NO.: 3004.49.00.10 ANDA NO.: 2086 99 THERAPEUTICE USE: :#LIPID LOWERING AGENT POTASSIUM MNBU0315505 001 CL ER CAP 10MEQ 500 NDC CODE: 68462035705 FDA PRODUCT CODE NO.: 65 R C F 14 H. T. S NO. : 3004.90.92.90 ANDA NO.: 20 2868 THERAPEUTICE USE: - TRE ATMENT OR PREVENTION OF HYPOK ALEMIA GABAPENTIN TAB 600M G 500 NDC CODE:68462012605 F MNBU0315505 001 DA PRODUCT CODE NO: 61 N C A 69 H. T. S NO.: 3004.90.92.3 0 ANDA NO.:-77-662 THERAPEUT ICE USE:-ANTICONVULSANT AGEN T COMMERCIAL & CUSTOM INVO ICE NO. F22387002396 DT. 28.0 3.2023 F22387002397 DT. 28.03 .2023 F22387002398 DT. 28.03. MNBU0315505 001 2023 F22387002399 DT. 28.03.2 023 S/BILL NO: 4004458 DT: 29 .03.2023 S/BILL NO: 4004452 D T: 29.03.2023 S/BILL NO: 4004 457 DT: 29.03.2023 S/BILL NO: 4004455 DT: 29.03.2023 NET W T.6857.916 KGS 02 DATA LOGGER S NOTIFY PARTY:2 GLENMARK MNBU0315505 001 PHARMACEUTICALS INC 750, CORP ORATE DRIVE, NEW JERSEY MAHW AH - 07430 USA

35 PALLETS 2250 CARTONS PHARMACEUTICALS AS UNDER G ABAPENTIN TAB 600MG 500 NDC C ODE:68462012605 FDA PRODUCT CODE NO: 61 N C A 69 H. T. S NO.: 3004.90.92.30 ANDA NO. :-77-662 THERAPEUTICE USE:-A MNBU0295651 001 NTICONVULSANT AGENT RANOLA ZINE ER TAB 1000MG 60 NDC COD E:68462032060 FDA PRODUCT COD E NO.: 61 D C B 02 H. T. S N O.: 3004.49.00.10 ANDA NO.:2 11082 THERAPEUTIC USE: - IT I S AN ANTI-ANGINAL MEDICATION . IT WORKS BY IMPROVING BLOOD MNBU0295651 001 FLOW TO HELP THE HEART WORK MORE EFFICIENTLY. IT IS USED TO TREAT CHRONIC ANGINA (CHE ST PAIN). IT IS NOT FOR USE D URING AN ACUTE (EMERGENCY) AT TACK OF ANGINA TOPIRAMATE ER CAP (Q) 25MG 30 NDC CODE:6 8462037230 3004.49.00.20 61 MNBU0295651 001 M C B 40 210278 INDOMETHAC IN ER CAP 75MG 60 NDC CODE:68 462032560 FDA PRODUCT CODE: 6 2 GCE42 H. T. S NO.:3004.90 .92.40 ANDA NO.203501 THERAP EUTIC USE: INDOMETHACIN IS US ED TO RELIEVE PAIN, SWELLING, AND JOINT STIFFNESS CAUSED MNBU0295651 001 BY ARTHRITIS, GOUT, BURSITIS, AND TENDONITIS. IT IS ALSO U SED TO RELIEVE PAIN FROM VARI OUS OTHER CONDITIONS. THIS M EDICATION IS KNOWN AS A NONST EROIDAL ANTI-INFLAMMATORY DRU G (NSAID). ... THIS EFFECT H ELPS TO DECREASE SWELLING AND MNBU0295651 001 PAIN. FENOFIBRATE CAP 134 MG 100 NDC CODE:68462058101 FDA PRODUCT CODE NO.: 61 JCE 09 H. T. S NO.: 3004.90.92.2 0 ANDA NO.: 205566 THERAPEUT ICE USE: - INDICATED AS ADJUN CTIVE THERAPY TO DIET FOR THE REDUCTION OF LDL-C, TOTAL-C MNBU0295651 001 , TRIGLYCERIDES AND APO B IN DULT PATIENTS WITH PRMARY H YPERCHOLESTEROLEMIA OR MIXED DYSLIPIDEMIA TACROLIMUS OIN T 0.1% 30GM NDC CODE:68462053 435 FDA PRODUCT CODE NO.: 64 T C J 08 H. T. S NO.: 3004. 49.00.50 ANDA NO.: 210393 TH MNBU0295651 001 ERAPEUTICE USE: - TACROLIMUS IS A TOPICAL IMMUNOSUPPRESSIV E OINTMENT USED FOR THE TREA TMENT OF MODERATE-TO-SEVERE ATOPIC DERMATITIS (ECZEMA). TACROLIMUS OINT 0.1% 60GM N DC CODE:68462053465 FDA PRODU CT CODE NO.: 64 T C J 08 H. MNBU0295651 001 T. S NO.: 3004.49.00.50 ANDA NO.: 210393 THERAPEUTICE USE : - TACROLIMUS IS A TOPICAL IMMUNOSUPPRESSIVE OINTMENT US ED FOR THE TREATMENT OF MODE RATE-TO-SEVERE ATOPIC DERMATI TIS (ECZEMA). TACROLIMUS C AP 1MG 100 NDC CODE:684620686 MNBU0295651 001 01 HTS NO: 3004.90.92.15 FDA CODE : 64 T C E 08 ANDA NO.2 06662 THERAPEUTIC USE : TO P REVENT REJECTION OF A KIDNEY, HEART, OR LIVER TRANSPLANT INDOMETHACIN ER CAP 75MG 90 NDC CODE:68462032590 FDA PROD UCT CODE NO.: 62 GCE42 H. T. MNBU0295651 001 S NO.: 3004.90.92.40 ANDA N O.: 203501 THERAPEUTICE USE: #INDOMETHACIN IS USED TO REL IEVE PAIN, SWELLING AND JOINT STIFFNESS CAUSED BY ARTHRITI S, GOUT, BURSITIS AND TENDONI TIS IT IS ALSO USED TO RELIEV E PAIN FROM VARIOUS OTHER CO MNBU0295651 001 NDITIONS.THIS MEDICATION IS KNOWN AS A NONSTEROIDAL ANTI -INFLAMMATORY DRUG THIS EFFEC T HELPS TO DECREASE SWELLING AND PAIN. COMMERCIAL & CUS TOM INVOICE NO. F22387002162 DT. 22.02.2023 F22387002164 D T. 22.02.2023 F22387002169 DT MNBU0295651 001 . 23.02.2023 F22387002166 DT. 22.02.2023 F22387002165 DT. 22.02.2023 NET WT. 3678.343 KGS 02 DATA LOGGERS HUMIDIT Y:65% SET TEMPERATURE : +20 D EGREES TEMPERATURE RANGE : +1 5 DEGREES TO +25 DEGREES NOTI FY PARTY:2 GLENMARK PHARMACEU MNBU0295651 001 TICALS INC 750, CORPORATE DRI VE, NEW JERSEY MAHWAH - 0743 0 USA S/BILL NO: 4002607 D T: 23.02.2023 S/BILL NO: 4002 604 DT: 23.02.2023 S/BILL NO: 4002608 DT: 23.02.2023 S/BIL L NO: 4002603 DT: 23.02.2023 S/BILL NO: 4002605 DT: 23.02.2 MNBU0295651 001 023

9 PALLETS 726 CARTONS PHARMACEUTICALS AS UNDER T HEOPHYLLINE ER TAB 300MG 100 NDC CODE:68462072101 63 B C B 30 3004.90.92.85 212184 TO RELEASE TABLETS ARE INDICATE D FOR THE TREATMENT OF THE S MNBU0441910 001 YMPTOMS AND REVERSIBLE AIRFLO W OBSTRUCTION ASSOCIATED WIT H CHRONIC ASTHMA AND OTHER C HRONIC LUNG DISEASES, E.G., E MPHYSEMA AND CHRONIC BRONCHIT IS NAPROXEN TAB 500MG 500 NDC CODE:68462019005 FDA PROD UCT CODE NO.:-62 G C A 49 H. MNBU0441910 001 T. S NO.: 3004.90.92.40 AND A NO.:-78-250 THERAPEUTICE U SE:-ANTI-INFLAMMATORY, ANALGE SIC TOPIRAMATE TAB 25MG 60 NDC CODE:68462010860 FDA PRO DUCT CODE NO.:-61 M C A 40 H . T. S NO.: 3004.49.00.20 AN DA NO.:- 77-627 THERAPEUTICE MNBU0441910 001 USE:-ANTICONVULSANT COMMER CIAL & CUSTOM INVOICE NO. F22 352005007 DT. 24.01.2023 F223 52005009 DT. 24.01.2023 NET W T.1620.153 KGS 01 DATA LOGGER S S/BILL NO: 7271100 DT 25- JAN-2023 S/BILL NO: 7268108 D T 25-JAN-2023 NOTIFY PART MNBU0441910 001 Y:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NE W JERSEY MAHWAH - 07430 USA

11 PALLETS 1586 CARTONS PH ARMACEUTICALS AS UNDER THEO PHYLLINE ER TAB 300MG 100 NDC CODE:68462072101 63 B C B 30 3004.90.92.85 212184 TO RE LEASE TABLETS ARE INDICATED F OR THE TREATMENT OF THE SYMP MNBU0622395 001 TOMS AND REVERSIBLE AIRFLOW OBSTRUCTION ASSOCIATED WITH C HRONIC ASTHMA AND OTHER CHRO NIC LUNG DISEASES, E.G., EMPH YSEMA AND CHRONIC BRONCHITIS TOPIRAMATE TAB 25MG 500 ND C CODE:68462010805 FDA PRODUC T CODE NO.: 61 M C A 40 H. T MNBU0622395 001 . S NO.: 3004.49.00.20 ANDA NO.:077627 THERAPEUTICE USE: ANTICONVULSANT TOPIRAMATE TAB 25MG 500 NDC CODE:6846201 0805 FDA PRODUCT CODE NO.: 6 1 M C A 40 H. T. S NO.: 3004 .49.00.20 ANDA NO.:077627 TH ERAPEUTICE USE: ANTICONVULSAN MNBU0622395 001 T TOPIRAMATE TAB 25MG 60 N DC CODE:68462010860 FDA PRODU CT CODE NO.:-61 M C A 40 H. T. S NO.: 3004.49.00.20 ANDA NO.:- 77-627 THERAPEUTICE U SE:-ANTICONVULSANT COMMERCI AL & CUSTOM INVOICE NO. F2235 2005033 DT. 25.01.2023 F22352 MNBU0622395 001 005034 DT. 25.01.2023 F223520 05032 DT. 25.01.2023 S/BILL NO: 7289432 DT 27-JAN-2023 S /BILL NO: 7296854 DT 27-JAN-20 23 S/BILL NO: 7285420 DT 27-J AN-2023 NET WT. 1844.447 KGS 01 DATA LOGGERS HUMIDITY :65% SET TEMPERATURE : +20 DE MNBU0622395 001 GREES TEMPERATURE RANGE : +15 DEGREES TO +25 DEGREES NOTIF Y PARTY:2 GLENMARK PHARMACEUT ICALS INC 750, CORPORATE DRIV E, NEW JERSEY MAHWAH - 07430 USA

FREIGHT PREPAID 86 CARTONS 681 KGM 2.12 QMT AUTOMOTIVE EQUIPMENT ON 2 PAL BSL 48977 TLLU5220405 001 AEROSOLS (ABOVE 1L) FLAMMABLE LIQUID, N.O.S. IMCO NUMBER:2.1 IMCO NUMBER:3 SERIAL NUMBER:1950 SERIAL NUMBER:1993 PACKAGE GROUP:2 DGS CONTACT: DIANA GUCKERT +498331944440 TLLU5220405 001 DGS CONTACT: EMERGENCY DGD CONTACT +331454259 DGS CONTACT: FREDERIC CHOURAKI +33247343388 CEO CONTACT: PHILIPPE ENTRINGER +33321435279 DGS CONTACT: WYNN'S +33557262900 DGS CONTACT: CATHERINE FARGET +33474023938 95 CARTONS 406KGM 1.94 MTQ TLLU5220405 001 ADHESIVES 2 PAL = 95 PACKAGES BSL 47879 AEROSOLS (ABOVE 1L) AEROSOLS (ABOVE 1L) AMINES, LIQUID, CORROSIVE, N.O.S. ENVIRONMENTALLY HAZARDOUS SUBSTANCE, LIQUID, N.O.S. TLLU5220405 001 IMCO NUMBER:2.1 IMCO NUMBER:2.2 IMCO NUMBER:8 IMCO NUMBER:9 SERIAL NUMBER:1950 SERIAL NUMBER:1950 SERIAL NUMBER:2735 SERIAL NUMBER:3082 TLLU5220405 001 PACKAGE GROUP:2 PACKAGE GROUP:3 4 CARTONS 33 KGM 0.46 MTQ STICKERS ON 1 PAL BSL 48775 4 PACKAGE(S) TLLU5220405 001 273 KGM 1.86 MTQ AUTO MAINTENANCE ON 4 PAL BOX BSL 49043 7 PACKAGE(S) 1133 KGM 4.21 QMT AUTOMOTIVE EQUIPMENT ON 7 TLLU5220405 001 PAL-BOX BSL 48858 5 CARTONS 2694 KGM 8.55 MTQ AUTOMOTIVE EQUIPMENT ON 5 PAL-BOX BSL 49021 TLLU5220405 001 32 PACKAGE(S) 63 KGM 0.28 MTQ AUTO MAINTENANCE ON 1 PAL = 32 PKG BSL 48980 2 PACKAGE(S) 116KGM TLLU5220405 001 1.34 MTQ AUTOMOTIVE EQUIPMENT ON 1 PAL + 1 PARCEL = 2 BOX BSL 47163 5 PACKAGE(S) 500KGM 4.73 MTQ AUTOMOTIVE EQUIPMENT ON 5 TLLU5220405 001 PAL-BOX BSL 48891 98 CARTONS 504KGM 2.12 QMT AEROSOLS (ABOVE 1L) FLAMMABLE LIQUID, N.O.S. ADHESIVES TLLU5220405 001 ENVIRONMENTALLY HAZARDOUS SUBSTANCE, LIQUID, N.O.S. ENVIRONMENTALLY HAZARDOUS SUBSTANCE, SOLID, N.O.S. IMCO NUMBER:2.1 IMCO NUMBER:3 IMCO NUMBER:3 IMCO NUMBER:9 TLLU5220405 001 IMCO NUMBER:9 SERIAL NUMBER:1950 SERIAL NUMBER:1993 SERIAL NUMBER:1133 SERIAL NUMBER:3082 SERIAL NUMBER:3077 PACKAGE GROUP:3 PACKAGE GROUP:2 TLLU5220405 001 PACKAGE GROUP:3 PACKAGE GROUP:3 AUTOMOTIVE EQUIPMENT ON 2 PAL = 98 PACKAGES BSL 48709 49 CARTONS 272KGM 2.74 MTQ TLLU5220405 001 ON 2 PAL TOOLS = 49 PACKAGES BSL 48019 2 PACKAGE(S) 533 KGM 0.74 MTQ AUTO MAINTENANCE ON 2 PAL = 2 PACKAGE BSL 47767 TLLU5220405 001 2 PACKAGE(S) 450 KGM 1.79 MTQ AUTOMOTIVE EQUIPMENT ON 2 PAL-BOX BSL 47248 2 PACKAGE(S) 371 KGM TLLU5220405 001 1.06 MTQ AUTOMOTIVE EQUIPMENT ON 2 PAL-BOX BSL 47511 4 PACKAGE(S) 337 KGM 1.47 MTQ AUTO MAINTENANCE ON 3 PALBOX + TLLU5220405 001 1 PACKAGE BSL 47515 2 CARTONS 94KGM 1.08 MTQ CAR MAINTENANCE 2 PACKAGES BSL 48441 TLLU5220405 001 5 CARTONS 326 KGM 2.01 MTQ AUTOMOTIVE EQUIPMENT ON 3 PAL + 2 PARCELS BSL 49045 6 PACKAGE(S) 376KGM TLLU5220405 001 1.44 MTQ AUTOMOTIVE EQUIPMENT 6 PACKAGES 6000KGM 5.24 MTQ BATTERIES, WET, FILLED WITH ACID IMCO NUMBER:8 TLLU5220405 001 SERIAL NUMBER:2794 AUTOMOTIVE EQUIPMENT ON 6 PALBOX BSL 46803 31 CARTONS 803 KGM 1.1 QMT FLAMMABLE LIQUID, N.O.S. TLLU5220405 001 IMCO NUMBER:3 SERIAL NUMBER:1993 PACKAGE GROUP:3 AUTOMOTIVE EQUIPMENT ON 1 PAL BSL 48738 3 PACKAGE(S) 511 KGM TLLU5220405 001 2.42 MTQ AUTOMOTIVE EQUIPMENT ON 3 PALLETS BSL 48317 9 PACKAGE(S) 9400 KGM 8.14 QMT BATTERIES, WET, FILLED WITH TLLU5220405 001 ACID IMCO NUMBER:8 SERIAL NUMBER:2794 AUTOMOTIVE EQUIPMENT ON 9 PAL-BOX BSL 48992 2 CARTONS 58KGM TLLU5220405 001 0.38 MTQ AUTOMOTIVE EQUIPMENT 56 CARTONS 311 KGM 1.14 MTQ AEROSOLS (ABOVE 1L) HYDROCARBONS, LIQUID, N.O.S. IMCO NUMBER:2.1 TLLU5220405 001 IMCO NUMBER:3 SERIAL NUMBER:1950 SERIAL NUMBER:3295 PACKAGE GROUP:3 MAINTENANCE AUTO ON 1 PAL BSL 48052 42 CARTONS 248KGM TLLU5220405 001 4.2 QMT AUTOMOTIVE EQUIPMENT ON 2 PAL = BSL 48846 PSN: FLAMMABLE LIQUID, N.O.S. UN NUMBER: 1993 - IMDG CLASS: 3 - PG: III - FLASHPOINT: 27 C CHEMICAL NAME: ETHANOL, METHANOL TLLU5220405 001 PSN: AEROSOLS UN NUMBER: 1950 - IMDG CLASS: 2.1 PSN: FLAMMABLE LIQUID, N.O.S. UN NUMBER: 1993 - IMDG CLASS: 3 - PG: III - FLASHPOINT: 54 C CHEMICAL NAME: PENTYLE ACETATE, PROPYL DIMETHYLPROPOXY PROPANOATE AQUATIC CHRONIC PE ACETATE TLLU5220405 001 PSN: ADHESIVES CONTAINING FLAMMABLE LIQUID UN NUMBER: 1133 - IMDG CLASS: 3 - PG: II - FLASHPOINT: 17 C PSN: ENVIRONMENTALLY HAZARDOUS SUBSTANCE, LIQ N.O.S. UN NUMBER: 3082 - IMDG CLASS: 9 - PG: III CHEMICAL NAME: CYCLOHEXANOL DIMETHYLETHYL ACE VERDYL PROPIONATE TLLU5220405 001 PSN: ENVIRONMENTALLY HAZARDOUS SUBSTANCE, LIQ N.O.S. UN NUMBER: 3082 - IMDG CLASS: 9 - PG: III CHEMICAL NAME: METHYL ETHER LIMONENE BENZYL ACETATE CITRAL PSN: ENVIRONMENTALLY HAZARDOUS SUBSTANCE, SOL N.O.S. UN NUMBER: 3077 - IMDG CLASS: 9 - PG: III TLLU5220405 001 CHEMICAL NAME: CYCLOHEXYLPROPIONATE ALLYLE, COUMARINE, ALPHA METHYLCINNAMALDEHYDE, BENZOA BENZYL HEXANOATE ALLYL PSN: BATTERIES, WET, FILLED WITH ACID ELECTRI STORAGE UN NUMBER: 2794 - IMDG CLASS: 8 CHEMICAL NAME: 378 NW BATTERIES PSN: AEROSOLS TLLU5220405 001 UN NUMBER: 1950 - IMDG CLASS: 2.1 PSN: AEROSOLS UN NUMBER: 1950 - IMDG CLASS: 2.1 PSN: AEROSOLS UN NUMBER: 1950 - IMDG CLASS: 2.2 PSN: AMINES, LIQUID, CORROSIVE, N.O.S. UN NUMBER: 2735 - IMDG CLASS: 8 - PG: II CHEMICAL NAME: OXYBIS ETHYLENEOXY BIS PROPYLA TLLU5220405 001 PSN: ENVIRONMENTALLY HAZARDOUS SUBSTANCE, LIQ N.O.S. UN NUMBER: 3082 - IMDG CLASS: 9 - PG: III CHEMICAL NAME: FATTY ACID AMIDE PSN: ENVIRONMENTALLY HAZARDOUS SUBSTANCE, LIQ N.O.S. UN NUMBER: 3082 - IMDG CLASS: 9 - PG: III CHEMICAL NAME: AMINES, POLYETHYLENEPOLY, TLLU5220405 001 TRIETHYLENETETRAMINE, FRACTION PSN: ENVIRONMENTALLY HAZARDOUS SUBSTANCE, LIQ N.O.S. UN NUMBER: 3082 - IMDG CLASS: 9 - PG: III CHEMICAL NAME: BISPHENOL A EPICHLOHYDRIN RESI PSN: AEROSOLS UN NUMBER: 1950 - IMDG CLASS: 2.1 PSN: AEROSOLS TLLU5220405 001 UN NUMBER: 1950 - IMDG CLASS: 2.1 PSN: AEROSOLS UN NUMBER: 1950 - IMDG CLASS: 2.1 PSN: AEROSOLS UN NUMBER: 1950 - IMDG CLASS: 2.1 PSN: AEROSOLS UN NUMBER: 1950 - IMDG CLASS: 2.1 PSN: HYDROCARBONS, LIQUID, N.O.S. TLLU5220405 001 UN NUMBER: 3295 - IMDG CLASS: 3 - PG: III - FLASHPOINT: 47 C PSN: AEROSOLS UN NUMBER: 1950 - IMDG CLASS: 2.1 PSN: FLAMMABLE LIQUID, N.O.S. UN NUMBER: 1993 - IMDG CLASS: 3 - PG: II - FLASHPOINT: 12 C CHEMICAL NAME: ISOPROPANOL TLLU5220405 001 PSN: BATTERIES, WET, FILLED WITH ACID ELECTRI STORAGE UN NUMBER: 2794 - IMDG CLASS: 8 CHEMICAL NAME: 555 NEW BATTERIES

35 PALLETS 1773 CARTONS PHARMACEUTICALS AS UNDER E ZETIMIBE-SIMVA TAB 10/40MG 30 NDC CODE:68462032330 FDA PRO DUCT CODE NO.: 61 J D C 15 H . T. S NO.: 3004.49.00.10 AN DA NO.: 208699 THERAPEUTICE U MNBU0627400 001 SE: - THIS COMBINATION MEDICA TION IS USED TO HELP LOWER B AD CHOLESTEROL AND FATS (SUCH AS LDL, TRIGLYCERIDES) AND R AISE GOOD CHOLESTEROL (HDL) IN THE BLOOD. EZETIMIBE WORKS BY REDUCING THE AMOUNT OF CH OLESTEROL YOUR BODY ABSORBS F MNBU0627400 001 ROM YOUR DIET. SIMVASTATIN B ELONGS TO A GROUP OF DRUGS KN OWN AS "STATINS." IT WORKS BY REDUCING THE AMOUNT OF CHOLE STEROL MADE BY THE LIVER. EZETIMIBE-SIMVA TAB 10/80MG 30 NDC CODE:68462032430 FDA PR ODUCT CODE NO.: 61 J D C 15 MNBU0627400 001 H. T. S NO.: 3004.49.00.10 A NDA NO.: 208699 THERAPEUTICE USE: - THIS COMBINATION MEDIC ATION IS USED TO HELP LOWER BAD CHOLESTEROL AND FATS (SUC H AS LDL, TRIGLYCERIDES) AND RAISE GOOD CHOLESTEROL (HDL) IN THE BLOOD. EZETIMIBE WORK MNBU0627400 001 S BY REDUCING THE AMOUNT OF C HOLESTEROL YOUR BODY ABSORBS FROM YOUR DIET. SIMVASTATIN BELONGS TO A GROUP OF DRUGS K NOWN AS "STATINS." IT WORKS B Y REDUCING THE AMOUNT OF CHOL ESTEROL MADE BY THE LIVER. COLESEVELAM HCL TAB 625MG 180 MNBU0627400 001 NDC CODE:68462043318 FDA PR ODUCT CODE NO.: 62 B D A 13 H. T. S NO.: 3004.49.00.10 A NDA NO.: 203480 THERAPEUTICE USE: - ANTIHYPERLIPO PROTEIN EMIC. DILTIAZEM HCL ER CAP 12HR 120MG 100 NDC CODE:68462 056201 62 O C B 24 3004.49.0 MNBU0627400 001 0.10 212317 FOR THE TREATMEN T OF HYPERTENSION. DILTIAZ EM HCL ER CAP 12HR 90MG 100 N DC CODE:68462085101 62 O C B 24 3004.49.00.10 212317 FOR THE TREATMENT OF HYPERTENSIO N. CARVEDILOL TAB 25MG 500 NDC CODE:68462016505 FDA PRO MNBU0627400 001 DUCT CODE NO : 62 O C A 22 H . T. S NO.: 3004.90.92.20 AN DA NO.:- 78-251 THERAPEUTICE USE:-BETA- ADRENOACEPTOR AN TAGONIST EZETIMIBE-SIMVA TA B 10/40MG 90 NDC CODE:6846203 2390 FDA PRODUCT CODE NO.: 6 1 J D C 15 H. T. S NO.: 3004 MNBU0627400 001 .49.00.10 ANDA NO.: 208699 T HERAPEUTICE USE: :#LIPID LOWE RING AGENT CHLORPROMAZINE H CL TAB 10MG 100 NDC CODE:6846 2086101 61 T C A 04 3004.90. 92.40 212144 TO TREAT PSYCHO TIC DISORDERS SUCH AS SCHIZO PHRENIA OR MANIC-DEPRESSION MNBU0627400 001 IN ADULTS PIMECROLIMUS CREA M 1% 30GM NDC CODE:6846206093 5 FDA PRODUCT CODE NO.: 61 S C J 04 H. T. S NO.: 3004.90 .92.45 ANDA NO.: 211769 THER APEUTICE USE: - AS SECOUND-LI NE THERAPY FOR THE SHORT-TERM AND NON-CONTINUOS CHRONIC T MNBU0627400 001 RERTMENT OF MILD TO MODERATE ATOPIC DERMATITIS IN NONIMMU NOCOMPROMISED ADULT AND CHILD REN 2 YEARS OF AGE TACROLI MUS OINT 0.1% 100GM NDC CODE: 68462053494 FDA PRODUCT CODE NO.: 64 T C J 08 H. T. S NO. : 3004.49.00.50 ANDA NO.: 21 MNBU0627400 001 0393 THERAPEUTICE USE: - TAC ROLIMUS IS A TOPICAL IMMUNOSU PPRESSIVE OINTMENT USED FOR T HE TREATMENT OF MODERATE-TO- SEVERE ATOPIC DERMATITIS (EC ZEMA). SIROLIMUS TAB 0.5MG 100 NDC CODE:68462068201 FDA PRODUCT CODE NO.: 64 T C A 1 MNBU0627400 001 2 H. T. S NO.: 3004.90.92.15 ANDA NO.: 208691 THERAPEUTI CE USE: TO PREVENT REJECTION OF KIDNEY TRANSPLANTS. CAR VEDILOL TAB 25MG 500 NDC CODE :68462016505 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO .: 3004.90.92.20 ANDA NO.:- MNBU0627400 001 78-251 THERAPEUTICE USE:-BET A- ADRENOACEPTOR ANTAGONIST COMMERCIAL & CUSTOM INVOICE NO. F22387001721 DT. 20.12.2 022 F22387001722 DT. 20.12.20 22 F22387001724 DT. 20.12.202 2 F22387001679 DT. 14.12.2022 S/BILL NO: 4018136 DT: 21.12 MNBU0627400 001 .2022 S/BILL NO:4018134 DT: 2 1.12.2022 S/BILL NO: 4018139 DT: 21.12.2022 S/BILL NO:4018 135 DT: 21.12.2022 NET WT. 4, 939.16 KGS 02 DATA LOGGERS HUMIDITY:65% SET TEMPERATURE : +18 DEGREES TEMPERATURE RAN GE : +15 DEGREES TO +25 DEGREE MNBU0627400 001 S NOTIFY PARTY:2 GLENMARK PH ARMACEUTICALS INC 750, CORPOR ATE DRIVE, NEW JERSEY MAHWAH - 07430 USA

17 PALLETS 956 CARTO NS PHARMACEUTICALS AS UNDER EZETIMIBE TAB 10MG 90 NDC CODE:68462022690 FDA PRODUCT CODE NO.: 61 J C A 15 H. T. S NO.: 3004.49.00.10 ANDA N O.: #078560 THERAPEUTICE USE: MNBU0631123 001 LIPID LOWERING AGENT EZET IMIBE TAB 10MG 500 NDC CODE:6 8462022605 FDA PRODUCT CODE N O.: 61 J C A 15 H. T. S NO.: 3004.49.00.10 ANDA NO.: #07 8560 THERAPEUTICE USE: LIPID LOWERING AGENT NAPROXEN SO D TAB 550MG 100 NDC CODE:6846 MNBU0631123 001 2017901 FDA PRODUCT CODE NO. :-62 G C A 50 H. T. S NO.: 3 004.90.92.40 ANDA NO.:-78-314 THERAPEUTICE USE:-ANTI -INF LAMMATORY, ANALGESIC EZETIM IBE TAB 10MG 500 NDC CODE:684 62022605 FDA PRODUCT CODE NO. : 61 J C A 15 H. T. S NO.: MNBU0631123 001 3004.49.00.10 ANDA NO.: #0785 60 THERAPEUTICE USE: LIPID L OWERING AGENT RUFINAMIDE TA B 400MG 120 NDC CODE:68462071 408 61 M C A 99 3004.90.92.3 0 205075 TO USED WITH OTHER MEDICATIONS TO PREVENT OR CO NTROL SEIZURES (EPILEPSY) AS MNBU0631123 001 SOCIATED WITH LENNOX-GASTAUT SYNDROME (LGS PIMECROLIMUS CREAM 1% 60GM NDC CODE:68462 060965 FDA PRODUCT CODE NO.: 61 S C J 04 H. T. S NO.: 30 04.90.92.45 ANDA NO.: 211769 THERAPEUTICE USE: - AS SECOU ND-LINE THERAPY FOR THE SHORT MNBU0631123 001 -TERM AND NON-CONTINUOS CHRON IC TRERTMENT OF MILD TO MODE RATE ATOPIC DERMATITIS IN NO N- IMMUNOCOMPROMISED ADULT A ND CHILDREN 2 YEARS OF AGE PIMECROLIMUS CREAM 1% 100GM NDC CODE:68462060994 FDA PROD UCT CODE NO.: 61 S C J 04 H. MNBU0631123 001 T. S NO.: 3004.90.92.45 AND A NO.: 211769 THERAPEUTICE US E: - AS SECOUND-LINE THERAPY FOR THE SHORT-TERM AND NON-C ONTINUOS CHRONIC TRERTMENT OF MILD TO MODERATE ATOPIC DER MATITIS IN NON- IMMUNOCOMPRO MISED ADULT AND CHILDREN 2 Y MNBU0631123 001 EARS OF AGE TACROLIMUS OINT 0.1% 100GM NDC CODE:68462053 494 FDA PRODUCT CODE NO.: 64 T C J 08 H. T. S NO.: 3004. 49.00.50 ANDA NO.: 210393 TH ERAPEUTICE USE: - TACROLIMUS IS A TOPICAL IMMUNOSUPPRESSIV E OINTMENT USED FOR THE TREA MNBU0631123 001 TMENT OF MODERATE-TO-SEVERE ATOPIC DERMATITIS (ECZEMA). COMMERCIAL & CUSTOM INVOICE NO. F22387001628 DT. 07.12.20 22 F22387001629 DT. 07.12.202 2 F22387001631 DT. 07.12.2022 F22387001632 DT. 07.12.2022 F22387001633 DT. 07.12.2022 MNBU0631123 001 NET WT. 1,931.60 KGS 11 DATA LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JE RSEY MAHWAH - 07430 USA S /BILL NO: 4017519 DT:08/12/20 22 S/BILL NO: 4017518 DT:08/ MNBU0631123 001 12/2022 S/BILL NO: 4017508 D T:08/12/2022 S/BILL NO: 4017 517 DT:08/12/2022 S/BILL NO: 4017514 DT:08/12/2022

44 PALLETS 3762 CARTONS PHARMACEUTICALS AS UNDER M UPIROCIN CREAM 2% 15GM NDC CO DE:68462056417 FDA PRODUCT CO DE NO.: 61GCJ82 H. T. S NO.: 3004.90.92.45 ANDA NO.: 201 587 THERAPEUTICE USE: - TOPI MNBU0534191 001 CAL ANTI-BACTERIAL GABAPENT IN TAB 800MG 500 NDC CODE:684 62012705 FDA PRODUCT CODE NO : 61 N C A 69 H. T. S NO.: 3004.90.92.30 ANDA NO.:-77-66 2 THERAPEUTICE USE:-ANTICONV ULSANT AGENT THEOPHYLLINE ER TAB 300MG 100 NDC CODE:684 MNBU0534191 001 62072101 63 B C B 30 3004.90 .92.85 212184 TO RELEASE TAB LETS ARE INDICATED FOR THE T REATMENT OF THE SYMPTOMS AND REVERSIBLE AIRFLOW OBSTRUCTI ON ASSOCIATED WITH CHRONIC AS THMA AND OTHER CHRONIC LUNG DISEASES, E.G., EMPHYSEMA AND MNBU0534191 001 CHRONIC BRONCHITIS NAPROX EN TAB 500MG 500 NDC CODE:684 62019005 FDA PRODUCT CODE NO .:-62 G C A 49 H. T. S NO.: 3004.90.92.40 ANDA NO.:-78-25 0 THERAPEUTICE USE:-ANTI-INF LAMMATORY, ANALGESIC TELMI SARTAN TAB 20MG 30 NDC CODE:6 MNBU0534191 001 8462019930 FDA PRODUCT CODE N O.: 62 O C A 09 H. T. S NO.: 3004.90.92.20 ANDA NO.:0900 32 THERAPEUTICE USE: INDICAT ED FOR THE TREATMENT OF HYPE RTENSION, TO LOWER BLOOD PRES SURE THEOPHYLLINE ER TAB 30 0MG 100 NDC CODE:68462072101 MNBU0534191 001 63 B C B 30 3004.90.92.85 2 12184 TO RELEASE TABLETS ARE INDICATED FOR THE TREATMENT OF THE SYMPTOMS AND REVERSIB LE AIRFLOW OBSTRUCTION ASSOCI ATED WITH CHRONIC ASTHMA AND OTHER CHRONIC LUNG DISEASES, E.G., EMPHYSEMA AND CHRONIC MNBU0534191 001 BRONCHITIS CARVEDILOL TAB 6.25MG 500 NDC CODE:684620163 05 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.9 0.92.20 ANDA NO.:- 78-251 TH ERAPEUTICE USE:-BETA- ADRENO ACEPTOR ANTAGONIST OMEPRAZ OLE DR CAP 40MG 90 NDC CODE:6 MNBU0534191 001 8462039790 FDA PRODUCT CODE N O.: 62KCF10 H. T. S NO.: 30 04.90.9160 ANDA NO.: 91672 T HERAPEUTICE USE: - -TREATMENT OF TREAT GASTROESOPHAGEAL RE FLUX DISEASE CARVEDILOL TA B 3.125MG 500 NDC CODE:684620 16205 FDA PRODUCT CODE NO ; MNBU0534191 001 62 O C A 22 H. T. S NO.: 300 4.90.92.20 ANDA NO.:- 78-251 THERAPEUTICE USE:-BETA- ADR ENOACEPTOR ANTAGONIST ROPI NIROLE TAB 0.5MG 100 NDC CODE :68462025401 FDA PRODUCT CODE NO.:-62 J C A 17 H. T. S NO .: 3004.90.92.40 ANDA NO.:- MNBU0534191 001 90-135 THERAPEUTICE USE:-TRE ATMENT OF PARKINSONISM THE OPHYLLINE ER TAB 400MG 100 ND C CODE:68462038001 FDA PRODUC T CODE NO.: 63 B C B 30 H. T . S NO.: 3004.90.92.85 ANDA NO.: 90-355 THERAPEUTICE USE: XANTHINE BRONCHODILATOR C MNBU0534191 001 OMMERCIAL & CUSTOM INVOICE NO. F22352003973 DT. 29.11.2022 F22352003967 DT. 29.11.2022 F22352003968 DT. 29.11.2022 F 22352003986 DT. 29.11.2022 S/ BILL NO: 5803458 DT 29-NOV-202 2 S/BILL NO: 5825658 DT 30-NO V-2022 S/BILL NO:5825563 DT 3 MNBU0534191 001 0-NOV-2022 S/BILL NO:5837452 DT 30-NOV-2022 NET WT. 10,375 .22 KGS 02 DATA LOGGERS HUM IDITY:65% SET TEMPERATURE : + 18 DEGREES TEMPERATURE RANGE : +15 DEGREES TO +25 DEGREES NOTIFY PARTY:2 GLENMARK PHARM ACEUTICALS INC 750, CORPORATE MNBU0534191 001 DRIVE, NEW JERSEY MAHWAH - 07430 USA

40 PALLETS 2861 CARTONS PHARMACEUTICALS AS UNDER CHLORPROMAZINE HCL TAB 50MG 10 0 NDC CODE:68462086301 61 T C A 04 3004.90.92.40 212144 TO TREAT PSYCHOTIC DISORDERS SUCH AS SCHIZOPHRENIA OR MA MNBU9048117 001 NIC-DEPRESSION IN ADULTS R ANOLAZINE ER TAB 1000MG 60 ND C CODE:68462032060 FDA PRODUC T CODE NO.: 61 D C B 02 H. T . S NO.: 3004.49.00.10 ANDA NO.:211082 THERAPEUTIC USE: - IT IS AN ANTI-ANGINAL MEDIC ATION. IT WORKS BY IMPROVING MNBU9048117 001 BLOOD FLOW TO HELP THE HEART WORK MORE EFFICIENTLY. IT IS USED TO TREAT CHRONIC ANGINA (CHEST PAIN). IT IS NOT FOR USE DURING AN ACUTE (EMERGENC Y) ATTACK OF ANGINA CHLORP ROMAZINE HCL TAB 100MG 100 ND C CODE:68462086401 61 T C A 0 MNBU9048117 001 4 3004.90.92.40 212144 TO T REAT PSYCHOTIC DISORDERS SUCH AS SCHIZOPHRENIA OR MANIC-D EPRESSION IN ADULTS INDOME THACIN ER CAP 75MG 60 NDC COD E:68462032560 FDA PRODUCT COD E: 62 GCE42 H. T. S NO.:300 4.90.92.40 ANDA NO.203501 TH MNBU9048117 001 ERAPEUTIC USE: INDOMETHACIN I S USED TO RELIEVE PAIN, SWELL ING, AND JOINT STIFFNESS CAUS ED BY ARTHRITIS, GOUT, BURSIT IS, AND TENDONITIS. IT IS AL SO USED TO RELIEVE PAIN FROM VARIOUS OTHER CONDITIONS. TH IS MEDICATION IS KNOWN AS A N MNBU9048117 001 ONSTEROIDAL ANTI-INFLAMMATORY DRUG (NSAID). ... THIS EFFE CT HELPS TO DECREASE SWELLING AND PAIN. GABAPENTIN TAB 600MG 500 NDC CODE:6846201260 5 FDA PRODUCT CODE NO: 61 N C A 69 H. T. S NO.: 3004.90. 92.30 ANDA NO.:-77-662 THERA MNBU9048117 001 PEUTICE USE:-ANTICONVULSANT AGENT COLESEVELAM HCL TAB 6 25MG 180 NDC CODE:68462043318 FDA PRODUCT CODE NO.: 62 B D A 13 H. T. S NO.: 3004.49. 00.10 ANDA NO.: 203480 THERA PEUTICE USE: - ANTIHYPERLIPO PROTEINEMIC. BISOPROLOL-HC MNBU9048117 001 TZ TAB 2.5/6.25MG 30 NDC CODE :68462087830 FDA PRODUCT CODE NO.: 62 O D A 18 H. T. S NO .: 3004.40.00.20 ANDA NO.: 2 15995 THERAPEUTICE USE: BISO PROLOL FUMARATE AND HYDROCHLO ROTHIAZIDE TABLETS ARE INDIC ATED IN THE MANAGEMENT OF HY MNBU9048117 001 PERTENSION. POTASSIUM CL ER CAP 10MEQ 100 NDC CODE:68462 035701 FDA PRODUCT CODE NO.: 65 R C F 14 H. T. S NO.: 300 4.90.92.90 ANDA NO.:202868 T HERAPEUTICE USE: - TREATMENT OR PREVENTION OF HYPOKALEMIA S/BILL NO: 4016362 DT: 16 MNBU9048117 001 .11.2022 S/BILL NO: 4016364 DT: 16.11.2022 S/BILL NO: 40 16359 DT: 16.11.2022 S/BILL N O: 4016357 DT: 16.11.2022 S/ BILL NO: 4016363 DT: 16.11.20 22 COMMERCIAL & CUSTOM IN VOICE NO. F22387001435 DT. 15 .11.2022 F22387001436 DT. 15. MNBU9048117 001 11.2022 F22387001437 DT. 15.1 1.2022 F22387001444 DT. 16.11 .2022 F22387001445 DT. 16.11. 2022 NET WT. 5,217.15 02 DA TA LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY: 2 GLENMARK PHARMACEUTICALS IN C 750, CORPORATE DRIVE, NEW MNBU9048117 001 JERSEY MAHWAH - 07430 USA

37 PALLETS 1615 CARTONS PHARMACEUTICALS AS UNDER PR AVASTATIN SOD TAB 80MG 90 NDC CODE:68462019890 FDA PRODUCT CODE NO.:-61 J C A 13 H. T. S NO.: 3004.90.92.20 ANDA N O.:-77-987 THERAPEUTICE USE: MNBU0232210 001 -HYPOLIPDAEMIC PRAVASTATIN SOD TAB 20MG 500 NDC CODE:684 62019605 FDA PRODUCT CODE NO .:-61 J C A 13 H. T. S NO.: 3004.90.92.20 ANDA NO.:-77-98 7 THERAPEUTICE USE:-HYPOLIPD AEMIC TOPIRAMATE ER CAP (Q) 150MG 30 NDC CODE:6846203703 MNBU0232210 001 0 3004.49.00.20 61 M C B 40 210278 TOPIRAMATE ER CAP ( Q) 25MG 30 NDC CODE:684620372 30 3004.49.00.20 61 M C B 40 210278 EZETIMIBE-SIMVA TA B 10/40MG 30 NDC CODE:6846203 2330 FDA PRODUCT CODE NO.: 6 1 J D C 15 H. T. S NO.: 3004 MNBU0232210 001 .49.00.10 ANDA NO.: 208699 T HERAPEUTICE USE: - THIS COMBI NATION MEDICATION IS USED TO HELP LOWER BAD CHOLESTEROL AN D FATS (SUCH AS LDL, TRIGLYC ERIDES) AND RAISE GOOD CHOLES TEROL (HDL) IN THE BLOOD. EZE TIMIBE WORKS BY REDUCING THE MNBU0232210 001 AMOUNT OF CHOLESTEROL YOUR B ODY ABSORBS FROM YOUR DIET. S IMVASTATIN BELONGS TO A GROUP OF DRUGS KNOWN AS "STATINS." IT WORKS BY REDUCING THE AM OUNT OF CHOLESTEROL MADE BY T HE LIVER. FROVATRIPTAN SUCC INATE TAB 2.5MG 9 NDC CODE:68 MNBU0232210 001 462069497 FDA PRODUCT CODE N O.:60 L C A 93 H. T. S NO.: 3004.90.92.28 ANDA NO.:204730 THERAPEUTICE USE: - USE:THE TREATMENT OF MIGRAINE HEADA CHES AND FOR SHORT TERM PREVE NTION OF MENSTRUAL MIGRAINE RANOLAZINE ER TAB 500MG 60 MNBU0232210 001 NDC CODE:68462031960 FDA PROD UCT CODE NO.: 61 D C B 02 H. T. S NO.: 3004.49.00.10 AND A NO.:211082 THERAPEUTIC USE: - IT IS AN ANTI-ANGINAL MED ICATION. IT WORKS BY IMPROVIN G BLOOD FLOW TO HELP THE HEAR T WORK MORE EFFICIENTLY. IT I MNBU0232210 001 S USED TO TREAT CHRONIC ANGIN A (CHEST PAIN). IT IS NOT FOR USE DURING AN ACUTE (EMERGE NCY) ATTACK OF ANGINA TACR OLIMUS OINT 0.1% 100GM NDC CO DE:68462053494 FDA PRODUCT CO DE NO.: 64 T C J 08 H. T. S NO.: 3004.49.00.50 ANDA NO.: MNBU0232210 001 210393 THERAPEUTICE USE: - TACROLIMUS IS A TOPICAL IMMUN OSUPPRESSIVE OINTMENT USED FO R THE TREATMENT OF MODERATE- TO-SEVERE ATOPIC DERMATITIS (ECZEMA). PRAVASTATIN SOD T AB 20MG 500 NDC CODE:68462019 605 FDA PRODUCT CODE NO.:-61 MNBU0232210 001 J C A 13 H. T. S NO.: 3004. 90.92.20 ANDA NO.:-77-987 TH ERAPEUTICE USE:-HYPOLIPDAEMIC INDOMETHACIN ER CAP 75MG 6 0 NDC CODE:68462032560 FDA P RODUCT CODE: 62 GCE42 H. T. S NO.:3004.90.92.40 ANDA NO. 203501 THERAPEUTIC USE: INDO MNBU0232210 001 METHACIN IS USED TO RELIEVE P AIN, SWELLING, AND JOINT STIF FNESS CAUSED BY ARTHRITIS, GO UT, BURSITIS, AND TENDONITIS. IT IS ALSO USED TO RELIEVE PAIN FROM VARIOUS OTHER CONDI TIONS. THIS MEDICATION IS KNO WN AS A NONSTEROIDAL ANTI-IN MNBU0232210 001 FLAMMATORY DRUG (NSAID). ... THIS EFFECT HELPS TO DECREAS E SWELLING AND PAIN. INDOM ETHACIN ER CAP 75MG 90 NDC CO DE:68462032590 FDA PRODUCT CO DE NO.: 62 GCE42 H. T. S NO. : 3004.90.92.40 ANDA NO.: 20 3501 THERAPEUTICE USE: #INDO MNBU0232210 001 METHACIN IS USED TO RELIEVE P AIN, SWELLING AND JOINT STIFF NESS CAUSED BY ARTHRITIS, GOU T, BURSITIS AND TENDONITIS IT IS ALSO USED TO RELIEVE PAIN FROM VARIOUS OTHER CONDITIO NS.THIS MEDICATION IS KNOWN AS A NONSTEROIDAL ANTI-INFLA MNBU0232210 001 MMATORY DRUG THIS EFFECT HELP S TO DECREASE SWELLING AND P AIN. INDOMETHACIN ER CAP 75 MG 60 NDC CODE:68462032560 F DA PRODUCT CODE: 62 GCE42 H. T. S NO.:3004.90.92.40 ANDA NO.203501 THERAPEUTIC USE: INDOMETHACIN IS USED TO RELIE MNBU0232210 001 VE PAIN, SWELLING, AND JOINT STIFFNESS CAUSED BY ARTHRITIS , GOUT, BURSITIS, AND TENDONI TIS. IT IS ALSO USED TO RELIE VE PAIN FROM VARIOUS OTHER C ONDITIONS. THIS MEDICATION IS KNOWN AS A NONSTEROIDAL ANT I-INFLAMMATORY DRUG (NSAID). MNBU0232210 001 ... THIS EFFECT HELPS TO DEC REASE SWELLING AND PAIN. C OMMERCIAL & CUSTOM INVOICE NO. F22387001394 DT. 07.11.2022 F22387001395 DT. 07.11.2022 F22387001398 DT. 07.11.2022 F 22387001399 DT. 08.11.2022 F2 2387001400 DT. 08.11.2022 F22 MNBU0232210 001 387001403 DT. 09.11.2022 F223 87001405 DT. 09.11.2022 S/BIL L NO:4016038 DT:09.11.2022 S/ BILL NO:4016040 DT:09.11.2022 S/BILL NO: 4016041 DT:09.11.2

34 PALLETS 1695 CARTONS PHARMACEUTICALS AS UNDER PO TASSIUM CL ER CAP 10MEQ 100 N DC CODE:68462035701 FDA PRODU CT CODE NO.:65 R C F 14 H. T . S NO.: 3004.90.92.90 ANDA NO.:202868 THERAPEUTICE USE: MNBU4208911 001 - TREATMENT OR PREVENTION OF HYPOKALEMIA CARVEDILOL TA B 12.5MG 500 NDC CODE:6846201 6405 FDA PRODUCT CODE NO : 6 2 O C A 22 H. T. S NO.: 3004 .90.92.20 ANDA NO.:- 78-251 THERAPEUTICE USE:-BETA- ADRE NOACEPTOR ANTAGONIST TACRO MNBU4208911 001 LIMUS OINT 0.1% 100GM NDC COD E:68462053494 FDA PRODUCT COD E NO.: 64 T C J 08 H. T. S N O.: 3004.49.00.50 ANDA NO.: 210393 THERAPEUTICE USE: - T ACROLIMUS IS A TOPICAL IMMUNO SUPPRESSIVE OINTMENT USED FOR THE TREATMENT OF MODERATE-T MNBU4208911 001 O-SEVERE ATOPIC DERMATITIS ( ECZEMA). TACROLIMUS OINT 0. 1% 60GM NDC CODE:68462053465 FDA PRODUCT CODE NO.: 64 T C J 08 H. T. S NO.: 3004.49.0 0.50 ANDA NO.: 210393 THERAP EUTICE USE: - TACROLIMUS IS A TOPICAL IMMUNOSUPPRESSIVE O MNBU4208911 001 INTMENT USED FOR THE TREATMEN T OF MODERATE-TO-SEVERE ATOP IC DERMATITIS (ECZEMA). PI MECROLIMUS CREAM 1% 100GM NDC CODE:68462060994 FDA PRODUCT CODE NO.: 61 S C J 04 H. T. S NO.: 3004.90.92.45 ANDA N O.: 211769 THERAPEUTICE USE: MNBU4208911 001 - AS SECOUND-LINE THERAPY FOR THE SHORT-TERM AND NON-CONT INUOS CHRONIC TRERTMENT OF MI LD TO MODERATE ATOPIC DERMAT ITIS IN NONIMMUNOCOMPROMISED ADULT AND CHILDREN 2 YEARS O F AGE S/BILL NO: 4015597 D T: 31.10.2022 S/BILL NO: 401 MNBU4208911 001 5596 DT: 31.10.2022 S/BILL NO : 4015595 DT: 31.10.2022 COMMERCIAL & CUSTOM INVOICE NO. F22387001313 DT. 29.10.2 022 F22387001320 DT. 29.10.20 22 F22387001323 DT. 29.10.202 2 NET WT. 4,083.58 KGS 02 D ATA LOGGERS SET TEMPERATURE MNBU4208911 001 : +18 DEGREES NOTIFY PARTY :2 GLENMARK PHARMACEUTICALS I NC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA

37 PALLETS 1767 CARTONS PHARMACEUTICALS AS UNDER G ABAPENTIN TAB 600MG 500 NDC C ODE:68462012605 FDA PRODUCT C ODE NO: 61 N C A 69 H. T. S NO.: 3004.90.92.30 ANDA NO.: -77-662 THERAPEUTICE USE:-AN MNBU0458240 001 TICONVULSANT AGENT TACROLI MUS OINT 0.1% 100GM NDC CODE: 68462053494 FDA PRODUCT CODE NO.: 64 T C J 08 H. T. S NO. : 3004.49.00.50 ANDA NO.: 21 0393 THERAPEUTICE USE: - TAC ROLIMUS IS A TOPICAL IMMUNOSU PPRESSIVE OINTMENT USED FOR T MNBU0458240 001 HE TREATMENT OF MODERATE-TO- SEVERE ATOPIC DERMATITIS (EC ZEMA). PIMECROLIMUS CREAM 1 % 100GM NDC CODE:68462060994 FDA PRODUCT CODE NO.: 61 S C J 04 H. T. S NO.: 3004.90.9 2.45 ANDA NO.: 211769 THERAP EUTICE USE: - AS SECOUND-LINE MNBU0458240 001 THERAPY FOR THE SHORT-TERM A ND NON-CONTINUOS CHRONIC TRE RTMENT OF MILD TO MODERATE AT OPIC DERMATITIS IN NON-IMMUN OCOMPROMISED ADULT AND CHILDR EN 2 YEARS OF AGE PRAVASTA TIN SOD TAB 20MG 90 NDC CODE: 68462019690 FDA PRODUCT CODE MNBU0458240 001 NO.:-61 J C A 13 H. T. S NO. : 3004.90.92.20 ANDA NO.:-77 -987 THERAPEUTICE USE:-HYPOL IPDAEMIC PRAVASTATIN SOD TA B 20MG 500 NDC CODE:684620196 05 FDA PRODUCT CODE NO.:-61 J C A 13 H. T. S NO.: 3004.9 0.92.20 ANDA NO.:-77-987 THE MNBU0458240 001 RAPEUTICE USE:-HYPOLIPDAEMIC AMLOD-OLMESARTAN TAB 10/20M G 30 NDC CODE:68462056730 FD A PRODUCT CODE NO.: 62 C D A 68 H. T. S NO.: 3004.90.92.2 0 ANDA NO.: 207807 THERAPEUT ICE USE: -MEDICATION USED TO TREAT HIGH BLOOD PRESSURE AND MNBU0458240 001 CORONARY ARTERY DISEASE P RAVASTATIN SOD TAB 10MG 90 ND C CODE:68462019590 FDA PRODUC T CODE NO.:-61 J C A 13 H. T . S NO.: 3004.90.92.20 ANDA NO.:-77-987 THERAPEUTICE USE :-HYPOLIPDAEMIC COMMERCIAL & CUSTOM INVOICE NO. F2238700 MNBU0458240 001 1292 DT. 26.10.2022 F22387001 295 DT. 26.10.2022 F223870012 96 DT. 26.10.2022 F2238700129 7 DT. 26.10.2022 F22387001298 DT. 26.10.2022 S/BILL NO: 40 15284 DT: 26.10.2022 S/BILL N O:4015282 DT: 26.10.2022 S/BI LL NO:4015296 DT: 26.10.2022 MNBU0458240 001 S/BILL NO: 4015297 DT: 26.10.2 022 S/BILL NO: 4015298 DT: 26 .10.2022 NET WT. 6,439.20 KG S 02 DATA LOGGERS SET TEM PERATURE : +18 DEGREES

8 PALLETS 544 CARTONS PH ARMACEUTICALS AS UNDER PIME CROLIMUS CREAM 1% 30GM NDC CO DE:68462060935 FDA PRODUCT CO DE NO.: 61 S C J 04 H. T. S NO.: 3004.90.92.45 ANDA NO.: 211769 THERAPEUTICE USE: - A MNBU0579792 001 S SECOUND-LINE THERAPY FOR T HE SHORT-TERM AND NON-CONTINU OS CHRONIC TRERTMENT OF MILD TO MODERATE ATOPIC DERMATITI S IN NON-IMMUNOCOMPROMISED A DULT AND CHILDREN 2 PIMECRO LIMUS CREAM 1% 30GM NDC CODE: 68462060935 FDA PRODUCT CODE MNBU0579792 001 NO.: 61 S C J 04 H. T. S NO. : 3004.90.92.45 ANDA NO.: 21 1769 THERAPEUTICE USE: - AS SECOUND-LINE THERAPY FOR THE SHORT-TERM AND NON-CONTINUOS CHRONIC TRERTMENT OF MILD TO MODERATE ATOPIC DERMATITIS I N NON-IMMUNOCOMPROMISED ADUL MNBU0579792 001 T AND CHILDREN 2 GABAPENTIN TAB 600MG 500 NDC CODE:68462 012605 FDA PRODUCT CODE NO: 61 N C A 69 H. T. S NO.: 300 4.90.92.30 ANDA NO.:-77-662 THERAPEUTICE USE:-ANTICONVULS ANT AGENT AMLOD-OLMESARTAN TAB 5/20MG 90 NDC CODE:68462 MNBU0579792 001 056690 FDA PRODUCT CODE NO.: 62 C D A 68 H. T. S NO.: 30 04.90.92.20 ANDA NO.: 207807 THERAPEUTICE USE: -MEDICATIO N USED TO TREAT HIGH BLOOD PR ESSURE AND CORONARY ARTERY DI SEASE COMMERCIAL & CUSTOM I NVOICE NO. F22387001128 DT. 3 MNBU0579792 001 0.09.2022 F22387001134 DT. 30 .09.2022 F22387001093 DT. 29. 09.2022 F22387001147 DT. 30.0 9.2022 S/BILL NO:4014370 DT: 06.10.2022 S/BILL NO: 4014371 DT: 06.10.2022 S/BILL NO: 40 14363 DT: 06.10.2022 S/BILL N O: 4014460 DT: 07.10.2022 NET MNBU0579792 001 WT. 1,492.73 04 DATA LOGGERS SET TEMPERATURE : +18 DEGR EES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, CORP ORATE DRIVE, NEW JERSEY MAHW AH - 07430 USA

32 PALLETS 1685 CARTONS PHARMACEUTICALS AS UNDER NO RGEST/EE TAB 0.25/0.035MG 84 NDC CODE:68462030929 FDA PROD UCT CODE NO.: 65 J D A 27 H. T. S NO.: 3006.60.00.00 AND A NO.: 200538 THERAPEUTICE US MNBU0579792 001 E: - ORAL CONTRACEPTIVES G ABAPENTIN TAB 600MG 500 NDC C ODE:68462012605 FDA PRODUCT C ODE NO: 61 N C A 69 H. T. S NO.: 3004.90.92.30 ANDA NO.: -77-662 THERAPEUTICE USE:-AN TICONVULSANT AGENT THEOPHY LLINE ER TAB 300MG 100 NDC CO MNBU0579792 001 DE:68462072101 63 B C B 30 3 004.90.92.85 212184 TO RELEA SE TABLETS ARE INDICATED FOR THE TREATMENT OF THE SYMPTOM S AND REVERSIBLE AIRFLOW OBS TRUCTION ASSOCIATED WITH CHRO NIC ASTHMA AND OTHER CHRONIC LUNG DISEASES, E.G., EMPHYSE MNBU0579792 001 MA AND CHRONIC BRONCHITIS COMMERCIAL & CUSTOM INVOICE NO. F22352003143 DT. 13.10.20 22 F22352003141 DT. 13.10.202 2 F22352003142 DT. 13.10.2022 S/BILL NO: 4822932 DT 14-OCT -2022 S/BILL NO: 4825093 DT 1 4-OCT-2022 S/BILL NO: 4822962 MNBU0579792 001 DT 14-OCT-2022 NET WT. 7,110 .69 05 DATA LOGGERS HUMIDI TY:65% SET TEMPERATURE : +18 DEGREES TEMPERATURE RANGE : + 15 DEGREES TO +25 DEGREES NOT IFY PARTY:2 GLENMARK PHARMACE UTICALS INC 750, CORPORATE DR IVE, NEW JERSEY MAHWAH - 074 MNBU0579792 001 30 USA

37 PALLETS 3230 CARTONS PH ARMACEUTICALS AS UNDER CLOT RIMAZOLE CREAM 1% 15GM NDC CO DE:68462018117 FDA PRODUCT CO DE NO.:61#W#C#J#04 H. T. S N O.: 3004.90.92.45 ANDA NO.: 90-219 THERAPEUTICE USE: TRE MNBU0509413 001 ATMENT OF CANDIDIASIS ROPIN IROLE TAB 0.25MG 100 NDC CODE :68462025301 FDA PRODUCT CODE NO.:-62 J C A 17 H. T. S NO .: 3004.90.92.40 ANDA NO.:- 90-135 THERAPEUTICE USE:-TRE ATMENT OF PARKINSONISM THE OPHYLLINE ER TAB 300MG 100 ND MNBU0509413 001 C CODE:68462072101 63 B C B 3 0 3004.90.92.85 212184 TO R ELEASE TABLETS ARE INDICATED FOR THE TREATMENT OF THE SYM PTOMS AND REVERSIBLE AIRFLOW OBSTRUCTION ASSOCIATED WITH CHRONIC ASTHMA AND OTHER CHR ONIC LUNG DISEASES, E.G., EMP MNBU0509413 001 HYSEMA AND CHRONIC BRONCHITIS PRAVASTATIN SOD TAB 40MG 5 00 NDC CODE:68462019705 FDA PRODUCT CODE NO.: 61 J C A 13 H. T. S NO.: 3004.90.92.20 ANDA NO.: 77-987 THERAPEUTIC E USE: -HYPOLIPDAEMIC GABA PENTIN TAB 600MG 500 NDC CODE MNBU0509413 001 :68462012605 FDA PRODUCT CODE NO: 61 N C A 69 H. T. S NO. : 3004.90.92.30 ANDA NO.:-77 -662 THERAPEUTICE USE:-ANTIC ONVULSANT AGENT THEOPHYLLI NE ER TAB 300MG 100 NDC CODE: 68462072101 63 B C B 30 3004 .90.92.85 212184 TO RELEASE MNBU0509413 001 TABLETS ARE INDICATED FOR THE TREATMENT OF THE SYMPTOMS A ND REVERSIBLE AIRFLOW OBSTRU CTION ASSOCIATED WITH CHRONIC ASTHMA AND OTHER CHRONIC LU NG DISEASES, E.G., EMPHYSEMA AND CHRONIC BRONCHITIS ACA MPROSATE CALCIUM DR TAB 333MG MNBU0509413 001 180 NDC CODE:68462043518 FDA PRODUCT CODE NO.: 60 T C C 9 9 H. T. S NO.: 3004.90.92.40 ANDA NO.:202229 THERAPEUTIC E USE: - FOR TREATING ALCOHOL DEPENDENCE ONDANSETRON TA B 8MG 30 NDC CODE:68462010630 FDA PRODUCT CODE NO.:-61 T MNBU0509413 001 C A 28 H. T. S NO.: 3004.90.9 2.40 ANDA NO.:- 77-535 THERA PEUTICE USE:-ANTI -EMETIC OLMESARTAN MEDOX TAB 5MG 30 N DC CODE:68462043630 FDA PRODU CT CODE NO.: 62CCA68 H. T. S NO.: 3004.90.9220 ANDA NO.: 203281 THERAPEUTICE USE: - MNBU0509413 001 -TREATMENT OF HYPERTENSION, A LONE OR WITH OTHER ANTIHYPER TENSIVE AGENTS, TO LOWER BLOO D PRESSURE DICLOFENAC SOD G EL 3% 100GM NDC CODE:68462035 594 FDA PRODUCT CODE NO.:62 G C J 18 H. T. S NO.: 3004.9 0.92.40 ANDA NO.:208301 THER MNBU0509413 001 APEUTICE USE: - USED FOR THE RELIEF OF JOINT PAIN OF OSTEO ARTHRITIS COMMERCIAL & CU STOM INVOICE NO. F22352003146 DT. 13.10.2022 F22352003115 DT. 12.10.2022 F22352003125 D T. 12.10.2022 F22352003126 DT . 12.10.2022 F22352003151 DT. MNBU0509413 001 13.10.2022 F22352003124 DT. 12.10.2022 S/BILL NO: 482300 0 DT 14-OCT-2022 S/BILL NO: 4767372 DT 12-OCT-2022 S/BILL NO: 4800093 DT 13-OCT-2022 S/BILL NO: 4798778 DT 13-OCT- 2022 S/BILL NO: 4825095 DT 1 4-OCT-2022 S/BILL NO: 479877 MNBU0509413 001 2 DT 13-OCT-2022 NET WT. 7,40 5.92 02 DATA LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK PHARM ACEUTICALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA

19 PALLETS 1005 CARTONS PH ARMACEUTICALS AS UNDER PIME CROLIMUS CREAM 1% 60GM NDC CO DE:68462060965 FDA PRODUCT CO DE NO.: 61 S C J 04 H. T. S NO.: 3004.90.92.45 ANDA NO.: 211769 THERAPEUTICE USE: - A MNBU0474723 001 S SECOUND-LINE THERAPY FOR T HE SHORT-TERM AND NON-CONTINU OS CHRONIC TRERTMENT OF MILD TO MODERATE ATOPIC DERMATITI S IN NONIMMUNOCOMPROMISED AD ULT AND CHILDREN 2 YEARS OF A GE GABAPENTIN TAB 600MG 500 NDC CODE:68462012605 FDA PR MNBU0474723 001 ODUCT CODE NO: 61 N C A 69 H . T. S NO.: 3004.90.92.30 AN DA NO.:-77-662 THERAPEUTICE USE:-ANTICONVULSANT AGENT POTASSIUM CL ER CAP 10MEQ 500 NDC CODE:68462035705 FDA PRO DUCT CODE NO.: 65 R C F 14 H . T. S NO.: 3004.90.92.90 AN MNBU0474723 001 DA NO.: 202868 THERAPEUTICE U SE: - TREATMENT OR PREVENTION OF HYPOKALEMIA GABAPENTIN TAB 600MG 500 NDC CODE:68462 012605 FDA PRODUCT CODE NO: 61 N C A 69 H. T. S NO.: 300 4.90.92.30 ANDA NO.:-77-662 THERAPEUTICE USE:-ANTICONVULS MNBU0474723 001 ANT AGENT TACROLIMUS CAP 5 MG 100 NDC CODE:68462068701 HTS NO: 3004.90.92.15 FDA COD E : 64 T C E 08 ANDA NO.20666 2 THERAPEUTICE USE: TO PREVE NT REJECTION OF A KIDNEY, HE ART, OR LIVER TRANSPLANT CO MMERCIAL & CUSTOM INVOICE NO. MNBU0474723 001 F22387001092 DT. 29.09.2022 F22387001087 DT. 29.09.2022 F 22387001086 DT. 29.09.2022 F2 2387001084 DT. 29.09.2022 F22 387001090 DT. 29.09.2022 S/BI LL NO: 4014161 DT:30.09.2022 S/BILL NO:4014165 DT:30.09.202 2 S/BILL NO: 4014166 DT:30.09 MNBU0474723 001 .2022 S/BILL NO: 4014169 DT:3 0.09.2022 S/BILL NO:4014163 D T:30.09.2022 NET WT. 4,220.3 1 02 DATA LOGGERS SET TEM PERATURE : +18 DEGREES NOTI FY PARTY:2 GLENMARK PHARMACEU TICALS INC 750, CORPORATE DRI VE, NEW JERSEY MAHWAH - 0743 MNBU0474723 001 0 USA

FREIGHT PREPAID 4 BOXES 4100 KGM 3.75 MTQ AUTOMOTIVE EQUIPMENT ON 4 PAL = 4 BOX BSL 42010 TLLU4547902 001 BATTERIES, WET, FILLED WITH ACID IMCO NUMBER:8 SERIAL NUMBER:2794 DGS CONTACT: BRUNO HILAIRE +33475661339 DGS CONTACT: DIANA GUCKERT +498331944440 DGS CONTACT: FREDERIC CHOURAKI +33247343388 CEO CONTACT: JOELLE MARTINEZ +33562642511 TLLU4547902 001 4 BOXES 309 KGM 2.45 MTQ AUTO MAINTENANCE ON 4 PAL = 4 BOX BSL 42012 6 PACKAGE(S) 499KGM TLLU4547902 001 4.13 QMT AUTO PARTS ON 4 PAL = 6 PKG BSL 40823+40824 87 PIECE(S) 530 KGM 1.1 QMT EQUIPMENT AUTO ON 1 PAL = 87 PCE TLLU4547902 001 BSL 42366 60 PACKAGE(S) 650KGM 3.99 MTQ AUTO MAINTENANCE ON 1 PAL = 60 PKG BSL 42343 6 CARTONS TLLU4547902 001 1171 KGM 2.98 MTQ AUTOMOTIVE EQUIPMENT 6 PACKAGE BSL 42310 30 C ARTONS 60KGM 0.36 MTQ TLLU4547902 001 ADHESIVES IMCO NUMBER:3 SERIAL NUMBER:1133 PACKAGE GROUP:3 AUTOMOTIVE EQUIPMENT ON 1 PAL = 30 PACKAGES BSL 41411 2 BOXES TLLU4547902 001 159KGM 3.18 QMT AUTOMOTIVE EQUIPMENT ON 2 PALBOX BSL 41416 3 BOXES 345 KGM 3.2 QMT TLLU4547902 001 AUTO PARTS ON 3 PAL = 3 BOX BSL 42249+42243 50 PIECE(S) 944KGM 2.41 MTQ AUTO MAINTENANCE ON 3 PAL = 50 PCE BSL 42195 10 CARTONS TLLU4547902 001 113 KGM 0.67 MTQ AUTO MAINTENANCE ON 1 PAL = 10 PACKAGE BSL 41630 2 BOXES 128 KGM 1.19 MTQ TLLU4547902 001 AUTO MAINTENANCE ON 2 PAL = 2 BOX BSL 41900 4 CARTONS 355KGM 2.14 QMT AUTOMOTIVE EQUIPMENT 4 PACKAGE TLLU4547902 001 BSL 41981 6 BOXES 122KGM 1.73 MTQ AUTOMOTIVE EQUIPMENT 2 BOXES 345 KGM 1.82 MTQ TLLU4547902 001 ENVIRONMENTALLY HAZARDOUS SUBSTANCE, SOLID, N.O.S. FLAMMABLE LIQUID, N.O.S. AEROSOLS (ABOVE 1L) ENVIRONMENTALLY HAZARDOUS SUBSTANCE, LIQUID, N.O.S. ADHESIVES IMCO NUMBER:9 TLLU4547902 001 IMCO NUMBER:3 IMCO NUMBER:2.1 IMCO NUMBER:9 IMCO NUMBER:3 SERIAL NUMBER:3077 SERIAL NUMBER:1993 SERIAL NUMBER:1950 SERIAL NUMBER:3082 TLLU4547902 001 SERIAL NUMBER:1133 PACKAGE GROUP:3 PACKAGE GROUP:3 PACKAGE GROUP:3 PACKAGE GROUP:2 AUTOMOTIVE EQUIPMENT 2 ON PAL = 2 BOX BSL 41568 TLLU4547902 001 185 PACKAGE(S) 7570 KGM 16.25 MTQ AUTO MAINTENANCE ON 11 PAL = 185 PKGS BSL 41533 125 C ARTONS 88KGM TLLU4547902 001 0.91 MTQ AUTOMOTIVE EQUIPMENT 1 ON PAL = 125 PACKAGES BSL 41259 2 BOXES 800KGM 2.28 MTQ AUTOMOTIVE EQUIPMENT TLLU4547902 001 1 CARTONS 56KGM 0.47 MTQ AUTOMOTIVE EQUIPMENT ON 1PAL = 1 PACKAGE BSL 42224 6 PACKAGE(S) 170 KGM TLLU4547902 001 0.9 MTQ CAR MAINTENANCE ON 4PAL+2PACKAGE=6PKG BSL 42261 7 BOXES 431 KGM 2.59 MTQ AUTO MAINTENANCE ON 7 PAL = 7 TLLU4547902 001 BOX BSL 41304 75 CARTONS 62KGM 0.86 MTQ AUTOMOTIVE EQUIPMENT ON 1 PAL = 75 PACKAGES BSL 42281 TLLU4547902 001 2 CARTONS 36KGM 0.14 MTQ CAR MAINTENANCE 2 PACKAGES BSL 41555 46 CARTONS 241 KGM 1.68 MTQ TLLU4547902 001 AEROSOLS (ABOVE 1L) IMCO NUMBER:2.1 SERIAL NUMBER:1950 AUTO MAINTENANCE 1 PAL = 46 PACKAGE BSL 41449 PSN: ADHESIVES CONTAINING FLAMMABLE LIQUID UN NUMBER: 1133 - IMDG CLASS: 3 - PG: II - TLLU4547902 001 FLASHPOINT: 17 C PSN: ADHESIVES CONTAINING FLAMMABLE LIQUID UN NUMBER: 1133 - IMDG CLASS: 3 - PG: III - FLASHPOINT: -26 C PSN: AEROSOLS UN NUMBER: 1950 - IMDG CLASS: 2.1 PSN: AEROSOLS UN NUMBER: 1950 - IMDG CLASS: 2.1 TLLU4547902 001 PSN: AEROSOLS UN NUMBER: 1950 - IMDG CLASS: 2.1 PSN: AEROSOLS UN NUMBER: 1950 - IMDG CLASS: 2.1 PSN: AEROSOLS UN NUMBER: 1950 - IMDG CLASS: 2.1 PSN: AEROSOLS UN NUMBER: 1950 - IMDG CLASS: 2.1 TLLU4547902 001 PSN: FLAMMABLE LIQUID, N.O.S. UN NUMBER: 1993 - IMDG CLASS: 3 - PG: III - FLASHPOINT: 54 C CHEMICAL NAME: (PENTYL ACETATE) PROPYL (2S)-2-(1,1-DIMETHYLPROPOXY)-PROPANOATE-AQUAT CHRONIC PSN: BATTERIES, WET, FILLED WITH ACID ELECTRI STORAGE TLLU4547902 001 UN NUMBER: 2794 - IMDG CLASS: 8 PSN: ENVIRONMENTALLY HAZARDOUS SUBSTANCE, SOL N.O.S. UN NUMBER: 3077 - IMDG CLASS: 9 - PG: III CHEMICAL NAME: (R)-P-MENTHA-1,8-DIENE (DLIMON PSN: ENVIRONMENTALLY HAZARDOUS SUBSTANCE, SOL N.O.S. UN NUMBER: 3077 - IMDG CLASS: 9 - PG: III TLLU4547902 001 CHEMICAL NAME: TETRAMETHYL ACETYLOCTAHYDRONAPHTALE,(E)2BENZYLIDENEOCTANA PSN: ENVIRONMENTALLY HAZARDOUS SUBSTANCE, SOL N.O.S. UN NUMBER: 3077 - IMDG CLASS: 9 - PG: III CHEMICAL NAME: P-MENTHA-1,8-DIEN VANILLINE,AL HEXANOATE PSN: ENVIRONMENTALLY HAZARDOUS SUBSTANCE, SOL TLLU4547902 001 N.O.S. UN NUMBER: 3077 - IMDG CLASS: 9 - PG: III CHEMICAL NAME: ALLYL 3-CYCLOHEXYLPROPIONATE,COUMARINE,ALPHA-METHYL MALDEHYDE,BENZYL BENZOATE,ALLYL HEXANOATE PSN: ENVIRONMENTALLY HAZARDOUS SUBSTANCE, SOL N.O.S. UN NUMBER: 3077 - IMDG CLASS: 9 - PG: III TLLU4547902 001 CHEMICAL NAME: ALLYL 3-CYCLOHEXYLPROPIONATE,COUMARINE,ALPHA-METHYL MALDEHYDE,BENZYL BENZOATE,ALLYL HEXANOATE PSN: ENVIRONMENTALLY HAZARDOUS SUBSTANCE, SOL N.O.S. UN NUMBER: 3077 - IMDG CLASS: 9 - PG: III CHEMICAL NAME: ALLYL 3-CYCLOHEXYLPROPIONATE,COUMARINE,ALPHA-METHYL TLLU4547902 001 MALDEHYDE,BENZYL BENZOATE,ALLYL HEXANOATE PSN: ENVIRONMENTALLY HAZARDOUS SUBSTANCE, LIQ N.O.S. UN NUMBER: 3082 - IMDG CLASS: 9 - PG: III CHEMICAL NAME: CYCLOHEXANOL,2-(1,1-DIMETHYLETHYL),1-ACETATE, R)-REL-,VERDYL PROPIONATE

36 PALLETS 1704 CART ONS PHARMACEUTICALS AS UNDER GABAPENTIN TAB 600MG 500 N DC CODE:68462012605 FDA PRODU CT CODE NO: 61 N C A 69 H. T . S NO.: 3004.90.92.30 ANDA NO.:-77-662 THERAPEUTICE USE SUDU8190101 001 :-ANTICONVULSANT AGENT RAN OLAZINE ER TAB 500MG 60 NDC C ODE:68462031960 FDA PRODUCT C ODE NO.: 61 D C B 02 H. T. S NO.: 3004.49.00.10 ANDA NO. :211082 THERAPEUTIC USE: - IT IS AN ANTI-ANGINAL MEDICATI ON. IT WORKS BY IMPROVING BLO SUDU8190101 001 OD FLOW TO HELP THE HEART WOR K MORE EFFICIENTLY. IT IS USE D TO TREAT CHRONIC ANGINA (C HEST PAIN). IT IS NOT FOR USE DURING AN ACUTE (EMERGENCY) ATTACK OF ANGINA TOPIRAMAT E ER CAP (Q) 200MG 30 NDC COD E:68462037130 3004.49.00.20 SUDU8190101 001 61 M C B 40 210278 SEVELAM ER HCL TAB 400MG 360 NDC CODE :68462044626 FDA PRODUCT CODE NO.: 63 L D A 04 H. T. S NO .: 3004.90.92.60 ANDA NO.:20 4724 THERAPEUTICE USE:SEVELA MER HYDROCHLORIDE TABLETS AR E A PHOSPHATE BINDER INDICATE SUDU8190101 001 D FOR THE CONTROL OF SERUM PH OSPHORUS IN PATIENTS WITH CHR ONIC KIDNEY DISEASE ON DIALY SIS POTASSIUM CL ER CAP 10M EQ 500 NDC CODE:68462035705 FDA PRODUCT CODE NO.: 65 R C F 14 H. T. S NO.: 3004.90.92 .90 ANDA NO.: 202868 THERAPE SUDU8190101 001 UTICE USE: - TREATMENT OR PRE VENTION OF HYPOKALEMIA TAC ROLIMUS OINT 0.1% 100GM NDC C ODE:68462053494 FDA PRODUCT C ODE NO.: 64 T C J 08 H. T. S NO.: 3004.49.00.50 ANDA NO. : 210393 THERAPEUTICE USE: - TACROLIMUS IS A TOPICAL IMMU SUDU8190101 001 NOSUPPRESSIVE OINTMENT USED F OR THE TREATMENT OF MODERATE -TO-SEVERE ATOPIC DERMATITIS (ECZEMA). TACROLIMUS OINT 0.1% 30GM NDC CODE:6846205343 5 FDA PRODUCT CODE NO.: 64 T C J 08 H. T. S NO.: 3004.49 .00.50 ANDA NO.: 210393 THER SUDU8190101 001 APEUTICE USE: - TACROLIMUS IS A TOPICAL IMMUNOSUPPRESSIVE OINTMENT USED FOR THE TREATM ENT OF MODERATE-TO-SEVERE AT OPIC DERMATITIS (ECZEMA). CHLORPROMAZINE HCL TAB 25MG 10 0 NDC CODE:68462086201 61 T C A 04 3004.90.92.40 212144 SUDU8190101 001 TO TREAT PSYCHOTIC DISORDERS SUCH AS SCHIZOPHRENIA OR MA NIC-DEPRESSION IN ADULTS C OMMERCIAL & CUSTOM INVOICE NO. F22387000975 DT. 13.09.2022 F22387000976 DT. 13.09.2022 F22387000977 DT. 13.09.2022 F 22387000981 DT. 14.09.2022 F2 SUDU8190101 001 2387000982 DT. 14.09.2022 NET WT. 6,833.79 02 DATA LOGGER S SET TEMPERATURE : +18 DEG REES NOTIFY PARTY:2 GLENMA RK PHARMACEUTICALS INC 750, C ORPORATE DRIVE, NEW JERSEY M AHWAH - 07430 USA . S/BIL L NO: 4013267 DT:14.09.2022 SUDU8190101 001 S/BILL NO: 4013268 DT: 14.09. 2022 S/BILL NO: 4013269 DT: 14.09.2022 S/BILL NO: 401327 3 DT: 14.09.2022 S/BILL NO: 4013272 DT:14.09.2022

45 PALLETS 3019 CARTONS PHA RMACEUTICALS AS UNDER TELMISA RTAN TAB 40MG 30 NDC CODE:684 62020030 FDA PRODUCT CODE NO. : 62 O C A 09 H. T. S NO.: 3004.90.92.20 ANDA NO.:090032 THERAPEUTICE USE: INDICATED MNBU0494720 001 FOR THE TREATMENT OF HYPERT ENSION, TO LOWER BLOOD PRESSU RE OMEPRAZOLE DR CAP 40MG 90 NDC CODE:68462039790 FDA PRO DUCT CODE NO.: 62KCF10 H. T. S NO.: 3004.90.9160 ANDA NO .: 91672 THERAPEUTICE USE: - -TREATMENT OF TREAT GASTROES MNBU0494720 001 OPHAGEAL REFLUX DISEASE LEVO CETIRIZINE DIHY TAB 5MG 90 ND C CODE:68462034690 FDA PRODUC T CODE NO.: 61 X C A 51 H. T . S NO.: 3004.90.91.80 ANDA NO.:90385 THERAPEUTICE USE: TREATMENT OF CHRONIC IDIOPATH IC URTICARIA MUPIROCIN OINT 2 MNBU0494720 001 % 22GM NDC CODE:68462018022 FDA PRODUCT CODE NO.: 61 G J J 81 H. T. S NO.: 3004.90.92 .45 ANDA NO.: 90-480 THERAPE UTICE USE: - ANTI-BACTERIAL COMMERCIAL & CUSTOM INVOICE NO . F22352002557 DT. 10.09.2022 F22352002554 DT. 10.09.2022 MNBU0494720 001 NET WT. 13,428.53 02 DATA L OGGERS SET TEMPERATURE : +1 8 DEGREES NOTIFY PARTY:2 G LENMARK PHARMACEUTICALS INC 7 50, CORPORATE DRIVE, NEW JERS EY MAHWAH - 07430 USA

17 PALLETS 835 CARTONS PH ARMACEUTICALS AS UNDER PRAV ASTATIN SOD TAB 80MG 500 NDC CODE:68462019805 FDA PRODUCT CODE NO.:61 J C A 13 H. T. S NO.: 3004.90.92.20 ANDA NO. :-77-987 THERAPEUTICE USE:-H MNBU3207778 001 YPOLIPDAEMIC PRAVASTATIN SO D TAB 80MG 90 NDC CODE:684620 19890 FDA PRODUCT CODE NO.:- 61 J C A 13 H. T. S NO.: 300 4.90.92.20 ANDA NO.:-77-987 THERAPEUTICE USE:-HYPOLIPDAEM IC EZETIMIBE-SIMVA TAB 10/1 0MG 90 NDC CODE:68462032190 MNBU3207778 001 FDA PRODUCT CODE NO.: 61 J D C 15 H. T. S NO.: 3004.49.00 .10 ANDA NO.: 208699 THERAPE UTICE USE: - THIS COMBINATION MEDICATION IS USED TO HELP L OWER BAD CHOLESTEROL AND FAT S (SUCH AS LDL, TRIGLYCERIDES ) AND RAISE GOOD CHOLESTEROL MNBU3207778 001 (HDL) IN THE BLOOD. EZETIMIBE WORKS BY REDUCING THE AMOUN T OF CHOLESTEROL YOUR BODY AB SORBS FROM YOUR DIET. SIMVAST ATIN BELONGS TO A GROUP OF D RUGS KNOWN AS "STATINS." IT W ORKS BY REDUCING THE AMOUNT O F CHOLESTEROL MADE BY THE LIV MNBU3207778 001 ER. PIMECROLIMUS CREAM 1% 3 0GM NDC CODE:68462060935 FDA PRODUCT CODE NO.: 61 S C J 0 4 H. T. S NO.: 3004.90.92.45 ANDA NO.: 211769 THERAPEUTI CE USE: - AS SECOUND-LINE THE RAPY FOR THE SHORT-TERM AND NON-CONTINUOS CHRONIC TRERTME MNBU3207778 001 NT OF MILD TO MODERATE ATOPIC DERMATITIS IN NONIMMUNOCOMP ROMISED ADULT AND CHILDREN 2 YEARS OF AGE PIMECROLIMUS CREAM 1% 100GM NDC CODE:68462 060994 FDA PRODUCT CODE NO.: 61 S C J 04 H. T. S NO.: 30 04.90.92.45 ANDA NO.: 211769 MNBU3207778 001 THERAPEUTICE USE: - AS SECOU ND-LINE THERAPY FOR THE SHORT -TERM AND NON-CONTINUOS CHRON IC TRERTMENT OF MILD TO MODE RATE ATOPIC DERMATITIS IN NO NIMMUNOCOMPROMISED ADULT AND CHILDREN 2 YEARS OF AGE TA CROLIMUS OINT 0.1% 100GM NDC MNBU3207778 001 CODE:68462053494 FDA PRODUCT CODE NO.: 64 T C J 08 H. T. S NO.: 3004.49.00.50 ANDA NO .: 210393 THERAPEUTICE USE: - TACROLIMUS IS A TOPICAL IMM UNOSUPPRESSIVE OINTMENT USED FOR THE TREATMENT OF MODERAT E-TO-SEVERE ATOPIC DERMATITIS MNBU3207778 001 (ECZEMA). TACROLIMUS OINT 0.1% 100GM NDC CODE:68462053 494 FDA PRODUCT CODE NO.: 64 T C J 08 H. T. S NO.: 3004. 49.00.50 ANDA NO.: 210393 TH ERAPEUTICE USE: - TACROLIMUS IS A TOPICAL IMMUNOSUPPRESSIV E OINTMENT USED FOR THE TREA MNBU3207778 001 TMENT OF MODERATE-TO-SEVERE ATOPIC DERMATITIS (ECZEMA). COMMERCIAL & CUSTOM INVOICE NO. F22387000878 DT. 30.08.20 22 F22387000898 DT. 31.08.202 2 F22387000901 DT. 31.08.2022 F22387000904 DT. 31.08.2022 S/BILL NO: 4012571 DT:30/08/2 MNBU3207778 001 022 S/BILL NO: 4012785 DT:03 /09/2022 S/BILL NO: 4012791 DT:03/09/2022 S/BILL NO: 4012 790 DT:03/09/2022 NET WT. 2,6 67.06 KGS 04 DATA LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK PHAR MACEUTICALS INC 750, CORPORAT MNBU3207778 001 E DRIVE, NEW JERSEY MAHWAH - 07430 USA

42 PALLETS 2696 CART ONS PHARMACEUTICALS AS UNDER OMEPRAZOLE DR CAP 20MG 100 NDC CODE:68462039601 FDA PRO DUCT CODE NO.: 62KCF10 H. T. S NO.: 3004.90.9160 ANDA NO .: 91672 THERAPEUTICE USE: - MNBU3937523 001 TREATMENT OF TREAT GASTROESO PHAGEAL REFLUX DISEASE VER APAMIL HCL ER TAB 240MG 100 N DC CODE:68462026001 FDA PRODU CT CODE NO.: 62 O C B 13 H. T. S NO.: 3004.90.92.20 ANDA NO.:-78-906 THERAPEUTICE US E:-ANGINA LEVOCETIRIZINE DI MNBU3937523 001 HY TAB 5MG 90 NDC CODE:684620 34690 FDA PRODUCT CODE NO.: 61 X C A 51 H. T. S NO.: 300 4.90.91.80 ANDA NO.:90385 TH ERAPEUTICE USE: TREATMENT OF CHRONIC IDIOPATHIC URTICARIA OXCARBAZEPINE TAB 300MG 100 NDC CODE:68462013801 FDA PR MNBU3937523 001 ODUCT CODE NO.:-61 M C A 45 H. T. S NO.: 3004.90.92.30 A NDA NO.:-77-802 THERAPEUTICE USE:-ANTI CONVULSANT AGENT VERAPAMIL HCL ER TAB 240MG 50 0 NDC CODE:68462026005 FDA P RODUCT CODE NO.: 62 O C B 13 H. T. S NO.: 3004.90.92.20 MNBU3937523 001 ANDA NO.:-78-906 THERAPEUTICE USE:-ANGINA VERAPAMIL HCL ER TAB 180MG 100 NDC CODE:68 462029301 FDA PRODUCT CODE NO .: 62 O C B 13 H. T. S NO.: 3004.90.92.20 ANDA NO.: 90-7 00 THERAPEUTICE USE: - ANGIN A OMEPRAZOLE DR CAP 40MG 90 MNBU3937523 001 NDC CODE:68462039790 FDA PR ODUCT CODE NO.: 62KCF10 H. T . S NO.: 3004.90.9160 ANDA N O.: 91672 THERAPEUTICE USE: - TREATMENT OF TREAT GASTROES OPHAGEAL REFLUX DISEASE CO MMERCIAL & CUSTOM INVOICE NO. F22352002193 DT. 20.08.2022 MNBU3937523 001 F22352002204 DT. 22.08.2022 S /BILL NO: 3655438 DT 22-AUG-20 22 S/BILL NO: 3655481 DT 22-A UG-2022 NET WT. 10,205.50 KG S 02 DATA LOGGERS SET TEMP ERATURE : +18 DEGREES NOTIF Y PARTY:2 GLENMARK PHARMACEUT ICALS INC 750, CORPORATE DRIV MNBU3937523 001 E, NEW JERSEY MAHWAH - 07430 USA

46 PALLETS 3226 CARTONS P HARMACEUTICALS AS UNDER OME PRAZOLE DR CAP 20MG 90 NDC CO DE:68462039690 FDA PRODUCT CO DE NO.: 62KCF10 H. T. S NO.: 3004.90.9160 ANDA NO.: 9167 2 THERAPEUTICE USE: - TREATM FSCU5718670 001 ENT OF TREAT GASTROESOPHAGEAL REFLUX DISEASE ONDANSETRO N ODT 4MG 30UD NDC CODE:68462 015713 FDA PRODUCT CODE NO,: -61 T C A 26 H. T. S NO.: 30 04.90.92.40 ANDA NO.:-78-152 THERAPEUTICE USE:-ANTI EMETI C OMEPRAZOLE DR CAP 20MG 10 FSCU5718670 001 00 NDC CODE:68462039610 FDA PRODUCT CODE NO.: 62KCF10 H. T. S NO.: 3004.90.9160 ANDA NO.: 91672 THERAPEUTICE USE: - TREATMENT OF TREAT GASTRO ESOPHAGEAL REFLUX DISEASE OXCARBAZEPINE TAB 300MG 100 N DC CODE:68462013801 FDA PRODU FSCU5718670 001 CT CODE NO.:-61 M C A 45 H. T. S NO.: 3004.90.92.30 ANDA NO.:-77-802 THERAPEUTICE USE :-ANTI CONVULSANT AGENT CA RVEDILOL TAB 6.25MG 500 NDC C ODE:68462016305 FDA PRODUCT C ODE NO : 62 O C A 22 H. T. S NO.: 3004.90.92.20 ANDA NO. FSCU5718670 001 :- 78-251 THERAPEUTICE USE:- BETA- ADRENOACEPTOR ANTAGONI ST LEVOCETIRIZINE DIHY TAB 5MG 90 NDC CODE:68462034690 FDA PRODUCT CODE NO.: 61 X C A 51 H. T. S NO.: 3004.90.91 .80 ANDA NO.:90385 THERAPEUT ICE USE: TREATMENT OF CHRONIC FSCU5718670 001 IDIOPATHIC URTICARIA COMM ERCIAL & CUSTOM INVOICE NO. F 22352002183 DT. 20.08.2022 F2 2352002190 DT. 20.08.2022 S/B ILL NO:3623090 DT 20-AUG-2022 S/BILL NO: 3629699 DT 20-AUG- 2022 NET WT: 6,892.58 KGS 02 DATA LOGGERS HUMIDITY:65% FSCU5718670 001 SET TEMPERATURE : +18 DEGREES TEMPERATURE RANGE : +15 DEGR EES TO +25 DEGREES NOTIFY PAR TY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, N EW JERSEY MAHWAH - 07430 USA

36 PALLETS 2310 CARTONS P HARMACEUTICALS AS UNDER HEA THER TAB 0.35MG 84 NDC CODE:6 8462030329 FDA PRODUCT CODE N O.: 65 J C A 24 H. T. S NO.: 3006.60.00.00 ANDA NO.:90-4 54 THERAPEUTICE USE: PREVENT MNBU4157080 001 ION OF PREGNANCY. GABAPENTI N TAB 800MG 500 NDC CODE:6846 2012705 FDA PRODUCT CODE NO : 61 N C A 69 H. T. S NO.: 3 004.90.92.30 ANDA NO.:-77-662 THERAPEUTICE USE:-ANTICONVU LSANT AGENT ROPINIROLE TAB 0.25MG 100 NDC CODE:68462025 MNBU4157080 001 301 FDA PRODUCT CODE NO.:-62 J C A 17 H. T. S NO.: 3004. 90.92.40 ANDA NO.:- 90-135 T HERAPEUTICE USE:-TREATMENT OF PARKINSONISM LEVOCETIRIZI NE DIHY TAB 5MG 90 NDC CODE:6 8462034690 FDA PRODUCT CODE N O.: 61 X C A 51 H. T. S NO.: MNBU4157080 001 3004.90.91.80 ANDA NO.:9038 5 THERAPEUTICE USE: TREATMEN T OF CHRONIC IDIOPATHIC URTIC ARIA FELODIPINE ER TAB 5MG 100 NDC CODE:68462023401 FDA PRODUCT CODE NO.: 62OCB32 H . T. S NO.: 3004.90.92.20 AN DA NO.: 90-365 THERAPEUTICE U MNBU4157080 001 SE: - TREATMENT OF HYPERTENS ION FELODIPINE ER TAB 10MG 100 NDC CODE:68462023501 FDA PRODUCT CODE NO.: 62OCB32 H . T. S NO.: 3004.90.92.20 AN DA NO.: 90-365 THERAPEUTICE U SE: - TREATMENT OF HYPERTENS ION COMMERCIAL & CUSTOM INV MNBU4157080 001 OICE NO. F22352002144 DT. 17. 08.2022 F22352002146 DT. 17.0 8.2022 F22352002147 DT. 17.08 .2022 NET WT. 6,178.72 KGS 02 DATA LOGGERS HUMIDITY:65% SET TEMPERATURE : +18 DEGREES TEMPERATURE RANGE : +15 DEGR EES TO +25 DEGREES NOTIFY PAR MNBU4157080 001 TY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, N EW JERSEY MAHWAH - 07430 USA

43 PALLETS 3350 CART ONS PHARMACEUTICALS AS UNDER MUPIROCIN OINT 2% 22GM NDC CODE:68462018022 FDA PRODUCT CODE NO.: 61 G J J 81 H. T. S NO.: 3004.90.92.45 ANDA N O.: 90-480 THERAPEUTICE USE: MNBU0380162 001 - ANTI-BACTERIAL ONDANSETR ON ODT 4MG 30UD NDC CODE:6846 2015713 FDA PRODUCT CODE NO, :-61 T C A 26 H. T. S NO.: 3 004.90.92.40 ANDA NO.:-78-152 THERAPEUTICE USE:-ANTI EMET IC LEVOCETIRIZINE DIHY TAB 5MG 90 NDC CODE:68462034690 MNBU0380162 001 FDA PRODUCT CODE NO.: 61 X C A 51 H. T. S NO.: 3004.90.91 .80 ANDA NO.:90385 THERAPEUT ICE USE: TREATMENT OF CHRONIC IDIOPATHIC URTICARIA POTA SSIUM CL ER TAB 10MEQ 100 NDC CODE:68462047101 FDA PRODUCT CODE NO.: 65 R C A 14 H. T. MNBU0380162 001 S NO.: 3004.90.9190 ANDA NO .: 203562 THIS MEDICATION IS A MINERAL SUPPLEMENT USED TO TREAT OR PREVENT LOW AMOUNTS OF POTASSIUM IN THE BLOOD.SO ME CONDITIONS THAT CAN LOWER YOUR BODY'S POTASSIUM LEVEL INCLUDE SEVERE PROLONGED DIAR MNBU0380162 001 RHEA AND VOMITING, HORMONE P ROBLEMS SUCH AS HYPERALDOSTER ONISM, OR TREATMENT WITH "WAT ER PILLS"/DIURETICS. ONDAN SETRON TAB 4MG 30 NDC CODE:68 462010530 FDA PRODUCT CODE N O.:-61 T C A 28 H. T. S NO.: 3004.90.92.40 ANDA NO.:- 77- MNBU0380162 001 535 THERAPEUTICE USE:-ANTI E METIC OLMESARTAN MEDOX TAB 40MG 30 NDC CODE:68462043830 FDA PRODUCT CODE NO.: 62CCA6 8 H. T. S NO.: 3004.90.9220 ANDA NO.: 203281 THERAPEUTIC E USE: - TREATMENT OF HYPERT ENSION, ALONE OR WITH OTHER MNBU0380162 001 ANTIHYPERTENSIVE AGENTS, TO L OWER BLOOD PRESSURE OLMESAR TAN MEDOX TAB 40MG 90 NDC COD E:68462043890 FDA PRODUCT COD E NO.: 62 CCA 68 H. T. S NO. : 3004.90.9220 ANDA NO.: 203 281 TREATMENT OF HYPERTENSIO N, ALONE OR WITH OTHER ANTIH MNBU0380162 001 YPERTENSIVE AGENTS, TO LOWER BLOOD PRESSURE COMMERCIAL & CUSTOM INVOICE NO. F22352002 120 DT. 16.08.2022 F223520021 21 DT. 16.08.2022 S/BILL NO: 3547747 DT 17-AUG-2022 S/ BILL NO: 3551621 DT 17-AUG-202 2 NET WT. 7,770.65 02 MNBU0380162 001 DATA LOGGERS HUMIDITY:65% SE T TEMPERATURE : +18 DEGREES T EMPERATURE RANGE : +15 DEGREES TO +25 DEGREES NOTIFY PARTY: 2 GLENMARK PHARMACEUTICALS IN C 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA

FREIGHT PREPAID 3 PACKAGES HT CLEANER ACCESSORIES 213.00 KG 2.33 M3 2 PACKAGES STERILE POD 28.00 KG SEKU6444752 001 0.16 M3 1 PACKAGES ANIOSGEL 246.00 KG 0.88 M3 22 PACKAGES CHRONIC CARTRIDGE 162.00 KG SEKU6444752 001 1.06 M3 1 PACKAGES MINI SIEVE SUPPORT 1.00 KG 0.01 M3 20 PACKAGES STEEL CABLE 860.00 KG SEKU6444752 001 1.14 M3 1 PACKAGES MAN ALU 521.00 KG 12.40 M3 60 PACKAGES CHIN GUARD 50.00 KG SEKU6444752 001 0.04 M3 30 PACKAGES HEMODIALYZER 252.00 KG 1.54 M3 618 PACKAGES DIALYSIS BAGS (570 PACKAGES) 6,444.90 KG SEKU6444752 001 20.40 M3 3 PACKAGES MEDICAL EQUIPMENT 27.00 KG 0.48 M3 1 PACKAGES LITHIUM BATTERIES 1.00 KG SEKU6444752 001 0.01 M3 2 PACKAGES MEDICAL PRODUCTS 4.00 KG 0.04 M3 1 PACKAGES CABINET 258.00 KG SEKU6444752 001 5.05 M3 1 PACKAGES GOLD SURGICAL 7.00 KG 0.03 M3 1 PACKAGES PERSONAL EFFECTS 130.00 KG SEKU6444752 001 1.44 M3 2 PACKAGES CONCRETE MIXERS 130.00 KG 1.44 M3 1 PACKAGES REFRIGERATED CABINET 122.00 KG SEKU6444752 001 1.20 M3 4 PACKAGES HIGH PRESSURE WASHER 208.00 KG 1.91 M3 2 PACKAGES HP CLEANER ACCESSORIES 182.00 KG SEKU6444752 001 2.11 M3 PSN: DISINFECTANT, LIQUID, CORROSIVE, N.O.S. UN NUMBER: 1903 - IMDG CLASS: 8 - PG: III CHEMICAL NAME: LACTIC ACID, GLYCOLIC ACID PSN: ETHANOL SOLUTION UN NUMBER: 1170 - IMDG CLASS: 3 - PG: II - FLASHPOINT: 22 C